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ABSTRACT 
 
 
Hoxa1 and Hoxa2 are master regulators in the development of hindbrain, ear, palate, bone 
and cardiovascular development. There is little information on the epigenetic regulator(s) of Hoxa2 
gene during development. In this thesis, I have determined whether regulation of Hoxa2 is 
occurring via a specific epigenetic pathway, and investigated the role of DNA methylation, 
noncoding RNAs (microRNAs and long non-coding RNAs) and histone protein modification.   
First, analysis of Hoxa2 promoter revealed the presence of three CpG islands near the 
Hoxa2 5′ regulatory region.  Using methylation specific PCR (MSP) and the bisulfite specific PCR 
(BSP) primers followed by DNA sequencing, I found the methylation status of CpG island 1 
remains unmethylated and that the DNA methylation status of the Hoxa2 promoter does not change 
with the spatio-temporal expression of Hoxa2 during palatogenesis. These findings indicate that 
DNA methylation does not appear to play a key role in the epigenetic regulation of Hoxa2 gene 
during palatogenesis. 
My second objective was to determine whether specific miRNAs impact Hoxa2 expression. 
I performed in-silico analysis and identified six miRNAs that have the potential to bind 3'UTR of 
the Hoxa2 gene. The miR-669b and miR-376c were capable of down regulating Hoxa2 expression 
at both transcriptional and translational level. Two direct miR-669b binding sites were identified 
on mouse Hoxa2 3'UTR. Luciferase assays showed that the two miR-669b binding sites appear to 
work independently of each other and that mutations within the seed sequences abrogated 
luciferase activity.  I further analyzed the degree of sequence similarity of both miR-669b binding 
sites and found that binding site 1 is evolutionarily conserved between the five species (human, 
mouse, rat, chimpanzee and dog). In the developing mouse palate (from E13 to E15), miR-669b 
showed a complementary expression to that of Hoxa2. No direct interaction between miR-376c 
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and Hoxa2 3'UTR was identified. Thus my results indicated that the miR-669b likely plays a role 
in regulating Hoxa2 expression during palate development 
My third objective was to characterize a new lncRNA (mHotairm1) that I identified 
between mouse Hoxa1 and Hoxa2 intergenic region. I demonstrated that mHotairm1 is involved 
in recruiting MLL1/WDR5 to Hoxa1 and Hoxa2 genes and regulating their expressions.  In situ 
hybridization histochemistry of E14 developing palate showed expression of mHotairm1 in medial 
edge epithelia (MEE), indicating mHotairm1 may play a role in the palatal fusion. Downregulation 
of mHotairm1 in NIH 3T3 cells resulted in significantly decreased expression of Hoxa1 and Hoxa2 
expression, whereas treatment with ATRA resulted in increased expression of mHotairm1, Hoxa1 
and Hoxa2. Using capture hybridization analysis of RNA targets (CHART) and pull down assays, 
I found that the TrxG protein WDR5 is associated with mHotairm1, and knockdown of mHotairm1 
resulted in reduced occupancy of gene activation mark H3K4me3 and increased occupancy of gene 
suppression mark H3K27me3, suggesting MLL1/WDR5 complex may be playing a role in the 
regulation of Hoxa1 and Hoxa2 gene expression through mHotairm1.  
Lastly, I found that WDR5 was sumoylated. This modification appears to be important for 
its interaction with mHotairm1 and MLL and for its cellular distribution, primarily to the nuclei. 
Following ATRA treatment, although the total WDR5 protein remained unchanged, an increase in 
sumoylated WDR5 was observed together with increased expression of mHotairm1, Hoxa1 and 
Hoxa2 gene. These findings reveal that sumoylated WDR5 with its interaction with mHotairm1 
plays an important role in H3K4me3 and H3K27me3 occupancy and influencing the epigenetic 
regulation of Hoxa1 and Hoxa2 genes. 
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CHAPTER 1 
1. Summary 
Hox genes are evolutionarily conserved homeodomain-containing transcription factors 
that specify cell identity in early development (McGinnis and Krumlauf, 1992; Banerjee-Basu 
and Baxevanis, 2001; Mallo and Alonso, 2013). In addition to their role in embryo 
development, Hox genes are also involved in different types of human diseases and cancer 
including leukemia (Alharbi et al., 2013) and breast cancer (Bhatlekar et al., 2014). In 
vertebrates, 39 Hox genes are organized into four Hox gene clusters (HoxA-D) and they encode 
Hox proteins that regulate specific morphological diversity along the anterior-posterior (AP) axis 
(Akin and Nazarali, 2005; De Kumar and Krumlauf, 2016.) Hoxa1 and Hoxa2 are the first Hox 
genes to be expressed during embryonic development (Murphy and Hill, 1991). Hoxa1 plays a 
role in hindbrain, inner ear and cardiovascular development (Makki and Capecchi, 2011; Qiao et 
al., 2015; Makki and Capecchi, 2012) and Hoxa2 is important for the development of inner ear, 
palate, hindbrain and bone (Minoux et al., 2013; Smith et al., 2009; Gavalas et al., 1997; 
Kitazawa et al., 2015). The proper expression of Hox genes is important in many biological 
procesesses, making regulation of Hox genes critical to living organisms. There is little 
information available on the mechanism(s) involved in the regulation of Hoxa2 gene expression. 
Hence, my research has involved in an investigation of the epigenetic regulation Hoxa2 gene 
expression during mouse palate development and in the NIH 3T3 cell line.  
Epigenetics refers to the heritable changes in gene expression without any changes in the 
DNA sequence. Regulation of gene expression can occur via several mechanisms that include 
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noncoding RNAs (e.g. microRNAs and long non-coding RNAs), biochemical modifications of 
DNA such DNA methylation or via histone protein modifications (Goldberg et al., 2007).  
DNA methylation which can occur on cytosine bases in CpG rich sequences and 
especially at the promoter regions can lead to gene silencing through the inhibition of 
transcription factor binding and the changing of chromatin structure into a repressive state 
(Domcke et al., 2015). Many studies have shown that proper DNA methylation is essential in 
embryonic development (Bird, 2002; Santos et al., 2005; Bartolomei and Ferguson-Smith, 2011; 
Lomvardas and Maniatis, 2016). Research in our laboratory has identified an important role of 
Hoxa2 in mouse palate development (Smith et al., 2009; Smith et al., 2013). In my study, I chose 
to investigate whether DNA methylation played a role in regulating the expression of Hoxa2 in 
early mouse palate development. Three CpG islands were found to be situated in the Hoxa2 
promoter region and their methylation status did not change during the temporal expression of 
Hoxa2 at any stages of palatal development. Further experiments were conducted to investigate 
the role of miRNA and long non-coding RNA in the regulation of Hoxa2 expression. 
microRNAs (miRNA) are ~22 nucleotide RNAs that can guide a RNA silencing pathway 
to regulate gene expression through their effect on messenger RNA (mRNA) levels (Usmani et 
al., 2016). The mature miRNAs interact with target mRNAs mostly within the 3' untranslated 
region (3' UTR) based on sequence complementarity between the miRNA and its target mRNA 
(Ha and Kim, 2014). Several Hox genes are regulated by miRNAs (Garaulet and Lai, 2015; Liu 
et al., 2013; Tang et al., 2014; Han et al., 2016); however, only one miRNA, miR-3960, has been 
identified to regulate Hoxa2 gene expression in primary mouse osteoblasts (Hu et al., 2011). 
miR-669b has previously been found to be able to bind to the 3′UTR of insulin-like growth 
factor1 receptor (IGF1R) and down regulate its expression (Liang et al., 2011). I performed in 
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silico analysis and predicted six miRNAs that can potentially bind Hoxa2 3'UTR, namely: miR-
376c, miR-669b, miR-431, miR-19a, miR-298 and miR-878-3p. Experimentally, I found miR-
669b and miR-376c can both down regulate Hoxa2 gene expression at the transcriptional and 
translational level. Moreover, two binding sites for miR-669b on Hoxa2 3′ UTR were identified 
using a luciferase reporter assay, while no direct binding of miR-376c was found on the Hoxa2 3′ 
UTR. 
Hox genes are also regulated by epigenetic activators of the Trithorax group (TrxG) and 
epigenetic repressors of the Polycomb group (PcG) (Beck et al., 2010). The activation of Hox 
genes by TrxG can involve trimethylation of Histone 3 lysine 4 (H3K4me3) by mixed lineage 
leukemia 1 (MLL1)/ WD repeat domain 5 (WDR5) complex (Beck et al., 2010). Long 
noncoding RNAs (lncRNAs) have emerged with important regulatory roles in gene expression. 
LncRNAs HOTTIP and Mistral are both transcribed from Hox gene clusters and can introduce 
MLL1/WDR5 to nearby Hox gene promoters to induce H3K4me3 and activate gene expression 
(Wang et al., 2011, Bertani et al., 2011). HOTAIRM1 is an antisense intergenic transcript 
transcribed between human HOXA1 and HOXA2 (Zhang et al., 2009). It can activate HOXA 
genes that are located at the 3' end of the HOXA cluster (3' HOXA genes) and its presence is 
necessary during myeloid differentiation. However, HOTAIRM1 transcripts have not been 
reported in other species and little is known of how 3' HOXA genes are regulated by HOTAIRM1. 
In my study, I have identified a new transcript from the mouse HoxA cluster that shares sequence 
similarity with human HOTAIRM1, which we classify as the mouse Hotairm1 (mHotairm1). I 
further demonstrated that mHotairm1 can activate the expression of Hoxa1 and Hoxa2 by 
introducing MLL1/WDR5 to their promoters which in turn enhances H3K4me3 occupancy. 
Findings also indicate that WDR5 sumoylation could be important for its interaction with 
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mHotairm1. Taken together, my results provide additional evidence that connects lncRNAs to 
recruitment of epigenetic activators to promoters of target genes and for the first time provides a 
mechanism of the regulation of 3' Hoxa genes via mHotairm1. 
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CHAPTER 2 
2. Literature Review 
In the following literature review, I will introduce Hox genes and the roles of Hoxa1 and 
Hoxa2 in development and in disease. I will also provide an overview of epigenetics and its 
impact on gene expression and regulation. Epigenetic mechanisms including DNA methylation, 
common histone post-translational modifications, miRNAs and lncRNAs, as well as the crosstalk 
between these will be discussed. In my PhD thesis work, sumoylation of a WDR5 protein 
appeared to be important in the histone methylation mediated Hox gene expression that is 
directed by lncRNA, hence sumoylation is also included in this literature review. 
 
2.1 Hox genes	  
Homeobox genes were first discovered in the fruit fly Drosophila (Bridges and Morgan, 
1923), and are evolutionarily conserved transcription factors that regulate specific morphological 
patterns and cellular diversity along the anterior-posterior (AP) axis (Lewis, 1978; Pearson et al., 
2005; Seifert et al., 2015). Alterations in homeobox gene expression can result in the 
transformation of one body structure to resemble a homologous body structure in form and shape 
(Arlotta and Hobert, 2015; Tijchon et al., 2015). This phenomenon was first observed in 
Drosophila and was termed ‘‘homeotic transformation’’ (Lewis, 1978; Hueber and Lohmann, 
2008).  
In Drosophila, a single homeotic complex (HOM-C) located on chromosome 3 consists 
of two separate clusters, Bithorax complex (BX-C) and Antennapedia complex (ANT-C) (Fig. 
2.1) (Lewis, 1978). The antennapedia class of homeobox genes are generally referred to as 
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“Hox” genes. Hox genes are highly conserved and clustered into multigene loci (Lewis, 1978; 
Ruddle et al., 1994; Santini et al., 2003; Yu et al., 2012; De Kumar and Krumlauf, 2016). In 
vertebrates, Hox genes have duplicated and evolved to generate multiple sets of paralogous genes 
which are organized in four separate chromosomal clusters (McGinnis and Krumlauf, 1992; 
Bailey et al., 1997; Akin and Nazarali, 2005; Duboule, 2007; De Kumar and Krumlauf, 2016).  
They function to govern embryonic morphogenesis as well as cell differentiation (Pineault and 
Wellik, 2014; Seifert et al., 2015). In the chromosomal cluster, all Hox genes are transcribed in 
the same 5' to 3' direction, and the more 3' a Hox gene is located on the chromosome, the more 
anteriorly it is expressed in the developing embryo (Gaunt et al., 1988; Favier and Dollé, 1997; 
Lappin et al., 2006; Mallo and Alonso, 2013).  
 
 
Figure 2.1. Schematic representation of Drosophila and murine Hox genes on chromosomal 
clusters. Hox genes are illustrated by black boxes. There are two clusters in the Drosophila 
HOM-C: Antennapedia (ANT-C) and Bithorax (BX-C). ANT-C is composed of: lab = labial, pb 
= proboscipedia, Dfd = Deformed, Scr = Sex Combs Reduced, and Antp = Antennapedia; BX-C 
is composed of: Ubx = Ultrabithorax, abd-A = abdominal A, Abd-B = Abdominal-B. There are 
39 murine Hox genes present on four separate (Hox a, Hox b, Hox c, Hox d) chromosomal 
clusters. This figure is taken from Akin and Nazarali (2005) with permission. 
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Hox genes are very important as they regulate numerous pathways in embryonic 
development and other biological processes (Fig. 2.2). All homeobox genes contain a 
“homeodomain” which is defined as a class of protein domain that contain a conserved 60 amino 
acid region encoded by 180 bp homeobox sequence (Scott et al., 1989; Nazarali et al., 1992; 
Banerjee-Basu and Baxevanis, 2001; Anderson et al., 2012; Bürglin and Affolter, 2016). Hox 
proteins can enhance or suppress the expression of downstream genes through the affinity 
between its homeodomain and target DNA sequences (McGinnis and Krumlauf, 1992; Gehring, 
1993; Kumar and Nazarali, 2001; Shah and Sukumar, 2010). The core structure of this domain 
consists of four alpha helices (Kissinger et al., 1990; Gehring et al., 1994; Akin and Nazarali, 
2005; Bürglin and Affolter, 2016). The coordinate activity between the N-terminal region of the 
first helix and cofactors within a transcriptional complex is required for Hox proteins to control 
specific gene expression and affect cell division and cellular functions (Mann and Affolter, 1998; 
Akin and Nazarali, 2005; Mann et al., 2009). The second and third helix form an evolutionarily 
conserved helix-turn-helix motif that is responsible for the recognition and binding of target 
DNA sequences (Gehring et al., 1994; Akin and Nazarali, 2005; Bürglin and Affolter, 2016). 
The hydrophilic face of helix 3 contacts the target DNA sequence in the major groove (Kissinger 
et al., 1990; Banerjee-Basu and Baxevanis, 2001; Svingen and Tonissen, 2006; Bürglin and 
Affolter, 2016). In vitro analysis determined an element of approximately 10-12 bases with a 
core sequence of TAAT to be a core binding site for Hox proteins (Kissinger et al., 1990; Kumar 
and Nazarali, 2001; Akin and Nazarali, 2005; Breitinger et al., 2012; Beh et al., 2016). 
In mice, there are four separate chromosomal clusters (Hox A, B, C, and D) composed of 
39 genes in total (Fig. 2.1). These Hox genes are arranged in a 3´ to 5´ order in each cluster with 
synteny to the Drosophila HOM-C (Fig. 2.1), with sequence similarity between genes on 
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different clusters, as well as their positions on the chromosomes (Akin and Nazarali, 2005; Mallo 
and Alonso, 2013). 
 
 
Figure 2.2. Examples of biological pathways that are regulated by Hox genes through their 
regulation of downstream targets. Several Hox-targeted genes that are important in 
development and cellular processes are shown. This figure is modified from Svingen and 
Tonissen (2006). 
 
2.1.1 Hoxa1 gene in embryonic development 
In embryonic development, Hoxa1 is one of the first Hox genes to be activated (Murphy 
and Hill, 1991). In mouse, starting from embryo day 7.5 (E7.5), Hoxa1 expression can be 
detected in the primitive streak, in newly formed mesoderm, and overlying neuroectoderm (Fig. 
2.3; Murphy and Hill, 1991). Hoxa1 expression extends anteriorly, and between E7.75 and E8.25 
its expression reaches the most anterior border in the presumptive hindbrain where its expression 
lasts for aprroximately 12 h (Murphy and Hill, 1991). By E8.5, Hoxa1 has retreated from this 
region and remains in more posterior regions (Murphy and Hill, 1991; Makki and Capecchi, 
2010). This expression pattern suggested a role of Hoxa1 in hindbrain development. In fact, 
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Hoxa1 knockout mice exhibit abnormal hindbrain development (Studer et al.; 1998; Helmbacher 
et al., 1998; Tischfield et al., 2005) and die shortly after birth from breathing defects (Chisaka et 
al., 1992). Hoxa1 null embryonic stem (ES) cells lack the ability to differentiate along a neural 
cell lineage following retinoic acid induction and express lower levels of neuronal differentiation 
markers compared to normal wild-type ES cells (Martinez-Ceballos and Gudas, 2008). Hoxa1 
acts upstream of four genes involved in hindbrain and neuron development: hepatocyte nuclear 
factor 1-beta (Hnf1b), forkhead box D3 (Foxd3), Zic family member 1 (Zic1) and LIM 
homeobox 5 (Lhx5) (Makki and Capecchi, 2011). Hoxa1 has also been proposed as a candidate 
gene for autism spectrum disorder (ASD), a common neurodevelopmental condition in children 
and adolescents (Song et al., 2011; Raznahan et al., 2012). A specific HOXA1-A218G mutation 
has received particular attention in ASD since the A218G genotype has the capacity to modify 
the rate of cerebellar growth (Raznahan et al., 2012). 
 
Figure 2.3. Schematic diagram of primitive streak and germ layers in mouse embryo. ( 
https://o.quizlet.com/9elYyZW.TOVAN103uQlAqw_m.png) 
	   10	  
In addition to the hindbrain, Hoxa1 also affects inner ear development (Makki and 
Capecchi, 2010). Although researchers previously believed that Hoxa1 expression was absent in 
mouse inner ear and the effects of loss of Hoxa1 on inner ear development was indirect (Murphy 
and Hill, 1991), Makki and Capecchi (2010) reported significant Hoxa1 cell lineage expression 
in the developing mouse otic epithelium, which raised the possibility that Hoxa1 may have a 
direct role in inner ear patterning.  Several genes regulating ear development have also been 
identified as downstream targets of Hoxa1. In Hoxa1 null mice, paired box 8 (Pax8) and 
fibroblast growth factor receptor 3 (Fgfr3), known to be important in ear development, were 
identified as downstream targets of Hoxa1 (Makki and Capecchi, 2011). A mutation in the 
Hoxa1 coding sequence in pigs resulting in a truncated protein lacking the homeodomain also 
induced malformations of both the outer and middle ears. At the genetic level, this mutation of 
Hoxa1 affected the expression of fibroblast growth factor 1 (FGF1) and FGFR3 in the FGF 
signaling pathway, a pathway that is crucial in ear pinna development (Qiao et al., 2015).  
Researchers have also demonstrated a previously unrecognized role of HOXA1 in 
cardiovascular development in humans (Tischfield et al., 2005). This finding lends credence to 
Makki and Capecchi’s findings that show in mice all cardiac neural crest cells in the outflow 
tract are derived from Hoxa1-expressing cells (Makki and Capecchi, 2011). Further research 
demonstrated that Hoxa1 knockout mice exhibit severe cardiovascular, cerebrovascular and 
glandular defects (Makki and Capecchi, 2012). Hoxa1 expression in cardiac progenitor cells 
(Bertrand et al., 2011) is known to form a gene regulatory network with Hoxb1 in the formation 
of the cardiac outflow tract (Roux et al., 2015). At the molecular level, Hoxa1 regulates the 
expression of Hnf1b, Foxd3 and Zic1 that are necessary for neural crest specification (Makki and 
Capecchi, 2011; Makki and Capecchi, 2012). In humans, homozygous truncation mutations in 
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HOXA1 can lead to Bosley–Salih–Alorainy syndrome (BSAS) or Athabascan brainstem 
dysgenesis syndrome (ABDS), from which patients can exhibit facial weakness, hypoventilation, 
swallowing dysfunction, deafness and heart defects (Bosley et al., 2007; Holve et al., 2003; Jin 
and Sukumar, 2016).  
 
2.1.2 Hoxa2 gene in embryonic development 
Hoxa2 is a member of the Hox gene family that shares a 60 amino acid homeodomain 
and encodes a 41-kDa protein (Nazarali et al., 1992; Tan et al., 1992; Smith et al., 2009). The 
Hoxa2 protein binds to downstream genes to regulate their expression in a spatio-temporal 
manner (Akin and Nazarali, 2005). Hoxa2 gene acts as the selector gene for second branchial 
arch patterning (Gendron-Maguire et al., 1993; Minoux et al., 2013; Cox et al., 2014) and plays 
an essential role in early embryo development.  
Hoxa2 is important for the development of skeletal structures derived from the second 
pharyngeal arch (PA) (Fig. 2.4A) and it determines the areas of skeletogenesis from the second 
PA mesenchyme by an inhibitory mechanism (Kanzler et al., 1998). In Hoxa2 knockout mice, 
the structures in the second PA are arranged as a mirror image of the first PA (Fig. 2.4A), 
indicating Hoxa2 may prevent the formation of the first PA (Gendron-Maguire et al., 1993). 
Tavella and Bobola (2009) have shown that the over expression of Hoxa2 in mice can cause 
failure of bones to form in the cranial base. During chondrogenesis, overexpression of Hoxa2 in 
cells entering chondrogenesis can impair cartilage development and lead to embryonic delay of 
ossification followed by a postnatal proportionate short stature with reduction in the length of the 
trunk and limbs (Massip et al., 2007; Deprez et al., 2012). At the molecular level, the persistent 
expression of Hoxa2 downregulates expression of genes controlling cell differentiation in 
	   12	  
chondrogenesis, namely bone morphogenetic protein 7 (Bmp7), msh homeobox 1 (Msx1), paired 
box 9 (Pax9), sex determining region Y- box 6 (Sox6), Sox9 and Wnt family member 5a (Wnt5a) 
(Deprez et al., 2013).  Ectopic expression of Hoxa2 in the Hox-negative cranial neural crest cells 
(CNCCs) in mice resulted in skeletal defects including absent or reduced bones in the skull vault 
and maxillary structures (Kitazawa et al., 2015).  
Hoxa2 also plays a role in ear development where a loss of Hoxa2 function in mice can 
cause an abnormal appearance of the external ear, a condition that is known as microtia (Kanzler 
et al., 1998; Santagati et al., 2005). Several bones in the middle ear are affected in Hoxa2-/- mice, 
including stapes, the styloid bone and the lesser horn of the hyoid bone (Fig. 2.4B; Kanzler et al., 
1998; Minoux and Rijli, 2010). In the mouse the whole auricle is derived from the Hoxa2-
expressing second PA neural crest-derived mesenchyme and Hoxa2 spatially organises cell 
proliferation during external ear development (Minoux et al., 2013). Further genetic analyses 
showed that Hoxa2 regulates the expression of bone morphogenetic protein 4 (Bmp4), bone 
morphogenetic protein 5 (Bmp5), twisted gastrulation (Tsg) (Minoux et al., 2013; Cox et al., 
2014) and H6 family homeobox 1 (Hmx1) (Rosin et al., 2016) in the developing pinna. In human 
studies, several mutations of HOXA2 coding region have been related to microtia (Alasti et al., 
2008; Monks et al., 2010). In some cases, HOXA2 haploinsufficiency (with only one functional 
copy of HOXA2 gene and the other copy inactivated by mutation) is also known to cause 
microtia and hearing loss (Brown et al., 2013; Jin and Sukumar, 2016).  
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Figure 2.4. Schematic diagram of mouse pharyngeal arches (PA) and developing ear. A. 
Schematic of E10.5 mouse embryo was shown with specific Hox code in each PA (a). 
Inactivation of Hoxa genes in NCCs resulted in a Hox-free ground pattern in all four PAs (b). B. 
Schematic diagram of the effect of Hoxa2 on PA2 derived lower jaw and middle ear structures. 
D – dentary bone; G – gonial bone; G* – modified gonial bone; I and I2 – incus and its 
duplicated counterpart; LH – lesser horns of the hyoid bone; M and M2 – malleus and its 
duplicated counterpart; Mc and Mc2 – Meckel's cartilage and its duplicated counterpart; SP – 
styloid process; S – stapes; T and T2 – tympanic bone and its duplicated counterpart. Figure 
taked from Minoux and Rijli (2010) with permission. 
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A previous study from our laboratory has shown that Hoxa2 plays a direct role in murine 
palate development (Smith et al., 2009). In mice at embryonic day 11.5 (E11.5), the CNCC-
derived cells bud out of the maxillary prominences to form two downward projecting structures 
of the palatal shelves. These shelves then undergo significant growth and grow vertically down 
the sides of the tongue until E13.5. At this point the two shelves begin to ascend and grow 
horizontally above the tongue. At E14.5, the palatal shelves contact one another and fuse 
completely at E15.5 (Ferguson, 1988) (Fig. 2.5). In vivo Hoxa2 protein is expressed in both 
epithelial and mesenchymal cells of the developing murine secondary palate (Nazarali et al., 
2000). Our laboratory has further demonstrated a spatial and temporal expression of Hoxa2 
mRNA and protein within the mouse palate from E12.5 to E15.5 (Smith et al., 2009). During 
development, palatal shelves emerge, elevate, and then fuse. The Hoxa2 expression pattern 
changes during this period as well, being highly expressed at the beginning of palatal 
development, peaking at E13.5 and declining significantly after E14.5 (Smith et al., 2009) (Fig. 
2.5). Increased cell proliferation and decreased fusion rates were also observed in Hoxa2 null 
mice. Several genes involved in palate development, including Msx1, Bmp4, Barx1 and Ptx1, 
have been identified as downstream targets of Hoxa2 within the palate (Smith et al., 2009).   
During nervous system development, Hoxa2 expression affects development of hindbrain 
and cerebellum through its impact on rhombomeres (Gavalas et al., 1997). In the vertebrate 
central nervous system (CNS), oligodendrocytes form myelin sheath. Our laboratory has shown 
that Hoxa2 is expressed throughout oligodendrogenesis (Nicolay et al., 2004). In a mouse model 
of Hoxa2 loss-of-function, early stages of oligodendrogenesis does not appear to be altered in the 
spinal cord (Nicolay et al., 2004), although over expression of Hoxa2 inhibits 
oligodendrogenesis throughout the brain (Miguez et al., 2012). In addition, we have shown that 
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overexpression of Hoxa2 in CG4 oligodendroglial cells increased cell proliferation but delayed 
CG4 oligodendroglial cell differentiation (Wang et al., 2011).  
As summarized above, Hoxa1 and Hoxa2 genes control many important embryonic 
developmental processes, hence it would be of great value to investigate how expression of 
Hoxa1 and Hoxa2 are regulated, especially at the epigenetic level. 
 
 
Figure 2.5. Mouse palate development and Hoxa2 expression. The developing secondary 
palate first extends vertically down the sides of the tongue from E11.5-E12.5 (A and B). This is 
followed by the two palatal shelves ascending horizontally above the tongue at E13.5 (C) and 
extending towards each other at E14.5 (D). The red dots in the figure indicate the expression of 
Hoxa2 at different stages of mouse palate development. The density of the dots represents the 
relative expression of Hoxa2. Figure taken from W. Zhang’s M.Sc., Thesis 2003.  
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2.1.3 Hox gene activation by all-trans retinoic acid (ATRA) 
All-trans retinoic acid (ATRA) is derived from vitamin A. It can activate the early 
expression of 3' Hox paralogs and is important in embryo development (Daftary and Taylor, 
2006; Cunningham and Duester, 2015). ATRA can activate gene expression via its cognate 
receptors, including retinoic acid receptors (RARs) and retinoid X receptors (RXRs). RAR and 
RXR can form a heterodimer complex and bind to target gene at a retinoic acid response element 
(RARE) located in enhancer regions (Cunningham and Duester, 2015). Without activation of RA 
binding, unliganded RAR-RAX heterodimer bind to RARE sequences to maintain repressed 
transcription. The unliganded RAR-RAX heterodimer can also recruit co-repressors to further 
help maintain repressed transcription. Upon the binding of ATRA to RAR-RXR heterodimer, a 
conformational change is induced in the heterodimer which leads to the recruitment of gene co-
activators and further induces gene expression (Daftary and Taylor, 2006; Cunningham and 
Duester, 2015). RARE sequences are found in many Hox genes and ATRA induces sequential 
activation of Hox genes that correlates with their positions on the chromosomal cluster (Kashyap 
et al., 2011; Cunningham and Duester, 2015). Following ATRA exposure, epigenomic 
reorganization of the Hox cluster occurs quickly (Kashyap et al., 2011). The 3’-Hoxa1 RARE is 
essential for ATRA mediated activation of Hoxa and Hoxb clusters (Kashyap et al., 2011). 
Important roles of ATRA have been reported in development including central nervous system 
development (Daftary and Taylor, 2006), limb development and organ development 
(Cunningham and Duester, 2015). 
 
 
 
	   17	  
2.2 Epigenetics 
Epigenetics refers to the heritable changes in gene expression without any changes in 
DNA sequences and is a major mechanism that regulates gene expression changes in response to 
gene-environment interactions (Holliday, 2006). At the molecular level, epigenetic pathways 
include regulation by noncoding RNAs and biochemical modifications of the DNA and histone 
proteins, such as methylation, acetylation and phosphorylation (Skinner, 2011; Yao et al., 2016). 
The importance of epigenetic modifications has long been recognized in the areas such as stem 
cell research, cancer (Pogribny, 2010) and developmental biology (Skinner, 2011; Yao et al., 
2016). 
 
2.2.1 DNA methylation 
DNA methylation is one of the most widely studied aspects in epigenetic mechanism. 
Proper DNA methylation is essential for mammalian embryonic development and is involved in 
gene repression, regulation of parental imprinting and X-chromosome inactivation (Bird, 2002; 
Santos et al., 2005; Bartolomei and Ferguson-Smith, 2011; Lomvardas and Maniatis, 2016). It is 
also closely related to diseases like cancer, neurodegenerative diseases, psychiatric disorders and 
cardiovascular diseases, and is a potential therapeutic target in many diseases (Abdelfatah et al., 
2016; Tang et al., 2016; Li et al., 2016; Fries et al., 2016; Napoli et al., 2016; Zhong et al., 2016). 
DNA methylation occurs on cytosine bases throughout the genome but is most relevant when 
present in sequences rich in CpG dinucleotides, which are called CpG islands, often found in 
promoter regions. Methylated DNA contains the covalent addition of a methyl group to cytosine 
residues at CpG dinucleotides. The enzymes that catalyze this reaction are the DNA 
methyltransferases (DNMTs). Mammalian DNMTs are comprised of three regions: (1) an N-
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terminal regulatory region which guides the localization of the enzymes to the nucleus and 
mediates their interactions with other proteins, DNA and chromatin; (2) a central linker region; 
and (3) a C terminal catalytic region which catalyzes the transfer of the methyl group from a 
cofactor molecule S-adenosyl-l-methionine (AdoMet or SAM) to the C5 position of the cytosine 
residue (Fig. 2.6; Jurkowska et al., 2011; Uysal et al., 2015).  
 
Figure 2.6. Schematic diagram of cytosine’s methylation and demethylation processes. 
DNA methylation on 5-cytosine (5mC) is carried out by DNMTs. 5mC can be demethylated by 
the ten-eleven translocation (TET) familly of DNA hydroxylases and converted back to cytosine 
through thymine DNA glycosylase (TDG)/ base excision and repair (BER) mechanism. 5mC can 
also be deaminiated and converted into thymine (T) and further be replaced by unmethylated C 
through BER mechanism. Figure modified from Xu et al., 2014. 
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Table 2.1. List of structures and functions of DNMTs 
DNMTs 
Structure 
Function Reference N-terminal regulatory 
region 
Linker 
region 
C terminal 
catalytic 
region 
DNMT1 Ö Ö Ö 
Copy pre-existing methylation 
patterns from parental strand onto 
newly synthesized daughter strand. 
Bestor, 1992; 
Uysal et al., 2015 
DNMT2  Ö Ö Transfer RNA methylation. Goll et al., 2006;  Jeltsch et al., 2016 
DNMT3a Ö Ö Ö Introduce new DNA methylation 
patterns in mammalian development 
and in germ cells. 
Okano et al., 1999; 
Uysal et al., 2015 DNMT3b Ö Ö Ö 
DNMT3L Ö Ö  Facilitate DNMT3a and DNMT3b in DNA methylation.  
Uysal et al., 2015; 
Basu et al., 2016 
 
 
Table 2.2 List of proteins that bind to methylated DNA 
 
Methyl-DNA 
binding Domain 
Major group 
members 
Binding 
preference Function References 
MBDs 
MeCP2, 
MBD1, MBD2 Single 5mC 
Transcriptional repressors;  
interact with gene co-
repressors 
Du et al., 2015; 
Wood and Zhou, 
2016 
MBD3 5mC, 5hmC, C Transcriptional repressors 
Shimbo et al., 
2013; Du et al., 
2015 
MBD4 Single 5mC DNA damage repair Laget et al., 2014 
The methyl-CpG 
binding zinc-finger 
proteins  
Kaiso Two methyl- CpG Transcriptional repressors Sasai et al., 2010; Bogdanović and 
Veenstra, 2009 ZBTB4, ZBTB38 Single 5mC Transcriptional repressors 
SET and SAR 
family proteins 
UHRF1  
Hemi-
methylated 
DNA 
Associate with DNMT1; 
DNA damage repair; 
recruitment of KDAC 
Unoki et al., 
2004; Berkyurek 
et al., 2014; Yang 
et al., 2013 
UHFR2 5hmC DNA damage repair Liu et al., 2016b; Yang et al., 2013 
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In mammals, five different DNMTs, namely DNMT1, DNMT2, DNMT3a, DNMT3b and 
DNMT3L have been identified and amongst all five DNMTs, the three active DNMTs are 
DNMT1, DNMT3a and DNMT3b (Table 2.1; Uysal et al., 2015). During DNA replication, 
hemimethylated DNA is created with only the parental strand having methylation marks while 
the newly synthesized strand remains unmethylated. DNMT1 preferentially recognizes 
hemimethylated DNA over unmethylated DNA and can copy pre-existing methylation patterns 
onto the new DNA strand to remethylate the daughter strand (Bestor, 1992; Uysal et al., 2015). 
In this way DNA methylation can be preserved during DNA replication. The de novo 
methyltransferases DNMT3a and DNMT3b are mainly responsible for establishing DNA 
methylation patterns in mammalian development and in germ cells by introducing cytosine 
methylation to previously unmethylated CpG sites (Okano et al., 1999). Unlike DNMT1, they do 
not show any significant preference between hemimethylated and unmethylated DNA (Okano et 
al., 1998; Uysal et al., 2015). Besides methylation of CpG sites, DNMT3a can also methylate 
cytosine residues at non-CpG sites but the biological function of these methylation sites remain 
unknown (Arand et al., 2012; Shirane et al., 2013).  DNMT3s are also able to read other 
epigenetic marks, like trimethylation of histone 3 lysine 4 (H3K36me3), to guide DNA 
methylation (Rondelet et al., 2016). In recent years, a function in the DNA demethylation 
pathway has also been identified for DNMT3a and DNMT3b. It has been reported that under low 
SAM concentrations, DNMT3a and DNMT3b can convert 5-methylcytosine (5mC) into T, 
which could further be replaced by an unmodified C by the base excision and repair (BER) 
mechanism (Chen et al., 2013; van der Wijst et al., 2015). DNMT3L does not contain 
methyltransferase active site motifs and thus lack DNA methyltransferase activity but it is also 
present in mammals and is functionally related to DNMT3a and DNMT3b and modulates their 
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catalytic activity (Suetake et al., 2004; Uysal et al., 2015). It can bind to the N terminus of 
Histone 3 to bring about DNA methylation and the recognition of unmethylated H3K4 by 
DNMT3L is important for the methylation function of DNMT3a (Basu et al., 2016; Hu et al., 
2009; Ooi et al., 2007). Due to a lack of an N-terminal regulatory domain, DNMT2 cannot 
catalyze DNA methylation. However, a functional study of DNMT2 showed that it is involved in 
methylation of transfer RNA through its C-terminal catalytic domain (Goll et al., 2006; Jeltsch et 
al., 2016). 
 
 
 
Figure 2.7. Mechanisms of DNA-methylation-mediated gene repression. (a) DNA 
methylation directly inhibit the binding of some transcription factors (TF). (b) Methyl-CpG-
binding proteins (MBPs) can recognize methylated DNA and recruit co-repressor molecules to 
silence transcription. They can also modify surrounding chromatin structure to achieve gene 
silencing.  
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DNA methylation usually occurs at the transcription start site and generally prevents 
transcription in two ways (Fig 2.7). First it can directly inhibit the binding of transcription factors 
or regulators to the DNA sequence (Fig 2.7a). Secondly, it can also indirectly recruit methyl-
CpG binding proteins (MBPs) which bind to and recognize 5-methylcytosines, to change 
chromatin into a repressive state (Fig 2.7b) (Bogdanovic and Veenstra, 2009; Deaton and Bird, 
2011; Moore et al., 2013; Domcke et al., 2015). DNA methylation can also occur within the 
coding region of the gene and was initially believed to inhibit transcriptional elongation (Klose 
and Bird, 2006) although later evidences showed that this methylation was not associated with 
transcriptional repression (Jones, 2012). However, it has been demonstrated that gene body 
methylation is positively correlated with active transcription, and further research has suggested 
that it may play a role in gene splicing (Shukla et al., 2011; Jones, 2012). The function of 
methylation within the coding region however, needs further investigation (Hellman and Chess, 
2007; Jones, 2012; Yang et al., 2014). Based on their functional domains, there are three families 
of proteins that bind to methylated DNA (Table 2.2), namely; (1) Methyl-CpG binding domain 
proteins (MBDs) including MeCP2, MBDs 1-6, SETDB1, SETDB2, BAZ2A and BAZ2B 
(reviewed by Fan and Hutnick, 2005; Moore et al., 2013; Du et al., 2015); (2) the methyl-CpG 
binding zinc-finger proteins of the Kaiso family where so far only three members have been 
described; Kaiso, ZBTB4 and ZBTB38 (Prokhortchouk et al., 2001; Sansom et al., 2007; Moore 
et al., 2013; Du et al., 2015); and finally (3) SET (Suppressor of variegation-enhancer of zeste-
trithorax) and the ring finger-associated (SAR) family composed of UHRF1 and UHFR2 (Pichler 
et al., 2011; Moore et al., 2013; Du et al., 2015).  Due to amino acid changes at critical positions 
in the methyl-CpG binding domain, MBD3 is the only MBD protein that binds to methyl-CpG, 
5-hydroxymethylated DNA (5hmC) as well as unmethylated DNA (Saito and Ishikawa, 2002; 
	   23	  
Yildirim et al., 2011; Shimbo et al., 2013). MBD4 can also act as a DNA repair enzyme (Walsh 
and Xu, 2006; Laget et al., 2014). MeCP2, MBD1 and MBD2 are transcriptional repressors and 
these MBD proteins were found to interact with co-repressors such as histone deacetylases, 
methyltransferases, and chromatin remodeling factors that regulate gene expression by acting on 
histone proteins (Sasai and Defossez, 2009; Du et al., 2015; Wood and Zhou, 2016). Similar to 
MBDs, ZBTB4 and ZBTB38 require only one methylated CpG for binding, while Kaiso requires 
two methyl-CpGs for binding (Sasai et al., 2010; Bogdanović and Veenstra, 2009).  UHRF1 acts 
as gene repressor via recruitment of the KDAC complex to the promoters (Unoki et al., 2004). 
UHRF1 is associated with DNMT1 as it also has a preferential binding affinity for hemi-
methylated DNA and specifically recruits DNMT1 to hemi-methylated sites during DNA 
replication (Bostick et al., 2007; Berkyurek et al., 2014). UHRF1 may also be important in 
histone modification (Sasai and Defossez, 2009; Qin et al., 2015). UHRF2 is a paralog of 
UHRF1 but have structural differences at the SRA domains. Due to this structural difference, 
UHRF2 has higher affinity to 5-hydroxymethylated cytosine (Liu et al., 2016b). UHRF1 and 
UHRF2 are also involved in DNA damage repair (Luo et al., 2013; Yang et al., 2013). 
Researchers also find DNA methylation in actively transcribed genes, thus it may also play a 
positive role in transcription regulation (Weber et al., 2007).  
DNA methylation is especially important in mammalian embryo development. Mutation 
in mouse Dnmt1 gene causes extensive demethylation of the genome and leads to embryonic 
lethality shortly after gastrulation (Li et al., 1992; Kurihara et al., 2008; Arand et al., 2012). 
Dnmt3b-/- mice have multiple developmental defects and embryos die at embryonic day E9.5 
while Dnmt3a-/- mice die shortly after birth (Okano et al., 1999). Loss of Dnmt3a in mouse 
embryonic cardiomyocytes alteres multiple signaling pathway in cardiomyocytes and inhibits 
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function of embryonic cardiomyocytes (Fang et al., 2016). DNMTs are necessary for bovine 
parthenogenetic preimplanatation embryo development as DNMT inhibitors can inhibit this 
process (Zhang et al., 2015). Unlike knockout of DNMTs, single knockout of MBDs in mice 
display only mild changes. This could be because MBDs can compensate each other or the 
silencing of genes by DNA methylation can also occur through different pathways (Sasai and 
Defossez, 2009; Du et al., 2015). MeCP2 is related to neural development as mutation of MeCP2 
can lead to severe neurodevelopmental disorders in females (Amir et al., 1999; Yang et al., 
2016). Similar to DNMT1 mutants, UHRF1 knockout mice die during early embryogenesis 
(Sharif et al., 2007). Hence all this evidence suggest that proper DNA methylation status is 
critical for embryonic development. As reviewed above, Hox genes are also essential in 
embryonic development. Thus it would be interesting to investigate how expression of Hox 
genes is controlled by DNA methylation during embryonic development. 
 
2.2.2 Histone modification 
Histone modifications can lead to either the activation or the silencing of gene 
transcription. Posttranslational histone modifications normally occur on the N-terminal tails of 
Histone H3 and H4. There are many types of modifications of histone proteins, including 
acetylation, methylation, phosphorylation, ubiquitination, sumoylation and ADP-ribosylation 
(Jenuwein and Allis, 2001; Spivakov and Fisher, 2007; Bannister and Kouzarides, 2011; 
Canovas and Ross, 2016). Histone modifications can regulate gene expression in three ways. 
First, they can regulate chromatin structure to alter DNA accessibility (Abel and Zukin, 2008; 
Canovas and Ross, 2016). Second, they serve as a signal by integrating responses to multiple 
biochemical signaling cascades and recruit the transcriptional machinery and chromatin 
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remodeling complexes (Abel and Zukin, 2008; Badeaux and Shi, 2013). Third, histone 
modifications can also mediate epigenetic changes in gene expression (Abel and Zukin, 2008; 
Moore et al., 2013). Below, I review three common histone modifications: histone acetylation, 
histone phosphorylation and histone methylation. 
 
2.2.2.1 Histone acetylation 
Histone acetylation occurs on a lysine residue in histones H2A, H2B, H3 and H4 and is 
associated with transcriptional activation by opening the chromatin structure (Graves et al., 
2016). Histone acetylation not only takes place on the N-terminal tail of histone proteins, but 
also to a lesser extent in the globular histone core (Bannister and Kouzarides, 2011; Graves et 
al., 2016). Histone acetylation of lysine is regulated by lysine acetyltransferases (KATs, also 
known as histone acetyltransferases, HATs) and lysine deacetylases (KDACs, also known as 
histone deacetylases, HDACs). The KATs can transfer an acetyl group to the lysine side chain, 
which neutralizes the lysine’s positive charge to weaken the electrostatic interactions between 
histones and the DNA phosphodiester backbone (Bannister and Kouzarides, 2011; Canovas and 
Ross, 2016) (Fig 2.8). Based on the structural and functional similarity of their catalytic domains, 
KATs are grouped into five families: p300/CBP family, the MYST-family, the GCN5-related N-
acetyltransferase (GNAT) superfamily, the nuclear receptor co-activator (NCOA)/steroid 
receptor coactivator (SRC) family and transcription-initiation-related factor KATs (Sheikh, 
2014; Canovas and Ross, 2016). CREB-binding protein (CBP) and its paralog p300 were 
originally identified to bind the cAMP-response element binding (CREB) protein (Chrivia et al., 
1993) and the adenovirus early-region 1A (E1A) protein (Eckner et al., 1994), respectively. 
Researchers further discovered that CBP/p300 also posess histone acetyltransferase activity 
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(Bannister and Kouzarides, 1996) and H3K14, H3K18, H3K27, H4K5 and H4K8 have all been 
identified as their targets (reviewed by Tie et al., 2009; Valor et al., 2013). CBP/p300 play 
important roles in cell growth and embryo development.  Loss of function of CBP and p300 are 
both lethal in mice (reviewed by Goodman and Smolik, 2000; Philip et al., 2015). KATs from all 
five families have been found to be important in neural development (Sheikh, 2014).  
 
 
 
Figure 2.8. Mechanisms of gene regulation by histone acetylation and histone 
phosphorylation.  DNA molecules are negatively charged. Histone acetylation and 
phosphorylation can neutralize the positive charge of histone. The interactions between histones 
and DNA are then weakened, making DNA accessible to transcription factors. Without 
acetylation/phosphorylation, chromatin is compacted and DNA is inaccessible to transcription 
factors. 
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KDACs are transcriptional repressors that reverse lysine acetylation, restore the positive 
charge of the lysine residue and thus stabilize the local chromatin architecture (Bannister and 
Kouzarides, 2011). KDACs are categorized into classical KDACs (KDAC1-11) and non-
classical KDACs based on their enzymatic mechanisms. Classical KDACs all share a conserved 
deacetylase domain whereas the catalytic function of non-classical KDACs is NAD+-dependent 
(Das Gupta et al., 2016). KDACs are important in embryonic development. Deletions of KDAC1, 
2, or 3 are all lethal in mice (Montgomery et al., 2008; Guan et al., 2009; Dovey et al., 2010; Lv 
et al., 2014). KDACs are also important in cell differentiation. Inhibition of KDACs activities 
can lead to early differentiation of embryonic stem cells (ESCs) (Lv et al., 2014). 
 
2.2.2.2 Histone phosphorylation 
Similar to histone acetylation, histone phosphorylation also activates gene expression. It 
occurs on serines, threonines and tyrosines of the N-terminal histone tails (Rossetto et al., 2012; 
Sawicka and Seiser, 2014). Protein kinases and phosphatases are the two groups of enzymes that 
add and remove the modification, respectively. Histone kinases transfer a phosphate group from 
ATP to the hydroxyl group of the target amino-acid, add negative charge to the histone and 
change the chromatin structure to increase DNA accessibiliby and activate the gene (Fig. 2.8) 
(Bannister and Kouzarides, 2011; Brehove et al., 2015). Histone phosphorylation is important in 
DNA damage repair, transcription regulation and chromatin remodeling (Rossetto et al., 2012; 
Sawicha and Seiser, 2014). 
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2.2.2.3 Histone methylation 
Histone methylation is associated with both transcriptional activation and gene silencing. 
Histone methylation occurs on lysines and arginines without changing the charge of the histone 
protein. There are three levels of histone lysine methylation: mono-, di- and tri-methylation (Ng 
et al., 2009; Bannister and Kouzarides, 2011). Histone lysine methyltransferase (HKMT) contain 
a so-called SET domain that catalyses the transfer of a methyl group from SAM to a lysine’s ε-
amino group (Bannister and Kouzarides, 2011; Fan et al., 2015). HKMTs are relatively specific 
enzymes with different enzymes within a family catalyzing different sites and levels of histone 
methylation. There are generally two classes of lysine demethylases (KDMs): the Jumonji C 
(JmjC) class and PHF8 (KDM7) families (Bannister and Kouzarides, 2011; Krishnan et al., 
2011). Methylation of histone on different lysine residues can result in different regulation 
functions. It is reported that methylation on histone H3K4, H3K36, and H3K79 are associated 
with transcriptional activation while the di- and tri-methylation on histone H3K9, H3K27 induce 
transcriptional inhibition (Fig 2.9) (Feng et al., 2007; Nguyen and Zhang, 2011). Different 
degrees of residue methylation may result in different biological functions as well. H4K20 
methylation has three states (mono-, di- and trimethylation). Mono- and di-methylation of 
H4K20 are involved in DNA replication in cell cycle and DNA damage repair, whie 
trimethylation of H4K20 is related to heterochromatin maintenance (Jørgensen et al., 2013). 
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Figure 2.9. Mechanisms of gene regulation by histone methylation.  Some histone 
methylation, like H3K4me3, can open chromatin structure and make DNA accessible to 
transcription factors. Other histone methylation, like H3K27me3, will result in compacted 
chromatin structure and DNA will not be accessible to transcription factors. 
 
 
 
2.2.2.4 Histone modification complexes 
Histone modification enzymes often form complexes with other proteins to carry their 
activity. These complexes are divided into two groups: the polycomb group (PcG) proteins and 
trithorax group (TrxG) proteins. The PcG and the TrxG proteins are epigenetic regulators 
responsible for the repression and activation, respectively of a group of genes important in 
development and cell fate specification. They are important for these genes to maintain 
previously established states of gene expression over multiple cell generations (Schuettengruber 
et al., 2011). The PcG and TrxG were first identified in Drosophila where they were shown to be 
required for the long-term repression and activation of the Antennapedia class of homeobox 
genes (Jurgens, 1985; Mallo and Alonso, 2013). The DNA regulatory elements that recruit PcG 
and TrxG factors to chromatin are referred to as PcG and TrxG response elements (PREs and 
TREs), respectively. Some TrxG and PcG components possess direct histone modification 
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activity while other TrxG and PcG proteins affect histone marks (Schuettengruber et al., 2007). 
PcG proteins are comprised of two types of epigenetic regulators: Polycomb Repressive 
Complex 1 (PRC1) and PRC2. PRC1 contains Bmi1, Ring1A, Ring1B, Cbx and Phc, and is 
responsible for ubiquitination of histone H2A at lysine 119, which is essential for Hox gene 
silencing (Cao et al., 2005; Mallo and Alonso, 2013; Piunti and Shilatifard, 2016). PRC2 is 
composed of Suz12, EED (embryonic ectoderm development) and Ezh1/2. Ezh2 catalyzes the di- 
and tri-methylation of histone H3 at lysine 27 which also acts to silence gene expression (Cao et 
al., 2002; Piunti and Shilatifard, 2016) and this mark is specifically recognized by PRC1 
(Schuettengruber et al., 2011; Piunti and Shilatifard, 2016). There are generally two classes of 
TrxG: one is composed of SET domain factors and the other includes components of ATP-
dependent chromatin remodeling complexes (Schuettengruber et al., 2011; Geisler and Paro, 
2015). The SET domain histone modification complexes include COMPASS, COMPASS-like, 
TAC1 and absent small or homeotic discs 1 (ASH1) complexes. COMPASS and COMPASS-
like complexes have H3K4 trimethylase activity and are composed of histone methytransferase 
(SET1A, SET1B, MLL1-4) and subunits including WD repeat domain 5 (WDR5), 
retinoblastoma binding protein 5 (RBBP5), absent small or homeotic 2-like (ASH2L) and 
DPY30. TAC1 and ASH1 complexes both coupled to CBP and counteract PcG silencing. ATP-
dependent chromatin remodeling complexes includes switch/sucrose nonfermentable (SWI/SNF), 
imitation switch (ISWI) and various chromodomain helicase (CHD)-containing complexes that 
can recognize the histone tail modifications to facilitate active transcription (Schuettengruber et 
al., 2011; Geisler and Paro, 2015). 
PcG and TrxG proteins play important roles in embryonic development and Hox gene 
regulation. PRC2 deficiency is fatal because single knockout of Suz12, EED or Ezh2 results in 
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early embryonic lethality in mice (Pasini et al., 2004; Faust et al., 1995; O’Carroll et al., 2001; 
Cheedipudi et al., 2014; Kadoch et al., 2016). Mutation of Ring1B (member of PRC1) also leads 
to embryonic lethality (Voncken et al., 2003; Morey et al., 2015) while other PRC1 deficiencies 
are less severe, only resulting in developmental abnormalities (reviewed by Jones and Wang, 
2010; Morey et al., 2015). In ES cells, Hox gene promoters often have ‘bivalent domains’, that 
is, they display both H3K4me3 and H3K27me3 marks. These bivalent domains appear to keep 
proper expression status of Hox genes (Bernstein et al., 2005; Montavon and Duboule, 2013). 
PcG and TrxG protein have a “ying-yang” effect on the bivalent domains. Mutation of PcG 
genes results in abnormal Hox gene expression and leads to irregular ES cell differentiation in 
both human and mouse (Lee et al., 2006; Boyer et al., 2006; Morey et al., 2015).  
 
2.2.2.5 Histone methyltransferase complex MLL1/WDR5  
Among all the PcG and TrxG protein complexes, MLL1/WDR5 complex is of special 
interest in my study (discussed later in the thesis). MLL1/WDR5 complex belongs to the TrxG 
protein complexes and is specifically responsible for the methylation of H3K4. Mutations in 
MLL1 are associated with several acute lymphoblastic and myelogenous leukemias from where 
it derives its name. MLL1 is an H3K4 methyltransferase that belongs to the evolutionarily 
conserved SET1 family. In humans, this gene is located on chromosome 11 and its cDNA is ~12 
kb in length. MLL1 gene encodes a protein of ~4000 amino acids in length which can be digested 
in cells by taspase into two fragments: a 320 kDa N-terminal fragment and a 180 kDa C-terminal 
fragment (Zhang et al., 2013). The two cleaved peptides remain associated to form a 
heterodimer.  
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MLL1 protein contains several conserved domains which are related to its functions in 
chromatin-mediated transcriptional regulation. The N-terminal fragment contains three DNA-
binding AT-hooks, followed by a cysteine-rich region with homology to DNA 
methyltransferases, referred to as the CxxC domain, followed by three plant homeodomain 
(PHD) zinc-finger-like motifs, and finally a bromo domain (BD) region. In the C-terminal 
fragment there is a transactivation domain (TAD) which can interact with CBP, a Win motif 
known as WDR5 binding site, and a SET domain which is responsible for the histone 
methyltransferase activity (Rasio et al., 1996; Nakamura et al., 2002; Zhang et al., 2013; 
Cosgrove and Patel, 2010) (Fig. 2.10A).  MLL1 is a H3K4 specific methyltranferase and the 
CxxC domain may play a role in targeting MLL1 to active genes because this domain selectively 
binds to non-methylated CpG islands (Birke et al., 2002; Long et al., 2013; Bina et al., 2013). 
The PHD domains aid to recognize lysine residues on chromatins (Taverna et al., 2007; Lalonde 
et al., 2014). Further research has showed that the TAD domain may also contribute to the 
specificity of MLL1. The TAD domain of MLL1 can interact with lysine acetyltransferases 
CBP/p300 which contains a number of protein-binding domains that mediate transcription factor 
recruitment (Cosgrove and Patel, 2010; Wang et al., 2013). In this way, MLL1 can increase the 
binding of other transcriptional activators to help activate gene expression.  In the TrxG, MLL1 
forms complex with other components, including WDR5, RBBP5, ASH2L and DPY30 (Zhang 
et al., 2013; Shinsky et al., 2015). These proteins can stimulate catalytic activity and product 
specificity of SET1-familiar methyltransferase, including MLL1. Deletion of any of these genes 
in yeast leads to a similar phenotype as observed in SET1 mutants (Nagy et al., 2002; Ernst and 
Vakoc, 2012).  
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Figure 2.10. Regulation of MLL1 by the core complex subunits. (A) MLL1 domain 
architecture. MLL1 contains the following functional domains: AT-hooks, CxxC, PHD, BD, 
TAD, Win motif and SET. Taspase can cleave MLL1 between BD and TAD into two peptide 
fragments. (B). Interaction of important subunits in MLL1 complex (Figure modified from Ernst 
and Vakoc, 2012).  
 
In mammalian cells, WDR5 seems essential for all forms of H3K4 methylation whereas 
knockdown of RBBP5 affects primarily H3K4me3 and H3K4me2 (Dou et al., 2006; Ernst and 
Vakoc, 2012). ASHL2 and DPY-30 have more specific role on H3K4me3 modification (Jiang et 
al., 2011; Dou et al., 2006; Tremblay et al., 2014). Research in yeast has also found that WDR5 
and RBBP5 proteins are essential for the stability of SET1 as depletion of either subunit leads to 
SET1 degradation (Steward et al., 2006). WDR5 binds directly to MLL1 through the Win motif 
in MLL1 in a 1:1 ratio (Patel et al., 2008; Shinsky et al., 2014) and bridges MLL1 with RBBP5 
and ASH2L. The hinge region in RBBP5 then binds directly to the SPRY domain of ASH2L, 
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and ASH2L in turn binds to DPY30 (reviewed by Ernst and Vakoc, 2012) (Fig. 2.10B). MLL1 
enzyme activity is relatively weakened in the absence of any of the associated subunits 
mentioned above. Research has revealed that the MLL1-WDR5-RBBP5 complex has only a mild 
enzyme activity and is only capable of mono-methylation (Patel et al., 2009; Shinsky et al., 2014; 
Shinsky et al., 2015). Adding ASH2L to the complex leads to a significant increase in H3K4 
methyltransferase activity and shifted the product specificity to di- and tri-methylation. The 
addition of DPY30 further increased the activity of the complex (Patel et al., 2009; Ernst and 
Vakoc, 2012).  
 
2.2.3 MicroRNA  
MicroRNAs are ~22 nucleotide (nt) RNAs first discovered in C. elegans that can guide a 
RNA silencing pathway to regulate gene expression through their effect on mRNA (Lee et al., 
1993; Felekkis et al., 2010; Usmani et al., 2016). Currently, many studies focus on miRNA 
regulated gene expression. Researchers have made several advancements on the roles of 
miRNAs in the areas of embryo development (Yan and Jiao, 2016; Green et al., 2015) as well as 
diseases including cancer (He et al., 2015; Usmani et al., 2016), cardiovascular disease (Elia and 
Condorelli, 2015), neurodevelopmental disease (Ardekani and Naeini, 2010) and metabolic 
disease (Deiuliis 2015). 
 
2.2.3.1 microRNA biogenesis 
In vivo, miRNA is synthesized as follows (Fig. 2.11): Initially a long primary transcript 
of the miRNA gene (pri-miRNA) composed of at least one hairpin-like miRNA precursor is 
cleaved by the nuclear microprocessor complex and the endonuclease Drosha complex in the 
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nucleus to form 50–120 nucleotide hair-pin secondary structures, named miRNA precursors (pre-
miRNA) (Ke et al., 2003; Kocerha et al., 2009; Ha and Kim, 2014). The 60- to 90-nt pre-
miRNAs form the stem-loop structures which are then transported by Exportin-5 from the 
nucleus to the cytoplasm where the pre-miRNA hairpin stem regions are excised by the 
endonuclease Dicer into 18 to 22 nt double strand RNAs (Bartel, 2004; Macfarlane and Murphy, 
2010; Ha and Kim, 2014). One of the two strands is the mature miRNA and the other counterpart 
is called miRNA*. The mature miRNAs bind to the miRNA-containing RNA-induced silencing 
complex (miRISC) and interact with target mRNAs mostly within the 3' untranslated region (3' 
UTR) based on sequence complementarity between the miRNA and its target mRNA (Maes et 
al., 2009; Ha and Kim, 2014). Argonaute (AGO), a large protein family, is a key component of 
RISCs (Carmell et al., 2002; Tang, 2005; Ha and Kim, 2014). AGO is associated with Dicer as 
well as the target sites of RISCs to cleave the target mRNAs (Tang, 2005; Ha and Kim, 2014). 
The most important determinant of miRNA function is the degree of complementarity between 
the proximal (5') region (also known as “seed” region or the “nucleus”) of the miRNA and the 
mRNA (Brennecke et al., 2005; Felekkis et al., 2010; Valinezhad Orang et al., 2014). MiRNAs 
can silence gene expression by triggering the degradation of the target mRNA or blocking 
translation of the target mRNA (Ipsaro and Joshua-Tor, 2015; Jonas and Izaurralde, 2015). 
Evidances show that 66-90% of miRNA-mediated gene repressions in mammalian cells are 
through the degradation of target mRNAs (Eichhorn et al., 2014; Jonas and Izaurralde, 2015). 
GW182 is a key protein in the miRNA-mediated mRNA degradation. After the recognition of 
mRNA target by RISCs, AGO protein interacts with GW182 protein, which then binds to the 
cytoplasmic deadenylase complexes PAN2-PAN3 and CCR4-NOT and triggers the cellular 5′-3′ 
mRNA decay pathway. The deadenylated mRNAs are then decapped and finally degraded 
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(Valinezhad Orang et al., 2014; Jonas and Izaurralde, 2015). Originally researchers had proposed 
that miRNAs can inhibit translation at both initiation and post-initiation steps (Olena and Patton, 
2010) but the use of ribosome profiling method ruled out the mechanisms occurring post-
initiation (Huntzinger and Izaurralde, 2011; Jonas and Izaurralde, 2015). The molecular 
mechanism for the miRNA inhibited translation initiation remains to be resolved (Jonas and 
Izaurralde, 2015). A mRNA transcript can have multiple miRNA binding sites and be repressed 
simultaneously by different miRNA’s. The same or different miRNAs bind within the same 
3′UTR and can act cooperatively to enhance repression (Doench and Sharp, 2004; Felekkis et al., 
2010).  
 
 
Figure 2.11. miRNA biogenesis and function. Transcribed by RNA polymerase II, long 
primary transcripts (pri-miRNA) are then processed in the nucleus into hairpins (pre-miRNA) by 
Drosha and DGCR8. Exportin 5 exports the pre-miRNA to cytoplasm where it is cleaved into a 
mature dsRNA duplex. One strand that is stably associated with Argonaute (AGO) is packaged 
into the RISC to target and regulate mRNAs. The other strand is unwound and degraded. The 
target mRNA is either degraded or translation is repressed. This figure is taken with permission 
from from Jung and Suh (2015). 
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Table 2.3. Regulation of Hox genes by miRNAs 
Species miRNA Hox Gene Target System impacted Reference 
Drosophila miR-iab-4 Ubx, Abd-A Halteres to wing 
transformation 
Ronshaugen et al., 2005 
miR-iab-8 Ubx, Abd-A Halteres to wing 
transformation  
Tyler et al., 2008 
Ubx CNS Thomsen et al., 2010 
Abd-A CNS Gummalla et al., 2012 
Ubx, Abd-A CNS, Fertility Garaulet et al., 2014 
Zebrafish miR-10 Hoxb1a, Hoxb3a Hindbrain Woltering and Durston, 
2008 
miR-196 Hoxb8a Body axis development He et al., 2011b 
Chick miR-196 Hoxb8 
 
Hindlimb development Brock et al., 2009 
Skeletogenesis McGlinn et al., 2009 
miR-130a Hoxa3 Tumorigenesis Han et al., 2016 
Mouse miR-196 Hoxb8 Hindlimb development Brock et al., 2009 
Hoxa7,Hoxc8, 
Hoxb8 
Vertebral number and 
vertebral identity  
Wong et al., 2015 
miR-181 Hoxa11 Skeletal muscle cell 
differentiation 
Naguibneva et al., 2006 
miR-3960 Hoxa2 Primary osteoblasts Hu et al., 2011 
miR-130a Hoxa5 Airway branching and 
lung microvascular 
development 
Mujahid et al., 2013 
miR-221 Hoxb5 
Human miR-196 HOXB8, 
HOXC8, 
HOXD8, HOXA7 
Cervical cancer (Hela) 
cells 
Yekta et al., 2004 
miR-196a HOXB9 Head and neck squamous 
cell carcinoma 
Darda et al., 2015 
miR-196b HOXA9 Lung cancer  Yu et al., 2015 
Chronic myeloid leukemia Liu et al., 2013 
MLL-rearranged leukemia Li et al., 2012 
miR-126, 
miR-145, let-
7 
HOXA9 Bone marrow 
 
Shen et al., 2008 
miR-193a-3p HOXC9 Bladder cancer Lv et al., 2015 
miR-135a HOXA10 Epithelial ovarian cancer Tang et al., 2014 
miR-100 HOXA1 Small cell lung cancer Xiao et al., 2014 
miR-99 HOXA1 Epithelial cell proliferation 
and migration 
Chen et al., 2013 
miR-10 HOXD10 Non-metastatic breast 
cancer 
Ma et al., 2007 
Ovarian cancer Nakayama et al., 2013 
miR-130a HOXA5 Human umbilical vein 
endothelial cells 
Chen and Gorski, 2008 
miR-221 HOXB5 Papillary thyroid 
carcinoma 
Kim et al., 2008 
miR-7, miR-
218 
HOXB3 Breast cancer Li et al., 2012 
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2.2.3.2 Regulation of Hox genes by miRNAs 
Studies show that miRNAs can regulate the expression of Hox genes and play important 
roles in embryonic development. Some miRNA genes are transcribed from Hox gene clusters 
like mir-10, mir-196 and iab-4 (Lagos-Quintana et al., 2011; Aravin et al., 2003; Woltering and 
Durston, 2008; Yekta et al., 2004; Hornstein et al., 2005). These miRNAs are expressed in 
patterns that approximate the characteristic expression of Hox genes. Other miRNAs have also 
been found to regulate Hox genes. Below I have summarized research on miRNAs and Hox gene 
regulation that has so far been investigated in several species including insects, mouse, chicken, 
fish and human cell lines (see Table 2.3). 
In Drosophila, three homeotic genes within BX-C encode homeobox proteins. They are 
Ultrabithorax (Ubx), Abdominal-A (Abd-A) and Abdominal- B (Abd-B) (Martin et al., 1995; 
Garaulet and Lai, 2015). Twe groups of Drosophila miRNAs are transcribed from BX-C and can 
regulate Hox gene expression (Garaulet and Lai, 2015). The iab-4–5p and iab-4–3p are located at 
the end of the iab-4 locus between abd-A and Abd-B genes (Aravin et al., 2003; Garaulet and 
Lai, 2015). Ronshaugen et al., (2005), demonstrated direct targeting of miR–iab-4–5p in Ubx 3′ 
UTR and showed that iab-4 miRNA down regulates Ubx activity in vivo. Over expression of 
mir-iab-4-5p attenuates Ubx protein levels and induces the transformation of halteres into wings 
(Ronshaugen et al., 2005). iab-4 miRNA was also predicted to repress the downstream targets of 
the homeobox genes (Grun et al., 2005). Thus iab-4 miRNA may fine-tune the development of 
Drosophila via both homeobox genes and their downstream targets (Chopra and Mishra, 2006). 
The miRNA iab-8 is a transcript produced on the sense strand of the coding region of BX-C but 
antisense to iab-4 (Tyler et al., 2008; Gummalla et al., 2012; Garaulet and Lai, 2015). Ubx 
appears to be a much stronger target of miR-iab-8-5p than of miR-iab-4-5p (Tyler et al., 2008; 
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Garaulet and Lai, 2015). Ectopic expression of iab-8 leads to haltere to wing transformation 
which is similar to what occurs after over expression of mir-iab-4-5p (Tyler et al., 2008; Bender, 
2008). Abd-A is also regulated by iab-8 where deletion of mir-iab-8 influenced the expression of 
both Ubx and Abd-A in the posterior larval ventral nerve cord (VNC) and disrupted CNS 
patterning and reproductive behavior in Drosophila (Garaulet et al., 2014).  
miRNAs are also very important in Zebrafish development. It has been shown that 
Dicer1, the microRNA-producing enzyme, is essential for Zebrafish development. Zebrafish 
embryos with blocked Dicer activity display abnormal morphogenesis during gastrulation, brain 
formation, somitogenesis, and heart development (Giraldez et al., 2005; He et al., 2011a). miR-
10 gene is located 5′ of the Hox-4 genes and binds to Zebrafish Hox genes. In Zebrafish, miR-
10c is located on the same primary transcript as Hoxb4a and is expressed in a Hox-4 like pattern 
in the spinal cord (Woltering and Durston, 2008; Mallo and Alonso, 2013). Binding sites of miR-
10 have been experimentally confirmed to occur in both Zebrafish Hoxb1a and Hoxb3a 3′ UTR 
and in the open reading frame (Woltering and Durston, 2008). It has been reported that miR-10 
represses Hoxb1a and Hoxb3a gene expression and its overexpression leads to loss of function 
phenotypes for both genes (Woltering and Durston, 2008). miR-196 is another hox-cluster 
miRNA that down regulates hoxb8a expression in zebrafish by targeting its 3′ UTR. An over 
expression or knockdown of miR-196 leads to abnormal embryo development in zebrafish (He et 
al., 2011b; Mallo and Alonso, 2013). 
In cultured human Hela cells, miR-196 down regulates the expression of HOXB8, 
HOXC8, HOXD8, and HOXA7 by binding to 3′ UTR regions (Yekta et al., 2004). In patients 
with chronic myeloid leukemia, lower levels of miR-196b expression were detected and further 
experiments showed that miR-196b targets HOXA9 and reduces cell proliferation rate (Liu et al., 
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2013). miR-196b mediated regulation of HOXA9 expression has also been reported in 
mesenchymal-like-state non-small cell lung cancer cells (Yu et al., 2015). HOXB9 is also 
regulated by miR-196a in head and neck squamous cell carcinoma (Darda et al., 2015).  Other 
experiments showed targeting of HOXD10 mRNA by miR-10 in cultured human non-metastatic 
breast cancer (SUM149) cells (Ma et al., 2007). Luciferase assays in HCT 116 cells 
demonstrated that miR-10a strongly repressed luciferase activities mediated by 3′ UTR vectors 
derived from HOXA3 and HOXD10 (Han et al., 2007). In ovarian cancer cells, over expression 
of miR-10b down regulated the expression of HOXD10 and accelerated the migration and 
invasion activities of these cancer cells (Nakayama et al., 2013). HOXA10 is another gene 
important in epithelial ovarian cancer (EOC). A down regulation of HOXA10 by miR-135a can 
lead to enhanced cell apoptosis and inhibition of cell growth and adhesion in EOC-derived cell 
lines (Tang et al., 2014).  Down regulation of both antiangiogenic homeobox genes GAX and 
HOXA5 by miR-130a was observed in human umbilical vein endothelial cells (HUVECs), 
though the antagonism is weaker for HOXA5 than what was observed for GAX (Chen and 
Gorski, 2008). miR-221 is highly expressed in human papillary thyroid carcinoma (PTC) cell 
lines and altered the expressions of many target genes (Kim et al., 2008). HOXB5 is one of the 
most significantly affected gene and was identified as a direct target of miR-221 (Kim et al., 
2008). miR-126, miR-145, and let-7 are all found to target the full-length HOXA9 cDNA and can 
block HOXA9 biological functions. More interestingly, miR-126 regulates HOXA9 by binding to 
the homeobox region rather than the 3′ UTR (Shen et al., 2008). Two tumor suppressor 
microRNAs, miR-7 and miR-218, were found to target HOXB3 in human breast cancer cell lines 
and further regulate the expression of tumor suppressor genes RASSF1A and Claudin-6 (Li et 
al., 2012). Three members of miR-99 family (miR-99a, miR-99b and miR-100) can bind directly 
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to HOXA1 mRNA. An over expression of miR-99 family led to reduced HOXA1 expression and 
caused reduced proliferation and cell migration (Chen et al., 2013; Xiao et al., 2014). miR-193a-
3p can directly regulate the expression of HOXC9 and plays an important role in bladder cancer 
chemoresistance. In bladder cancer cell lines, ectopic expression of miR-193a-3p reduced 
HOXC9 expression and led to chemoresistance to several drugs (Lv et al., 2015). 
In mouse embryos, Hoxb8 is directly cleaved by miR-196 (Yekta et al., 2004). miR-196 
was also shown to regulate Hoxb8 in both mouse and chick hindlimb development (Brock et al., 
2009). Observations by McGlinn and colleagues showed that loss of function of miR-196 in 
chick embryos led to extensive skeletal defects including homeotic transformations (McGlinn et 
al., 2009). Hox genes, Hoxa7 and Hoxc8, have also been identified as targets of miR-196 in 
mouse embryo development (Wong et al., 2015). miR-130a regulates Hoxa3 expression at the 
protein level in the chick and is involved in the regulation of cell proliferation in tumorigenesis 
associated with the chicken Marek’s disease (Han et al., 2016).  miR-181 is strongly upregulated 
during differentiation of skeletal muscle cells. miR-181 can downregulate Hoxa11 protein 
expression and is suggested to play a role in skeletal-muscle differentiation (Naguibneva et al., 
2006). In mouse embryo development, miR-130a and miR-221 were shown to regulate both 
airway branching and lung microvascular development by targeting Hoxa5 and Hoxb5, 
respectively (Mujahid et al., 2013). While a significant number of miRNAs have been reported 
to regulate Hox gene expression, only one miRNA has been reported to directly target Hoxa2. 
Hu and colleagues identified a novel miR-3960 from primary mouse osteoblasts and instead of 
targeting the 3′ UTR region, it targets Hoxa2 coding region. Together with miR-2861 which 
targets the Hoxa2 downstream gene, Runx2, miR-3960 can form a regulatory feedback loop and 
	   42	  
plays an important role in osteoblast differentiation (Hu et al., 2011). Whether there are any 
specific miRNAs that target Hoxa2 3′ UTR still remain to be discovered. 
 
2.2.4 Long noncoding RNA (lncRNA) 
Although 70-90% of the mammalian genome is believed to be transcribed, only 1% of 
the genome encodes protein (Lee, 2012). Researchers previously considered these noncoding 
transcripts as transcriptional noise, but are beginning to realize that many of these noncoding 
transcripts have functions, and are now classified as long noncoding RNAs (lncRNAs). 
LncRNAs are a group of RNAs that do not encode proteins, and are comparably longer than 
other short noncoding RNAs, such as microRNAs and tRNAs. A majority of lncRNAs share the 
same transcriptional machinery with mRNAs, namely; (1) their transcription is catalyzed by 
RNA polymerase II; (2) lncRNAs also have 5' methylguanosine cap and 3' polyadenylation and 
often undergo splicing (Mercer and Mattick, 2013). However, lncRNAs usually lack an extended 
open reading frame (ORF). It is difficult to determine the exact number of human lncRNAs. 
Researchers estimate there are at least 5,000 to 15,000 long noncoding transcripts with many 
lncRNAs yet to be annotated (reviewed by Mercer and Mattick, 2013). Although there are a 
large number of lncRNAs, individual lncRNA tend to express in significantly lower quantities 
compared to their protein-coding counterparts, making these difficult to detect (Cabili et al., 
2011). LncRNAs can be transcribed between or within coding genes. Many lncRNAs are 
transcribed from the antisense of coding genes (Mercer and Mattick, 2013).  
LncRNAs have emerged with important regulatory roles in gene expression. An 
important question that needs addressing is, how do lncRNAs regulate gene expression? At the 
structural level, lncRNAs carry their regulatory function by interacting with other molecules, 
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including DNA, RNA and protein. Proteins are the most common partner of lncRNAs, with at 
least 15% of expressed proteins having RNA binding capacity (Baltz et al., 2012). Proteins 
usually do not recognize a specific lncRNA sequence but tend to interact with their secondary 
structures (Mercer and Mattick, 2013). Significant evidence indicates that lncRNAs can recruit 
chromatin-modifying proteins to specific promoter sites. The indication that lncRNAs may be 
crucial accessory factors for Polycomb function first arose when researchers found the 
interacting factors of Xist: PRC2 (Zhao et al., 2008). In fact, many histone methyltransferases 
(HMTases) lack DNA binding domain but usually have RNA binding capacity, indicating 
lncRNAs may play an important role in guiding HMTases to certain chromatin loci (Bernstein 
and Allis, 2005). Some lncRNAs can also interact with mRNAs. For example, AS Uchl1 is a 
lncRNA anti-sense to mouse ubiquitin carboxyterminal hydrolase L1 (Uchl1). It can interact 
with Uchl1 mRNA to regulate its stability and translation (Carrieri et al., 2012). Although there 
is currently little evidence for direct binding of lncRNA to DNA, researchers have reported a 
lncRNA, the pRNA (promoter-associated RNA) which forms a DNA:RNA triplex with 
ribosomal DNA (rDNA) promoter to be specifically recognized by the DNA methyltransferase 
DNMT3b (Schmitz et al., 2010). LncRNAs are biologically important in many processes. Below 
I will review several examples of lncRNAs that have important biological functions. 
 
2.2.4.1 LncRNAs and X-Inactivation 
In mammals to balance the dosage of X-linked genes between the two genders, a majority 
of genes on one X-chromosome are inactivated in females, known as X-chromosome 
inactivation (XCI) (Lyon, 1961; Yue et al., 2015). This inactivation process is driven by a series 
of lncRNAs, including Xist, Tsix, RepA and Jpx (Froberg et al., 2013; Yue et al., 2015).  Xist is 
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one of the first lncRNAs identified to induce chromosome-wide silencing on inactive X (Xi) 
(Penny et al., 1996). In the active X (Xa), Tsix is expressed which is antisense to Xist and can 
block the expression of Xist (Lee, 2000). As mentioned earlier, Xist can silence X-chromosome 
by recruiting PRC2 to specific gene sites. At the 5′ end of Xist, there is a repeat motif identified 
as “Repeat A” (Zhao et al., 2008). This motif directly interacts with EZH2, the histone 
methyltransferase in PRC2, which trimethylates histone H3 at lysine 27. With the help of Xist, 
PRC2 is initially localized to “PRC2 strong sites” (e.g. the bivalent domains and CpG islands) 
along the Xi. It then migrates to other parts of the chromosome and eventually silences the entire 
chromosome (Pinter et al., 2012; Valencia and Wutz 2015; Goodrich et al., 2016). A recent 
study also showed that Xist can silence transcription through KDAC3. Moreover, KDAC3 is 
critical for Xist-mediated recruitment of PRC2 across Xi (McHugh et al., 2015). Expression of 
Xist is regulated by other noncoding RNAs. Jpx and Ftx are two noncoding RNAs encoded 
upstream of Xist promoter that act as activators of Xist (Nora et al., 2012; Goodrich et al., 2016). 
In Xa, Tsix controls Xist expression by methylating its promoter and modulating its chromatin 
structure (Sado et al., 2005). Evidence showed that Tsix can interact with PRC2 and establishes 
H3K27me3 on Xist as well as recruit DNMT3a to enhance hypermethylation on Xist promoter 
(Sado et al., 2005; Ohhata et al., 2008; Furlan and Rougeulle, 2016).  
 
2.2.4.2 LncRNAs from Hox loci 
There are several lncRNAs that have been identified to be transcribed from Hox clusters 
(Fig. 2.12). Investigation on the transcriptional activity of the human HOX loci showed that 
many of the intergenic regions are actively transcribed and most of the transcripts from the 
intergenic regions are lncRNAs (Rinn et al., 2007; De Kumar and Krumlauf, 2016). Up to 74% 
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of these lncRNAs are transcribed from the opposite-strand of HOX genes. Rinn and colleges 
concluded that Hox lncRNAs play important biological roles based on the following key facts: 1. 
Some lncRNAs are conserved in evolution; 2. Like HOX genes, these lncRNA have different 
expression patterns along the A-P axes depending on their physical location on the chromosome; 
3. These lncRNAs possess specific sequence motifs based on their site-specific expression 
patterns (Rinn et al., 2007; De Kumar and Krumlauf, 2016). 
 
 
 
 
Figure 2.12. Noncoding transcripts originating from the four Hox clusters. Relative 
positions of non-coding transcripts (green) are shown on the basis of human Hox coding genes 
(red) as landmark. Arrows indicate the direction of transcription.  
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Table 2.4. Summary of lncRNAs transcribed from the HOX gene cluster. 
LncRNA Binding 
partner 
Epigenetic 
marks 
induced 
Target gene 
regulation 
Functions and 
Systems 
References 
HOTAIR PRC2 
(Suz12 and 
EZH2) 
H3K27me3 HOXD8, 
HOXD9, 
HOXD10, 
HOXD11              
 
¯ 
Human primary 
foreskin fibroblast 
cells 
Rinn et al., 
2007 
¾ DNA 
methylation 
PTEN                    ¯ Human laryngeal 
squamous cell 
cancer  
Li et al., 2013 
PRC2 
(EZH2) 
H3K27me3 P21 ¯ Cell cycle 
disorder 
 
Liu et al., 
2016a 
PRC2 H3K27me3 WIF-1 ¯ Activate Wnt 
pathway in cancer 
cells 
Ge et al., 
2013; Li et 
al.,2016  
HOTTIP TrxG 
(WDR5) 
H3K4me3 Hoxa10,Hoxa1
1, Hoxa13 
­ Mouse and chick 
embryo 
development 
Wang et al., 
2011 
¾ ¾ P21 ¯ Regulate cell 
growth and 
apoptosis in 
colorectal cancer  
Lian et al., 
2016 
¾ ¾ cyclin D1, 
CDK4 and β-
catenin 
­ Activate the 
Wnt/β-catenin 
pathway in 
osteosarcoma 
Li et al., 2016 
Mistral TrxG 
(MLL1) 
H3K4me3 Hoxa6, Hoxa7  ­ Stem cell 
differentiation 
Bertani et al., 
2011 
HOTAIR
M1 
¾ ¾ HOXA1, 
HOXA4, 
HOXA5 
­ Myeloid 
differentiation 
and maturation 
Zhang et al., 
2009; Zhang 
et al., 2014 
HOXA-
AS2 
PRC2 H3K27me3 P21, PLK3, 
DDIT3 
¯ Gastric cancer Xie et al., 
2015 
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HOTAIR was the first lncRNA to be studied in human HOX clusters. HOTAIR is a HOX-
C loci antisense transcript expressed in posterior and distal sites (Rinn et al., 2007). It has been 
reported to bind to Suz12 and EZH2, components of PRC2 and induces H3K27me3 in HOXD 
locus in human primary foreskin fibroblast cells (Rinn et al., 2007). HOTAIR expression is 
related to several types of cancers. HOTAIR promoter contains estrogen response elements and 
its expression can be induced by estradiol in the human breast cancer cell line MCF7 (Bhan et 
al., 2013). HOTAIR is essential for the growth of many cancer cells and knockdown of HOTAIR 
induces apoptosis in these cancer cells (Bhan et al., 2013; Kong et al., 2015; Tang et al., 2016). 
In human laryngeal squamous cell carcinoma cell line Hep-2, HOTAIR suppresses the 
expression of PTEN, a tumor suppressor gene, via DNA methylation (Li et al., 2013). 
Knockdown of HOTAIR in Hep-2 cells also leads to apoptosis and can inhibit the invasion of 
Hep-2 cells (Li et al., 2013). Other genes and pathways regulated by HOTAIR in cancer cells 
include p21, NF-κB and Wnt/β-catenin pathway (Liu et al., 2016a; Özeş et al., 2016; Li et al., 
2016). Expression of HOTAIR also increased proliferation and invasion of several tumor cells 
(Fang et al., 2016, Lee et al., 2016). HOTAIR is also involved during heart failure (Greco et al., 
2016). 
HOTTIP is an antisense transcript transcribed from 5' to HOXA13 and is required for the 
activation of 5' HOXA genes (Wang et al., 2011). HOTTIP is expressed in distal human 
fibroblasts and in posterior sites of mouse and chick embryos. Knockdown of HOTTIP in chick 
embryo causes shortened forelimbs. ChIP-seq results showed that the down regulation of 
HOTTIP decreased H3K4me3 occupancy in 5' HOXA genes, from where HOTTIP is 
transcribed. Further results showed that HOTTIP can bind directly to WDR5, a protein 
interacting with histone methyltransferase MLL in TrxG. HOTTIP is essential for the recruitment 
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of MLL1 to 5' HOXA genes through WDR5 (Wang et al., 2011). Like HOTAIR, HOTTIP also 
plays a very important role in cancer but through regulation of different HOX genes. HOTTIP 
regulated HOXA13 expression contributes to the progression of several cancers (Ren et al., 2015; 
Li et al., 2015b; Zhang et al., 2016). HOTTIP can also regulate the expression of p21 and Wnt/β-
catenin pathway and enhance tumor cell proliferation and migration (Li et al., 2016; Cheng et al., 
2015; Lian et al., 2016). 
Mistral is another lncRNA found in HoxA cluster. It is an antisense transcript located 
between Hoxa6 and Hoxa7 in mice (Bertani et al., 2011). Similar to HOTTIP, it can activate 
nearby gene expression (Hoxa6 and Hoxa7) by interacting with MLL1. In this way it induces 
H3K4me3 modification in Hoxa6 and Hoxa7 and this process is important in stem cell 
differentiation (Bertani et al., 2011).  
A model has been suggested by Rinn et al. (2007) that transcription of lncRNA in cis 
(e.g. HOTTIP) may recruit TrxG proteins such as MLL1 and WDR5 to chromatin, leading to 
H3K4me3 and gene activation (Fig. 2.13A). While lncRNAs transcribed but acting in trans may 
interact with PRC2 and result in H3K27me3 modification and gene silencing (Fig. 2.13B). The 
later findings on HOTTIP and Mistral support this model. 
Other lncRNAs identified from the Hox cluster include HOTAIRM1 and HOXA-AS2. 
HOTAIRM1 is an antisense intergenic transcript transcribed between human HOXA1 and HOXA2 
(Zhang et al., 2009). It can activate 3' HOXA genes and its presence is necessary during myeloid 
differentiation and myeloid maturation (Zhang et al., 2009; Zhang et al., 2014). HOXA-AS2 is a 
lncRNA located between the HOXA3 and HOXA4 genes in the HOXA cluster (Zhao et al., 
2013). Its expression was found in NB4 promyelocytic leukemia cells and human peripheral 
blood neutrophils. HOXA-AS2 expression is responsive to all-trans retinoic acid (ATRA) 
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induction in NB4 cells and can negatively regulate ATRA-induced NB4 cell apoptosis by 
regulating caspase 8 and 9 pathway (Zhao et al., 2013). HOXA-AS2 can also recruit PRC2 to P21, 
PLK3 and DDIT3 genes to induce H3K27me3 and silence their expression in gastric cancer cells 
(Xie et al., 2015).  
 
 
Figure 2.13. Model of long ncRNA regulation of chromatin domains via histone-
modification enzymes. (A) Transcription of lncRNAs in cis may recruit TrxG proteins to 
chromatin, leading to H3K4 tri-methylation, open the chromatin structure and transcriptionally 
activate neighboring HOX genes. (B) lncRNAs acting in trans, in contrast, can recruit PRC2 to 
chromatin, causing a compacted chromatin structure and lead to H3K27 methylation and gene 
repression.  
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2.2.5 Cross talk between epigenetic regulators 
Thus far I have reviewed how each individual epigenetic regulator can influence gene 
expression. The reality is usually that the regulation of gene expression is not controlled simply 
by one epigenetic regulator but is interrelated with many different epigenetic regulators having a 
coordinated affect on gene expression. Hence, more often multiple epigenetic regulators are 
involved in regulating the expression of a single gene.  One good example is the regulation of 
gene expression via lncRNA mediated histone methylation that was reviewed above. Histone 
methylation and histone acetylation are also closely related. It has been reported that TrxG 
proteins can interact directly with KAT CBP and monomethylation of H3K4 can enhance 
H3K27 acetylation through CBP (Tie et al., 2014). 
In addition, epigenetic regulators have the ability to affect each other. First, the ability of 
DNA methylation and histone modification to regulate gene expression suggests that the 
expression of lncRNA and miRNA may be regulated by these modifications (Han et al., 2007). It 
is predicted that over 90% of the human miRNA promoters are located 1,000 bp upstream of the 
mature miRNA (Zhou et al., 2007). In human colorectal cancer cell line CRC, hsa-miR-9 gene is 
included within 1,000 bp of a CpG island which is hypermethylated (Bandres et al., 2009). The 
hsa-miR-9 expression is downregulated in primary CRC compared to matched normal colorectal 
epithelial tissues (Bandres et al., 2006). Both DNA demethylation and H3 deacetylation 
upregulate the expression of the mature hsa-miR-9 (Bandres et al., 2009). Han et.al. (2007) have 
reported 13 miRNAs in colon cancer cells HCT116 that are regulated by DNA methylation. 
Moreover, a high level of CpG site demethylation is essential for the re-expression of these 
miRNAs (Han et al., 2007). When comparing patients with leukemia to healthy individuals, a 
higher degree of DNA methylation in the CpG islands of miR-196b promoter and a lower 
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expression of miR-196b was observed in patients with chronic myeloid leukemia (Liu et al., 
2013). Research has shown that miR-127 is induced from its own promoter after treatment with 
demethylating drug 5-aza-20-deoxycytidine (5-Aza-CdR) and 4-phenylbutyric acid (PBA) in 
both LD419 and T24 cells. This induction is observed together with a decrease in DNA 
methylation levels and an increase in histone H3 acetylation as well as histone H3K4 
methylation (Saito et al., 2006). Scott and colleagues observed that when they inhibited histone 
deacetylase, 40% of tested miRNAs showed significant changes in expression level within 5 h of 
treatment (Scott et al., 2006). LncRNA HOTAIR mediates changes in histone methylation status 
on miR-205 promoter to regulate miR-205 expression in bladder cancer cells (Sun et al., 2015). 
While DNA methylation and histone modification can regulate the expression of 
miRNAs and lncRNAs, several researchers have found that miRNAs can also influence DNA 
methylation and histone modification. First, miRNAs themselves can target genes that control 
epigenetic pathways. Clues have been found for miR-140 to target histone deacetylase 4 in mice 
(Tuddenham et al., 2006). Ezh2, described earlier as a component of PRC2, has its expression 
regulated by miR-26a, miR-101, miR-205 and miR-214 (reviewed by Sato et al., 2011). Bmi1 
belongs to PRC1 and is regulated by miR-128 (Godlewski et al., 2008) and mir-203 (Wellner et 
al., 2009). In prostate cancer, down regulation of miR-449a causes overexpression of KDAC-1 
(Noonan et al., 2009). miR-29 family of miRNAs are shown to directly target DNMT 3a and 3b 
(Fabbri et al., 2007). miR-142-3p downregulates the expression of TrxG proteins ASH1L and 
MLL1 in thyroid follicular tumorigenesis (Colamaio et al., 2015). An intriguing experiment 
presented that miR-165 and miR-166 can interact with the newly processed PHABULOSA 
(PHB) mRNA and induce DNA methylation (Bao et al., 2004). Another research study showed 
that the accumulation of miRNA: target-RNA duplexes hypermethylate the genes encoding 
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target RNAs, leading to gene silencing (Khraiwesh et al., 2010). miRNAs can also regulate 
lncRNA expression. For example, iab-4 non-coding RNA is a substrate for miRNA (Bender, 
2008). miR-192 and miR-204 can directly suppress expression of HOTTIP in hepatocellular 
carcinoma (Ge et al., 2015). 
 
2.3 WDR5 
The WD40 repeat (also known as the WD or beta-transducin repeat) proteins are a group 
of proteins containing a highly conserved core/repeating units of approximately 40 amino acids 
that usually terminate with tryptophan (Trp, W) - aspartic acid (Asp, D) dipeptide (Neer et al., 
1994). WD repeat proteins normally contain 4-16 WD repeats (Li and Roberts, 2001). The WD 
repeat proteins are a large family of proteins present in all eukaryotes and involved in a variety 
of cellular activities including cell division (Li et al., 2015a), transmembrane signalling (Neer et 
al., 1994), autophagy (Grimmel et al., 2015), gene regulation (Sun et al., 2015) and apoptosis (Li 
et al., 2015a). These proteins play key roles in the formation of protein-protein complexes in 
nearly all the major pathways and organelles unique to eukaryotic cells, associating them with 
many genetic diseases (Smith, 2008). 
WDR5 is a protein belonging to the WD repeat protein family. It was first identified in 
2001 and named BIG-3 (BMP-2 induced gene 3kb, Gori et al., 2001). Later it was renamed 
WDR5 (WD repeat protein 5) as it contains seven WD-40 repeats (Gori et al., 2005). As a 
member of the WD repeat protein family, WDR5 is hypothesized to have the three common 
features shared by WD repeat proteins (Li and Roberts, 2001) and these are: 1) the WD repeat 
domains are folded into beta propellers; 2) the WD repeat domains can reversibly assemble to 
multiple protein complexes and serve as a platform without any catalytic activities; 3) WDR5 
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may be involved in regulating cellular functions, such as cell division, cell-fate determination, 
gene transcription, and mRNA modification. In fact, WDR5 is linked to various diseases 
including leukemia (Ali et al., 2014), breast carcinogenesis (Dai et al., 2015), prostate cancer 
(Kim et al., 2014) and pulmonary hypertension (Chen et al., 2015). 
 
2.3.1 Structure of WDR5 
Since the first structural determination of WD repeat protein in 1995 (Wall et al., 1995), 
hundreds of different WD repeat proteins have been identified (Neer and Smith, 2000). These 
WD repeat proteins share a common beta-propeller structure composed of several four-stranded 
anti-parallel beta sheets/blades (Li and Roberts, 2001; Smith, 2008). Each WD repeat sequence 
encodes a structure of four beta anti-parallel strands but the repeat structure is not equivalent to a 
single blade. Rather, each repeat consists the first three strands of one blade and the last strand of 
the previous blade (Fig. 2.14e; Li and Roberts, 2001; Smith, 2008). In this way, the molecule can 
be more stabilized (Neer et al., 1994). These repeats also have a high percentage of hydrophobic 
residues to form the contact surface between the blades (Neer and Smith, 2000). The WD 
domain structure has two ends: the narrower end is often called the top, and wider end is called 
the bottom. In addition, there is a central tunnel that varies in shape and diameter based on the 
number of blades included (Neer and Smith, 2000). 
The crystal structure of WDR5 is usually studied together with its associated complexes. 
Like other WD40 repeat proteins, WDR5 exhibits a typical propeller-like structure with seven 
blades and a narrow central tunnel (Han et al., 2006). Below I summarize important structures of 
WDR5 that interact with different proteins and complexes.  
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Figure 2.14. Structure of WDR5. (a). Top and side views of crystal structure of WDR5 bound 
to N terminus of H3. H3 is bound to top face (the narrower end) of the β propeller of WDR5 
(Taken from Couture et al., 2006 with permission). (b). Top and side views of crystal structure of 
WDR5 bound to MLL1. Similar to H3, MLL1 is also bound to top face of the β propeller of 
WDR5. (Taken from Song and Kingston, 2008 with permission) (c). Top and side views of 
crystal structure of WDR5 bound to RBBP5. RBBP5 is bound to the bottom face (the wider end) 
of the β propeller, (opposite site of H3 binding site). (d). Side view of crystal structure of WDR5 
bound to KANSL1 and KANSL2. KANSL1 is bound to top face the β propeller of WDR5 and 
KANSL2 is bound to the bottom face (Taken from Dias et al., 2014 with permission). (e). WD 
repeat proteins share a common beta-propeller structure composed of several anti-parallel beta 
sheets/blades. The four-stranded anti-parallel beta sheets encoded by the same WD repeat 
sequence is marked in the same color. Each blade is composed of the first three parallel sheets of 
one WD repeat and the last parallel sheet of the previous WD repeat (Adapted from Valeyev et 
al., 2008). 
 
 
 
 
Recognition of Histone 3 - The top face (the narrower end) of the β propeller of WDR5 
can recognize H3 protein, specifically the first three amino acids, Ala-Arg-Thr (ART, 
immediately preceding Lys4) of H3 (Fig. 2.14a, Han et al., 2006). There are several key amino 
acids in WDR5 involved in the binding to H3. The carboxylate side chain of Asp107 in WDR5 
hydrogen bonds to the free amino group of Ala1 in H3. Ser91 and Cys261 in WDR5 also form a 
hydrogen bond to the backbone amide and carbonyl oxygen of Arg2 in H3 peptide. Tyr131 in 
WDR5 interacts with Ala1 in H3 via van der Waals contact (Han et al., 2006 and Couture et al., 
2006). WDR5 have varied binding capacities to H3K4 with different degrees of methylation 
(Wysocka et al., 2005). Although the methyl groups of H3K4me2 are located on the surface of 
WDR5 with no obvious contact with WDR5, Han and colleagues believed that H3K4 
dimethylation (H3K4me2) has the strongest binding affinity to WDR5 because the two methyl 
groups of Lys4 can form an extra pair of nonconventional hydrogen bonds with the carboxylate 
oxygen of Glu322 in WDR5. Compared with H3K4me2, H3K4 monomethylation (H3K4me1) 
has only one nonconventional hydrogen bond with Glu322, causing reduced interaction with 
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WDR5. The extra methyl group in H3K4me3 causes loss of the hydrogen bond, resulting in 
weaker affinity with WDR5 (Han et al., 2006 and Schuetz et al., 2006).  
MLL1-WDR5-RBBP5 complex - As mentioned earlier, WDR5 together with RBBP5 
and MLL can form an H3K4 methytransferase complex. MLL proteins can bind WDR5 through 
a Win motif. More detailed structure analysis indicated that Win motif of MLL1 binds WDR5 at 
the top face of the β propeller, which is the same binding pocket for H3 (Fig. 2.14b, Patel et al., 
2008; Song and Kingston, 2008). There are several key amino acids in MLL1 Win motif that 
interact with WDR5. Gly3762 and Ser3763 of the MLL1 form multiple hydrogen bond and van 
der Waals interactions with Ala47, Ala65, Gly89, Ile90, and Asp107 in WDR5. The side chain of 
Arg3765 of MLL1 inserts into the central tunnel of WDR5 and form hydrogen bond and 
hydrophobic interactions with Ser91, Phe133, Ser175, Ser218, Cys261, Phe263, and Ile305 in 
WDR5. In addition, the Arg3765 is positioned between Phe133 and Phe263 of WDR5. These 
facts make Arg3765 of MLL1 the key amino acid for WDR5 binding. Ala47 and Tyr260 in 
WDR5 interacts with Ala3766 of MLL1 and Tyr-260 in WDR5 makes van der Waals contacts 
with Ala3766, Glu3767, and Val3768 in MLL1. His3769 of MLL1 interacts with WDR5 
residues: Lys259, Phe149, Asp172, Pro173, and Tyr191 (Patel et al., 2008; Song and Kingston, 
2008).  
RBBP5 consists of an N-terminal β-propeller domain and a C-terminal hinge region. 
RBBP5 binds to WDR5 through its hinge region and more precisely, the segment located 
between residues 371 and 380 (Odho et al., 2010; Avdic et al, 2011). RBBP5 binds to a V-
shaped cleft formed by the junction of blades 5 and 6 of WDR5 at its bottom face (the wider end) 
of the β propeller, which is on the opposite site of H3 and MLL1 binding sites (Fig. 2.14c). 
Similar to the binding of H3 and MLL1, WDR5 binds RBBP5 by maintaining several hydrogen 
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bonds and van der Waals interactions. The Gln289 side chain in WDR5 makes van der Waals 
contacts with Glu374 in RBBP5. WDR5 can form two hydrophobic pockets for RBBP5 binding. 
Pocket 1 is created by amino acid Leu249, Tyr228, Leu240 and Lys250 in WDR5 to make 
hydrophobic interactions with Val375 in RBBP5. And pocket 2 consists of Phe-266, Val-268, 
and Leu-288 in WDR5 to bind Val377 in RBBP5. Val 375 in RBBP5 also forms two hydrogen 
bonds with Gln289 side chain in WDR5.  Asp376 and Ser379 in RBBP5 all form hydrogen 
bonds with Asn225 in WDR5 and WDR5′s Pro224 carbonyl group hydrogen bonds to Thr378 in 
RBBP5. There is also interaction between the RBBP5 Val380 and the WDR5 Arg181 (Odho et 
al., 2010; Avdic et al, 2011).  
KANSL1/WDR5/KANSL2 complex - The nonspecific lethal (NSL) complex is a 
distinct multi-protein complex. Together with the KAT MOF (male absent on the first), they 
form an evolutionarily conserved KAT complex (Dias et al., 2014). WDR5, KANSL1 and 
KANSL2 are all subunits of NSL complex and both KANSL1 and KANSL2 can interact with 
WDR5 (Zhao et al., 2013; Dias et al., 2014). Interestingly, KANSL1 and KANSL2 binds to 
opposite sides of WDR5 β propeller like MLL1 and RBBP5 (Fig. 2.14d, Dias et al., 2014). 
KANSL1 interacts with WDR5 by a region centered on Arg592 in a similar manner to MLL 
proteins and H3. Arg592 in KANSL1 inserts into the central tunnel of the β propeller of WDR5 
and form hydrogen bonds with Phe133, Phe263, Ser91, and Cys261 in WDR5. Thr587 and 
Val589 in KANSL1 form additional hydrogen bonds with Lys67, Ala65, and Gly89 in WDR5. 
Arg594 in KANSL1 makes a salt bridge with Asp107 in WDR5 and Val596 in KANSL1 makes 
a hydrophobic interaction with Tyr191, Pro216, and Leu234 in WDR5. Mutation on Arg592 in 
KANSL1 lead to unstable interaction with WDR5 and has resulted in protein degradation (Dias 
et al., 2014). KANSL2, like RBBP5, binds to the bottom face of the β propeller of WDR5. 
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Leu411, Val413, and Val414 of KANSL2 insert into a hydrophobic cleft between blades 5 and 6 
of the WDR5 domain. The mutation of either Leu411 or Val413 in KANSL2 is sufficient to 
disrupt its interaction with WDR5 (Dias et al., 2014). 
LncRNA binding interface on WDR5 - LncRNA HOTTIP and RBBP5 have shared 
binding cleft on WDR5 - the cleft between blades 5 and 6. Mutations of WDR5 on Tyr228, 
Leu240, Lys250, and Phe266 can significantly reduce its ability to bind HOTTIP. And among 
these mutations, F266A only affected its binding to HOTTIP without any defects in binding of 
MLL1 and RBBP5 (Yang et al., 2014). 
 
2.3.2 Biological functions of WDR5 
2.3.2.1 WDR5 is an important subunit in several protein complexes 
WDR5 is required as a scaffold for multi-protein complex interactions. It plays a role in 
facilitating the assembly of many chromatin-modifying complexes. The function of WDR5 as a 
subunit of the Histone methyltransferase complex MLL/WDR5/RBBP5 was first discovered in 
2005 (Wysocka et al., 2005) and is now becoming the most well studied function of WDR5. 
WDR5 is important for the recognition of H3 and for linking the methytransferase MLL to the 
rest of the WRAD complex. WDR5 is specifically and directly associated with methylated H3K4 
and knockdown of WDR5 in human cells affects global H3K4 methylation levels (Wysocka et 
al., 2005). Together with the SET1-family complex, they achieve transcriptional activation via 
methylation of H3K4.  
WDR5 is also a subunit of the histone acetyltransferase complex MOF/NSL. MOF is a 
member of the MYST family of histone acetyltransferases and is important in DNA damage 
repair and the maintenance of cell cycle and genomic stability (Zhao et al., 2013). MOF/NSL 
	   59	  
complex can acetylate H4 on K16, K5, and K8 (Zhao et al., 2013). MOF directly interacts with 
KANSL1. WDR5 interacts with both KANSL1 and KANSL2 and brings the MOF/NSL complex 
together (Dias et al., 2014). In Drosophila, a point mutation of NSL1 that disrupts its interaction 
with WDS (WDR5 in Drosophila) is entirely lethal to females and partially lethal to males (Dias 
et al., 2014).  
Since histone methylation on H3K4 and histone acetylation are all gene activation marks 
and both MLL/SET complex and MOF/NSL complex share a common WDR5 subunit, a 
question that needs addressing: is there any crosstalk between these two modifications? Indeed, 
there is a crosstalk between MOF-mediated H4K16 acetylation and MLL/SET-mediated H3K4 
methylation. Mutation or knockdown of MOF led to a reduced global histone H3K4 di-
methylation level in human cells while overexpression of MOF promoted H3K4 mono-, di- and 
tri-methylation. In contrast, the knockdown of RBBP5 only affected global H3K4 methylation 
level but had less effect on H4K16 acetylation. These findings indicate that MOF/NSL mediated 
H4 acetylation contributes to H3K4me2 by MLL/SET complexes (Zhao et al., 2013). More 
interestingly, WDR5 interacts with PKN1-mediated histone H3 threonine 11 phosphorylation 
(H3T11P), which in turn recruits MLL/SET complex leading to H3K4me3 occupancy (Kim et 
al., 2014). Since WDR5 is also a subunit of MOF/NSL complex, it is highly possible that 
H3T11P can also recruit MOF/NSL complex leading to H4 acetylation.  
WDR5 is also reported to be a component of a CHD8 (chromodomain, helicase, DNA-
binding) complex which is a group of ATP-dependent chromatin remodeling enzymes critical for 
the regulation of chromatin structure by modulating the contacts between histones and DNA 
(Thompson et al., 2008).  
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2.3.2.2 Role of WDR5 in regulation of Hox gene expression 
As a component of multiple histone modification complexes, WDR5 plays an important 
role in gene regulation. Hox genes are well known targets of MLL/SET complex. Knockdown of 
WDR5 led to decreased H3K4me3 occupancy over the promoter regions of HOXA9 and HOXC8 
and resulted in decreased expression of HOXA9 and HOXC8 (Wysocka et al., 2005). Hoxa2 and 
Hoxa10 are also targets of MLL/SET complex. The arginine methyltransferase PRMT6 (protein 
arginine methyltransferase 6) mediated H3R2 methylation can inhibit recruitment of WDR5 and 
H3K4 trimethylation and overexpression of PRMT6 resulted in decreased Hoxa2 and Hoxa10 
expression (Hyllus et al., 2007). The lncRNA HOTTIP interacts with WDR5 and induces 
H3K4me3 on 5' HOXA genes. Knocking down of WDR5 greatly abolished transcription of 
HOTTIP and 5′ HOXA genes in  primary foreskin fibroblast cells (Wang et al., 2011). 
 
2.3.2.3 WDR5 is important in cell differentiation and development  
WDR5 is also important for bone growth and skeletal development. WDR5 is expressed 
in osteoblasts, osteocytes as well as growth plate chondrocytes (Gori et al., 2001). The 
overexpression of Wdr5 in a murine prechondroblastic cell line led to increased cAMP 
production and parathyroid hormone (PTH) binding as well as accelerated formation of 
mineralized nodules, which are all signs of increased osteoblastic differentiation (Gori et al., 
2001). The persistent acceleration of osteoblast differentiation caused by overexpression of 
WDR5 was confirmed by postnatal analyses of transgenic mice and suggested that this effect is 
associated with the activation of the canonical Wnt pathway (Gori et al., 2006). Wdr5 
suppression resulted in significantly decreased alkaline phosphatase activity, Runx2 and 
osteocalcin expression, and absence of mineralized matrix formation, which are all indicators of 
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inhibited osteoblast differentiation (Zhu et al., 2008). WDR5 can also affect chondrocyte 
differentiation by modulating the expression of Twist-1 and fibroblast growth factor 18 (FGF18) 
(Gori et al., 2009). Down regulation of Wdr5 in developing chick limb confirmed that Wdr5 is 
required in vivo for endochondral bone development (Zhu et al., 2010). The down regulation of 
Wdr5 resulted in impaired chondrocyte maturation, delayed endochondral bone development and 
shortened skeletal elements (Zhu et al., 2010). In ameloblastoma, abnormal bone resorption and 
bone formation are observed. Patients with ameloblastoma showed down regulated WNT-related 
bone-forming genes including WDR5 and Runx2, further supporting that WDR5 is important in 
bone formation (Sathi et al., 2012). 
The transcription and regulatory networks in pluripotent ES cells are complicated and 
critical for the maintenance of ES cell differentiation and self-renewal and WDR5 is critical in 
maintaining epigenetic status in these networks. The expression of WDR5 has been found to be 
upregulated during the formation of induced pluripotent stem (iPS) cells and downregulated 
upon ES cell differentiation (Ang et al., 2011). Also higher levels of Wdr5 expression and 
H3K4me3 occupancy were observed in ES cells compared to somatic cells and tissues, 
suggesting a role for Wdr5 in ES and iPS cell maintenance (Ang et al., 2011). The knockdown of 
Wdr5 induced changes in ES cell morphology and resulted in loss of self-renewal. Furthermore, 
the depletion of pluripotency transcription factor Oct4 led to down regulated Wdr5 expression 
and decreased global H3K4me3 occupancy (Ang et al., 2011). In addition, the binding of 
lncRNA and WDR5 are important for ES cell pluripotency and differentiation. The binding of 
lncRNAs appears to be able to stabilize WDR5 protein and several ES cell lncRNAs that can 
bind WDR5 have been shown to be essential for maintaining ES cell fate (Yang et al., 2014). In 
mouse ES cells, expression of LincRNA1230 can block the localization of Wdr5 at the promoters 
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of early neural genes and inhibit the cells from adopting a neural cell fate (Wang et al., 2016). As 
a component of KAT complex MOF/NSL, WDR5 is also important in facilitating the 
maintenance of H4K16ac in ES cells (Li et al., 2012; Mu et al., 2015). 
 
2.3.2.4 Essential role of WDR5 in antiviral signaling pathway 
Viral infection can cause the assembling of a virus-induced complex on the outer 
membrane of mitochondria and activate NF-ƘB and IRF3 to induce type I interferons (IFNs) 
(Wang et al., 2010). WDR5 is associated with virus-induced signaling adaptor (VISA), the key 
protein for assembling the virus-induced complex, and is translocated from nucleus to the 
mitochondria outer membrane. Knockdown of WDR5 disrupted the formation of VISA 
associated virus-induced complex and inhibited the trigger of NF-ƘB and IRF3 expression, 
suggesting that WDR5 plays an important role in cellular antiviral response (Wang et al., 2010). 
 
2.4 Sumoylation and its role in nuclear protein translocation 
Sumoylation is a posttranslational modification by an approximately 10 kDa 
Small Ubiquitin-like Modifier (SUMO) proteins. This family of small proteins can modify the 
function of their target protein by covalently attaching to and detaching from them. Three 
enzymes are involved in sumo conjugation process: an E1 activating enzyme, an E2 conjugating 
enzyme and an E3 sumo ligase. Sumoylation is involved in several important cellular processes, 
including cell cycle, subcellular transportation, regulation of transcription and protein stability 
(reviewed by Hay, 2005; Kumar and Zhang, 2015).  
Among all the important functions of sumoylation, I have focused on its role in protein 
translocation. SUMOylation has emerged as a major mediator of nucleo-cytoplasmic 
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translocations of proteins. RanGAP1, the first SUMO substrate being identified, is a cytoplasmic 
protein (Matunis et al, 1996). The sumoylated RanGAP1 can activate the small GTPase protein 
Ran, a key player in the nuclear pore complex (NPC) that controls the nucleocytoplasmic 
trafficking of proteins (Mahajan et al., 1997). In HEK293 cells, five sumoylation sites have been 
identified on CDC73 protein yet only the sumoylation on K136 is located within the nuclear 
localization sequence and is responsible for the nuclear localization of CDC73 (Lamoliatte et al., 
2014). The serine/threonine kinase GSK3b is a protein important in neuronal development. 
GSK3b can be sumoylated and is present in both cytoplasm and nucleus under normal 
conditions. A mutation of GSK3b that inhibit sumoylation resulted in exclusion of GSK3b in the 
nucleus (Eun Jeoung et al., 2008; Berndt et al., 2012). Three lysine residues of the IGF1R can be 
SUMO-1 sumoylated and the mutations of these SUMO-1 sites prohibited the translocation of 
IGF1R into the nucleus (Sehat et al., 2010). Sumoylation can also translocate proteins from 
nucleus to cytoplasm, examples include MEK1 and TEL. The cytoplasmic localization of both 
proteins are dependent on their sumoylation and disruption of sumoylation prevents the nuclear 
export of both proteins (Sobko et al., 2002; Wood et al., 2003). SUMO activation enzyme (SAE) 
can rapidly shuttle in and out of nucleus when it is not sumoylated at the C-terminus of SAE2 
subunit. Sumoylation at the C-terminus of SAE2 subunit prevents the protein from being 
exported out from the nucleus (Truong et al., 2012). 
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CHAPTER 3 
3. Goal of the project 
3.1 Hypotheses to be tested： 
Hoxa2 gene has been found to play a very important role in palate development in mice 
(Smith et al., 2009). DNA methylation is an epigenetic pathway that can regulate gene 
expression through the methylation of CpG islands on gene promoter. I first hypothesized that 
CpG islands exist on Hoxa2 promoter and DNA methylation of the Hoxa2 gene promoter will 
regulate Hoxa2 expression in the developing mouse palate. 
micorRNAs are small noncoding RNAs that can lead to gene silencing and have been 
found to regulate hox genes in embryo development. Yet only one miRNA has been reported to 
directly target Hoxa2 gene. My second hypothesis is that specific miRNAs will directly bind 
Hoxa2 3' UTR and down regulate Hoxa2 expression at both transcriptional and translational 
level. 
Hotairm1 is a lncRNA identified in human that is transcribed between Hoxa1 and Hoxa2 
and can activate the expression of Hoxa1 and Hoxa2. The regulatory mechanisms of Hotairm1 
remain unstudied. My second hypothesis is that a noncoding transcript exists in the mouse 
genome between Hoxa1 and Hoxa2 genes and that can regulate their expression. This lncRNA 
will regulate Hoxa1 and Hoxa2 genes expression via histone modification. WDR5 is sumolylated 
and this modification is important in lncRNA induced histone methylation of Hoxa1 and Hoxa2 
genes. 
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3.2 Objectives: 
To test my first hypothesis, my objectives are to investigate the DNA methylation status 
of Hoxa2 promoter in developing mouse palate and to determine whether Hoxa2 expression will 
be regulate by DNA methylation in this process. 
To test my second hypothesis, my objectives are to determine if specific miRNA binding 
sites are present on 3' UTR of Hoxa2 mRNA and to determine if the miRNA’s identified from 
above, are expressed in the developing mouse palate and whether this correlates with Hoxa2 
expression. 
To test my third hypothesis, my objectives are to characterize a lncRNA transcribed 
between Hoxa1 and Hoxa2 and determine whether this lncRNA plays a role in regulating Hoxa1 
and Hoxa2 expression. To identify the histone modification complex that interacts with the 
lncRNA. To investigate whether WDR5 is sumolylated and whether this modification plays a 
role in the function of WDR5.  
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CHAPTER 4 
4. Materials and methods  
4.1 Materials 
4.1.1 Chemicals and reagents 
Chemicals, reagents, kits, antibodies, miRNA mimic and siRNA, primers, vectors, 
enzymes and equipments used in the materials and methods section are listed below. 
 
Table 4.1. List of chemicals, reagents and equipments. 
 
Item and Catalog Number Supplier 
Chemical and Reagent 
1Kb Plus DNA Ladder (10787-018) Invitrogen 
Acrylamide:bis (1610125) Bio-Red Laboratories, Ltd. 
Agar (214010) BD Biosciences 
Agarose (BP1356-100) Fisher Scientific, Co. 
All trans retinoic acid (R2625) Sigma-Aldrich, Co. 
Ammonium persulfate (A9164) Sigma-Aldrich, Co. 
Ampicillin (A1066) Sigma-Aldrich, Co. 
b-mercaptoethanol (1610710) Bio-Red Laboratories, Ltd. 
Bovine serum albumin (BSA) (05471) Sigma-Aldrich, Co. 
Bovine calf serum (BCS) (SH30073.03) HyClone Laboratories, Inc. 
Coomassie blue (B0149) Sigma-Aldrich, Co. 
Denhardt’s solution (D2532) Sigma-Aldrich, Co. 
DMSO (317275-500ML) Millipore Canada, Ltd. 
dNTPs (R0193) Thermo Fisher Scientific, Co. 
Dulbecco's Modified Eagle Medium (DMEM) 
(SH30022.01) 
HyClone Laboratories, Inc. 
EDTA (EDS-100G) Sigma-Aldrich, Co. 
EGTA (E3889) Sigma-Aldrich, Co. 
Ethanol (P016EAAN) GreenField Specialty Alcohols, Inc.  
Fetal bovine serum (FBS) (F1051) Sigma-Aldrich, Co. 
Fisher BioReagents EZ-Run Prestained Rec 
Protein Ladder (BP3603500) 
Fisher Scientific, Co. 
Glutathione Agarose (Pierce) (16100) Thermo Fisher Scientific, Co. 
Glycerol (BDH1172-4LG) BDH Inc. 
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Glycine (BP381-1) Fisher Scientific, Co. 
HEPES (H3784) Sigma-Aldrich, Co. 
HiperFect transfection reagent (301705) Qiagen Inc. 
Kanamycin sulfate (60615) Sigma-Aldrich, Co. 
Lipofectamine 2000 (11668019) Invitrogen 
N-ethylmaleimide (NEM) (sc-202719) Santa Cruz Biotechnology, Inc. 
Methanol (A452-4) Fisher Scientific, Co. 
Formaldehyde (28908) Sigma-Aldrich, Co. 
Precision Plus Protein Kaleidoscope Protein 
Standards (1610375EDU) 
Bio-Red Laboratories, Ltd. 
Protease inhibitor cocktail (P8340) Thermo Fisher Scientific, Co. 
Protein A agarose (sc-2001) Santa Cruz Biotechnology, Inc. 
PVDF transfer membrane (88520) Thermo Fisher Scientific, Co. 
Streptavidin ultralink resin (Pierce) (20347) Thermo Fisher Scientific, Co. 
Sodium chloride (NaCl) (S271-3) Fisher Scientific, Co. 
Sodium dodecyl sulfate (SDS) (436143) Sigma-Aldrich, Co. 
Sodium hydrogencarbonate (NaHCO3) 
(236527) 
Sigma-Aldrich, Co. 
Sodium pyruvate (SH30239.01) HyClone Laboratories, Inc. 
Spermidine (S2626) Sigma-Aldrich, Co. 
Spermine (S4264) Sigma-Aldrich, Co. 
Subcloning Efficiency™ DH5α™ Competent 
Cells (18265-017) 
Invitrogen 
Sucrose (S5-3) Sigma-Aldrich, Co. 
SUPERase In™ RNase Inhibitor (AM2694) Ambion, Inc. 
SYBR Green PCR Master Mix (4472908) Applied Biosystems 
Taqman universal master mix (4370048) Applied Biosystems 
TEMED (T7024)  Sigma-Aldrich, Co. 
Tris (BP153-1) Fisher Scientific, Co. 
Triton X-100 (T9284-500ML) Sigma-Aldrich, Co. 
Tween 20 (BP337-500) Thermo Fisher Scientific, Co. 
Tryptone (BP1421-500) Fisher Scientific, Co. 
X-gal (CAS7240-90-6) Fisher Scientific, Co. 
Yeast extract (212750) BD Biosciences 
Commercially Available Kits 
Clarity Western ECL Blotting Substrate Kit 
(1705061) 
Bio-Red Laboratories, Ltd. 
EpiTect MSP kit (59305) Qiagen, Inc. 
EZ DNA methylation kit (D5001) Zymo Research, Co. 
GeneJET PCR Purification kit (K0701) Thermo Fisher Scientific, Co. 
GeneJET Plasmid Miniprep Kit (K0503) Thermo Fisher Scientific, Co. 
IsHyb In Situ Hybridization Kit (K2191050) BioChain Institute, lnc.  
LucPair miR Duo-Luciferase Assay Kit 
(LPFR-M010) 
GeneCopoeia 
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miScript II RT Kit (218161) Qiagen, Inc. 
miScript SYBR Green PCR Kit (218073) Qiagen, Inc. 
PureLink Genomic DNA Mini Kit (K1820-
01) 
Invitrogen 
QIAquick Gel Extraction kit (28704) Qiagen, Inc. 
QuantiTect Reverse Transcription Kit 
(205311) 
Qiagen, Inc. 
QuikChange Lightening Site-Directed 
Mutagenesis Kit (210518) 
Agilent Technologies  
RNeasy Protect Mini Kit (74124) Qiagen, Inc. 
Antibodies 
Anti-Digoxigenin-fluorescein, Fab fragments 
(11207741910) 
Roche Diagnostics  
GAPDH antibody (G-9) (sc-365062) Santa Cruz Biotechnology, Inc. 
Goat Anti-Mouse IgG (H+L) HRP Conjugate 
(1706516) 
Bio-Red Laboratories, Ltd. 
Goat Anti-Rabbit IgG (H+L) HRP Conjugate 
(1706515) 
Bio-Red Laboratories, Ltd. 
Histone H3 antibody (ab1791) Abcam, Inc. 
Histone H3 (tri methyl K4) antibody (ab8580) Abcam, Inc. 
Histone H3 (tri methyl K27) antibody 
(ab6002) 
Abcam, Inc. 
Normal mouse IgG (sc-2025) Santa Cruz Biotechnology, Inc. 
Normal mouse IgM (sc-3881) Santa Cruz Biotechnology, Inc. 
Normal rabbit IgG (sc-2027) Santa Cruz Biotechnology, Inc. 
SUMO1 21C7 antibody Developmental Studies Hybridoma Bank  
WDR5 antibody (A-6) (sc-393116) Santa Cruz Biotechnology, Inc. 
WDR5 antibody (ab22512) Abcam, Inc. 
Commercially Available miRNA mimic and siRNA 
AllStars Negative Control siRNA 
(SI03650318) 
Qiagen, Inc. 
Syn-mmu-miR-376c-3p miScript miRNA 
Mimic (MSY0003183) 
Qiagen, Inc. 
Syn-mmu-miR-669b-5p miScript miRNA 
Mimic (MSY0003476) 
Qiagen, Inc. 
Commercially Available Primers 
FAM-labeled Hoxa2 Taqman primer Applied Biosystems 
Hs_RNU6-2_11 miScript Primer Assay 
(MS00033740) 
Qiagen, Inc. 
Mm_miR-19a_1 miScript Primer Assay 
(MS00001302) 
Qiagen, Inc. 
Mm_miR-298_1 miScript Primer Assay 
(MS00002016) 
Qiagen, Inc. 
Mm_miR-376c_1 miScript Primer Assay Qiagen, Inc. 
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(MS00002268) 
Mm_miR-431_1 miScript Primer Assay 
(MS00002373) 
Qiagen, Inc. 
Mm_miR-669b_1 miScript Primer Assay 
(MS00002716) 
Qiagen, Inc. 
Mm_miR-878-3p_1 miScript Primer Assay 
(MS00012789) 
Qiagen, Inc. 
Prime Time qPCR Primers Hoxa1 
(Mm.PT.51.10819147.g) 
IDT Integrated DNA Technologies, lnc. 
Prime Time qPCR Primers Hoxa2 
(Mm.PT.51.7231226) 
IDT Integrated DNA Technologies, lnc. 
VIC-labled b-actin Taqman primer Applied Biosystems 
Vectors 
pEZX-MT01 (CmiT000001-MT01) GeneCopoeia 
pEZX-MT01-Hoxa2 (MmiT029383-MT01) GeneCopoeia 
pGEM-T Easy Vector System I (PR-A1360) Promega, Co. 
pGEX-6p-1 (28-9546-48) GE Healthcare 
Enzymes 
BamH I (FastDigest) (FD0054) Thermo Fisher Scientific, Co. 
EconoTaq DNA polymerase (30031-2) Lucigen Co. 
EcoR I (FastDigest) (FD0274) Thermo Fisher Scientific, Co. 
Proteinase K (P2308) Sigma-Aldrich, Co. 
Equipment  
AccuSpin Micro 17 Thermo Fisher Scientific, Co. 
Branson digital sonifier 250  Branson Ultrasonics 
CKX41 Microscope Olympus Canada, INC. 
Isotemp Digital Block Dry Heater Thermo Fisher Scientific, Co. 
Milli-Q Advantage A10 Water Purification 
System 
Millipore Canada, Ltd. 
Monobloc Weighing Technology AB54-S METTLER TOLEDO 
Moxi Z Mini Automated Cell Counter ORFLO Technologies 
MyCycler Thermal Cycler Bio-Red Laboratories, Ltd. 
NanoVue Plus Spectrophotometer GE Healthcare 
pH 700 Benchtop Meter OAKTON Instruments 
PowerPac Basic Power Supply Bio-Red Laboratories, Ltd. 
Sorvall Legend X1 Centrifuge Thermo Fisher Scientific, Co. 
StepOne Real-Time PCR System Applied Biosystems Canada 
Syngene G:Box  Syngene 
UV Transilluminator TM-10E UVP 
Vortex-Genie 2 VWR 
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Table 4.2. Names and addresses of distributors  
 
Company Location 
Abcam, Inc. Toronto, ON, Canada 
Agilent Technologies  Santa Clara, CA, USA 
Ambion, Inc. Foster City, CA, USA 
Applied Biosystems Canada Streetsville, ON, Canada 
Branson Ultrasonics Danbury, CT, USA 
BD Biosciences Mississauga, ON, Canada 
BDH Inc. Toronto, ON, Canada 
BioChain Institute, lnc.  Newark. CA, USA 
Bio-Red Laboratories, Ltd. Mississauga, ON, Canada 
Developmental Studies Hybridoma Bank  Iowa City, IA, USA 
Fisher Scientific, Co. Ottawa, ON, Canada 
GE Healthcare Mississauga, ON, Canada 
GeneCopoeia Rockville, MD, USA 
GreenField Specialty Alcohols, Inc.  Brampton ON, Canada 
HyClone Laboratories, Inc. Logan, UT, USA 
IDT Integrated DNA Technologies, lnc. Coralville, IA, USA 
Invitrogen Canada, Inc. Burlington, ON, Canada 
Lucigen, Co. Middleton, WI, USA 
METTLER TOLEDO Mississauga, ON, Canada 
Millipore Canada, Ltd. Etobicoke, ON, Canada 
Santa Cruz Biotechnology, Inc. Dallas, TX, USA 
Sigma-Aldrich, Co. Oakville, ON, Canada 
Thermo Fisher Scientific, Co. Waltham, MA, USA 
OAKTON Instruments Vernon Hills, IL, USA 
Olympus Canada, INC. Richmond Hill, ON, Canada 
ORFLO Technologies Ketchum, ID, USA 
Promega, Co. Madison, WI, USA 
Qiagen, Inc. Mississauga, ON, Canada 
Roche Diagnostics  Laval, QC, Canada 
Syngene Cambridge, UK 
UPV Upland, CA, USA 
VWR Mississauga, ON, Canada 
Zymo Research, Co. Irvine, CA, USA 
 
4.1.2 Cell lines 
In this study, NIH 3T3 (ATCC CRL-1658) and EG7 (ATCC CRL-2113) cell lines were 
used. NIH 3T3 is a mouse embryonic fibroblast cell line that exhibits expression of both Hoxa1 
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and Hoxa2. In addition, Hoxa2 promoter was demonstrated to be unmethylated in this cell line 
(X. Wang, PhD Thesis, 2013). EG7 cell line is derived from the murine T-cell lymphoma EL-4 
transfected with cDNA for ovalbumin (OVA). Previous studies from our laboratory has shown 
Hoxa2 promoter to be highly methylated with no Hoxa2 expression in the EG7 cell line (X. 
Wang, PhD Thesis, 2013).  
 
4.1.3 Animals 
Female timed-pregnant CD-1 mice were obtained from Animal Resources Centre, 
University of Saskatchewan. All procedures were approved by the University Committee on 
Animal Care and Supply at the University of Saskatchewan. 
 
4.2 Methods 
4.2.1. Cell culture conditions 
The mouse embryonic fibroblast NIH 3T3 cell line was cultured in Dulbecco's Modified 
Eagle Medium (DMEM) supplemented with 10% bovine calf serum (BCS) and 1% 
antibiotic/antimycotic (Ab/Am). The mouse lymphocyte EG7 cell line was cultured in DMEM 
supplemented with 10% FBS, 110 mg/L sodium pyruvate and 1% Ab/Am. Both cell cultures 
were incubated with 5% CO2 and 100% relative humidity at 37° C. 
 
4.2.2. DNA methylation analysis 
4.2.2.1 Sodium bisulfite modification 
Genomic DNA samples were extracted from NIH 3T3 cell line, EG7 cell line and E12 to 
E15 mouse palate tissue using PureLinkÒ Genomic DNA Mini Kit (Invitrogen). Genomic DNA 
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was modified with bisulfite reagent for DNA methylation analysis using the EZ DNA 
methylation kit (Zymo Research, USA). According to the manufacturer’s instructions, 2 µg of 
genomic DNA was modified per sample. NanoVue UV/visible Spectrophotometer (GE 
Healthcare) was used to determine the concentration and purity of bisulfite treated DNA 
samples. Bisulfite treated DNA samples were stored at -20°C.  
 
4.2.2.2 Methylation specific PCR  
After sodium bisulfite modification of genomic DNA, DNA methylation within promoter 
associated CpG islands was determined with methylation specific PCR (MSP) primers listed in 
Table 4.3. The principle used to design MSP primers are shown in Figure 4.1. Bisulfite treatment 
of DNA can convert unmethylated cytosine (C) into uracil (U) while the methylated C will 
remain as C. In this way the methylation status of a CpG island can be identified by its sequence 
after bisulfite conversion. MSP primers were designed to include at least one CpG site in the 
primer sequence and based on the sequence differences between methylated and unmethylated 
CpG island following bisulfite treatment. Two sets of primers were designed for each CpG island, 
the methylated primer set and the unmethylated primer set. In total, six pairs of MSP primers 
were designed to detect methylation status of the three CpG rich regions of the Hoxa2 promoter 
(Table 4.3). 
For the PCR amplification (a total of 50µl), 200 ng of bisulfite-modified DNA, 2 × 
EpiTect MSP master mix (Qiagen), 200 µM of each dNTP and 500 nM of each forward and 
reverse primer was used. The PCR cycle for region 1 and 3 (MPS-CpG1 and MPS-CpG3) started 
with a Taq activation step at 95°C for 10 min, followed by 35 cycles of 94°C for 15sec, 53°C for 
30sec, 72°C for 30sec and a final extension step at 72°C for 10 min. The PCR cycle for region 2 
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(MPS-CpG2) had 1 cycle of 95°C for 10 min, followed by 35 cycles of 94°C for 15sec, 55°C for 
30sec, 72°C for 30sec and a final extension step at 72°C for 10 min. 
 
Figure 4.1. Bisulfite determination of DNA methylation. Under the treatment of bisulfite 
conversion, the methylated cytosine (C) in the genomic DNA will remain as C, while 
unmethylated C will be convered into uracil (U). Based on this, methylation specific primers 
(MSP) can be designed for methylated and unmethylated sequences. During PCR, U will be 
replaced with thymine (T). BSP primers are designed in the sequences that lack CG sites. 
 
 
4.2.2.3 Bisulfite specific PCR and sequencing 
After sodium bisulfite modification of genomic DNA, bisulfite specific PCR (BSP) 
amplification was carried out. BSP primers were designed in the sequences that lack CG sites so 
the CpG island, whether methylated or not, can be amplified by the same BPS primer and the 
sequence difference can be tested by DNA sequencing (Fig. 4.1). For the PCR amplification (a 
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total of 50µl), 200 ng of bisulfite-modified DNA, 10×EconoTaq buffer, 2.5 units of EconoTaq 
DNA polymerase (Invitrogene), 200 µM of each dNTP and 500 nM of each forward and reverse 
primer (Table 4.3) were used. The PCR cycle started with one step at 95°C for 3min, followed 
by 35 cycles of 95°C for 30sec, 55°C for 30sec, 72°C for 40sec and a final extension step at 
72°C for 10 min. DNA samples were run on a 1% agarose gel and target bands were excised 
from the gel and purified using QIAquick Gel Extraction kit (Qiagen). The purified DNA 
samples were then cloned into pGEM® T-easy vector (Fig.4.2, Promega). The ligation system 
(10 µl) was set up with 5µl 2x Rapid Ligation Buffer, 1 µl pGEM® T-easy vector, 1 µl T4 DNA 
ligase and 3 µl gel purified PCR product (pGEM®-T Easy Vector System I, Promega). Ligation 
was carried at 10°C over night, followed by 5 min incubation at 70°C to inactivate T4 DNA 
ligase. Ligation product was then transformed into DH5α™ Competent Cells (Subcloning 
Efficiency™, Invitrogen). For each transformation, 5 µl ligation product was incubated with 50 
µl DH5α™ competent cells for 40 min on ice and heat shocked at 42°C for 90 s. Cells were then 
incubated on ice for 2 min and recovered in 200 µl LB medium (10g Bacto-Tryptone, 5g Bacto-
yeast extract and 10g NaCl in 1L medium, PH 7.4) for 30 min at 37°C. The cells were then 
spread in LB-ampicillin agar plates (10 ml LB per plate with 1% ampicillin and 1.5% agar) with 
20mM IPTG and 80µg/ml X-gal for blue-white screening. The plates were incubated at 37°C 
overnight and each single white clone was picked and cultured in 4ml LB with 1% ampicillin 
overnight at 37°C. Cells were then collected and plasmids were purified with GeneJET Plasmid 
Miniprep Kit (Thermo Fisher Scientific) as per manufacture’s protocol. The plasmids containing 
BSP amplification fragments were sequence analyzed with an ABI PRISMTM system using M13 
forward primer at the National Research Council, Plant Biotechnology Institute, Saskatoon, SK. 
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Figure 4.2. pGEM® T-easy vector map (Promega). pGEM®-T Easy Vector is a linearized 
vector with a single 3 ́-terminal thymidine (T) at both ends. PCR products generated by certain 
polymerases are adenine (A) tailed and can be ligated to pGEM®-T Easy Vector based on A-T 
pairing. pGEM®-T Easy Vector has the α-peptide coding region of the enzyme β-galactosidase 
(lacZ) which allows blue/white screening on indicator plates. The pGEM®-T Easy Vector also 
provides three single-enzyme digestions (EcoRI, BstZI and NotI) for release of the insert. Figure 
taken from Promega 
http://embed.widencdn.net/img/promega/ws62vit9cf/640px/1473VA05_6B.jpeg?u=7fvzhm. 
 
 
4.2.3. Prediction and analysis of miRNA binding sites on mouse Hoxa2 3' UTR 
The website http://www.microrna.org was used to predict miRNAs that may bind to 
mouse 3' UTR of Hoxa2 gene, and comparisons made with the binding site present in mouse 3' 
UTR Hoxa2 gene with other species including human, rat, chimpanzee and dog using Genbank 
(NCBI). 
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4.2.4. RNA Isolation and Reverse Transcription (RT) 
For the mRNA study, total RNA was isolated from NIH 3T3 cells, mouse embryo palate 
shelves (E12 to E15) and mouse tissue samples (head, forelimb, hindlimb and tail) from E13 
embryos using RNeasy Protect Mini Kit (Qiagen). Each sample was reverse transcribed to cDNA 
using QuantiTect® Reverse Transcription Kit (Qiagen). Genomic DNA (gDNA) elimination 
reaction was set up to a total volume of 14 µl with 2 µl 7x gDNA Wipeout Buffer, 500ng 
template RNA and incubated for 2 min at 42°C and placed on ice immediately. Reverse-
transcription master mix was prepared with 1 µl Quantiscript Reverse Transcriptase, 4 µl 5x 
Quantiscript RT Buffer and 1 µl RT Primer Mix and added to gDNA eliminated RNA template 
from the previous step. The reverse transcription was then carried out by incubating the system at 
42°C for 1 h and 3 min at 95°C to inactivate Quantiscript Reverse Transcriptase. cDNA samples 
were then stored at -20°C for further experiments. For miRNA study, total RNA including small 
RNA was isolated from NIH 3T3 cell culture and mouse embryo palate shelves (E12 to E15) 
using miRNeasy Mini Kit (Qiagen) and was reverse transcribed into cDNAs using miScript II 
RT Kit (Qiagen). A total volume of 20 µl reverse-transcription reaction containing 4 µl 5x 
miScript HiSpec Buffer, 2 µl 10x miScript Nucleics Mix, 2 µl miScript Reverse Transcriptase 
Mix and 500 ng template RNA was incubated for 60 min at 37°C followed by 5 min incubation 
at 95°C to inactivate miScript Reverse Transcriptase Mix. cDNA samples were stored at - 20°C 
for further experiments. 
 
4.2.5. Quantitative real-time PCR (qRT-PCR)  
In miRNA study, Hoxa2 gene expression was detected using FAM (fluorescein amidite)-
labeled Taqman gene expression primers (Applied Biosystems). VIC-labeled b-actin Taqman 
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primers were used as endogenous control. PCR reaction started with a 2 min initiation at 50°C 
and 10 min denaturation at 95°C, followed by 40 cycles with each cycle consisting of 15 s at 
95°C and 70 s at 60°C (Smith et al., 2009). Mature miRNAs were detected with individual 
miRNA SYBR® green primers (Qiagen). Small nuclear RNA (snRNA) RNU6B was used as 
control gene of miRNA expression and was detected with RNU6B SYBR® green primers 
(Qiagen). Amplification system of 25µl was prepared with miScript SYBR® Green PCR Kit 
(Qiagen) with 25ng cDNA input and the reaction cycles were as follows: 15 min initial 
activation at 95°C, followed by 40 cycles of 15s at 94°C, 30s at 55°C and 30s at 70°C in 7300 
ABI detection system. All reactions were run in replicates of 2, n=4. 
For the lncRNA study, Hoxa1, Hoxa2 and mHotairm1 expressions were detected using 
primers as listed in Table 4.1 and Table 4.3. b-actin was detected using primers listed in Table 
4.3 as control house keeping gene.  SYBR® Green PCR Master Mix (Applied Biosystems) was 
used and the reaction cycles were as follows: 10 min initiation at 95°C, followed by 40 cycles of 
15s at 95°C and 60s at 60°C in 7300 ABI detection system. All reactions were run in replicates 
of 2, n=3. 
Relative quantity (RQ) value was determined by the 2(-∆∆Ct) method described in the 
(Smith et al., 2009) and from Applied Biosystems User Bulletin (ABI PRISM 7700 Sequence 
Detection System, Applied Biosystems, 2001). 
 
4.2.6. Western blot analysis 
Protein samples were collected from NIH 3T3 cells and E13 Hoxa2-/- mice embryos with 
radioimmunoprecipitation assay buffer (RIPA buffer). Samples were then quantified using a Bio-
Rad DC Protein Assay kit and denatured for 10 min with 2X loading buffer. Each sample was 
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electrophoresed in a 10% polyacrylamide-SDS gel and transferred to a PVDF transfer membrane 
(Thermo Fisher Scientific) using Xcell II Blot Module (Invitrogen) for wet transfer in 1X 
transfer buffer containing 12 mM Tris, 96 mM glycine and 20% methanol, for 1.5 h at 20V/150 
mAmp.  
In miRNA study, the blotting and detection of Hoxa2 protein was performed as described 
in Smith et al. (2009). Briefly, PVDF membranes were blocked in 3% skim milk (in PBS) at 
4 °C for 1 h and then incubated with the rabbit anti-Hoxa2 antiserum (Hao et al., 1999) at a 
dilution of 1:1000 in 3% skim milk overnight at 4 °C. Membrane were then washed 3 x 10 min 
with 0.1% Tween-20 in PBS (PBST) and incubated for 1 h at room temperature with horse 
radish peroxidase (HRP) conjugated secondary goat anti-rabbit IgG (1:3000 in 5% skim milk, 
Bio-Rad). Visualization of proteins was performed by a Clarity™ Western ECL Blotting 
Substrate Kit (Bio-Rad) as per manufacture’s instructions, followed by exposure of the 
membranes using Syngene imaging system (Syngene, Cambridge, UK). The same membranes 
were probed with GAPDH antibody as an internal control (sc-365062, 1:3000, Santa CruzÒ) for 
1h at room temperature and secondary anti-mouse IgG antibody (1:3000, Bio-RadÒ) for 1h at 
room temperature.  
In lncRNA study, to detect WDR5 protein, transfer membranes were blocked in 3% 
bovine serum albumin (BSA) for 1 h (in PBST) followed by overnight incubation with anti-
WDR5 antibody (ab22512, 1:1000, AbcamÒ) at 4°C, and subsequent incubation with secondary 
anti-rabbit IgG antibody (1:3000, in 5% skimmed milk in PBST, Bio-RadÒ) for 1 h at room 
temperature. Sumoylated protein was detected by overnight incubation with SUMO1 21C7 
antibody (1:500, in 3% BSA, Developmental Studies Hybridoma Bank) at 4°C and secondary 
anti-mouse IgG antibody (1:3000, in 5% skimmed milk, Bio-RadÒ) for 1h at room temperature.  
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4.2.7. MiR-669b and miR-376c over expression 
NIH 3T3 cells (6 ×104/well) were seeded in a 24-well plate in 0.5 ml culture medium. 
HiperFect Transfection Reagent, (6 µl, QiagenÒ) and 300 ng of either miRNA-669b mimic, 
miR-376c mimic (QiagenÒ) or control siRNA (QiagenÒ) were applied to each well based on 
HiperFect transfection protocol (QiagenÒ). Cells were then incubated under normal growth 
conditions and RNA samples were isolated after 24 h and 48 h incubation. Protein samples were 
collected after 24 h incubation. 
 
4.2.8. Hoxa2-3'UTR mutation vector construction 
The vector pEZX-MT01-Hoxa2 (GeneCopoeiaTM) contained full length mouse Hoxa2 
3'UTR. QuikChange Lightening Site-Directed Mutagenesis Kit (Agilent Technologies) was used 
to carryout site directed mutations on Hoxa2 3'UTR. pEZX-MT01-Hoxa2mut1 was generated 
using forward primer 669b1F and reverse primer 669b1R (Table 4.3) with an AA-CG mutation 
(Fig. 5.5A). pEZX-MT01-Hoxa2mut2 was generated using forward primer 669b2F and reverse 
primer 669b2R (Table 4.3) with an AA-CG mutation (Fig.5.5A). Mutation reaction was set up 
(50 µl) with 5 µl of 10x reaction buffer, 100ng pEZX-MT01-Hoxa2 vector template, 125 ng of 
forward and reverse primers, 1 µl of dNTP mix, 1.5 µl of QuikSolution reagent and 1 µl of 
QuikChange Lightning Enzyme. The mutation PCR started with 2 min incubation at 95°C, 
followed by 18 cycles of 20s at 95°C, 10s at 60°C and 3 min at 68°C, and a 5 min extension at 
68°C. The PCR products were then digested with 2 µl of Dpn I restriction enzyme at 37°C for 5 
min to digest the parental vector DNA. Mutated vectors were then transformed into XL10-Gold 
ultracompetent cells as described in manufacturer’s protocol (QuikChange Lightening Site-
Directed Mutagenesis Kit, Agilent Technologies). Each single clone was picked and incubated in 
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4 ml LB medium with 1% Kanamycin over night at 37°C.  Plasmid was purified from bacterial 
culture using GeneJET Plasmid Miniprep Kit (Thermo Fisher Scientific) as per manufacture’s 
protocol and target mutation was confirmed via sequencing with an ABI PRISMTM system at the 
National Research Council, Plant Biotechnology Institute, Saskatoon, SK. A double mutation 
vector pEZX-MT01-Hoxa2mut1+2 containing both mutation1 and mutation2 was also 
generated. 
 
4.2.9. Luciferase assay  
The vector pEZX-MT01 (Genecopoeia) encoding firefly luciferase (hLuc) and renilla 
luciferase (hRLuc) was used as negative control in luciferase assay (Fig. 4.3A). NIH 3T3 cells (6 
×104) were seeded in each well of a 24-well plate in 0.5 ml culture medium and cultured for 24 h. 
After 24 h incubation, either miR-669b mimic (Qiagen), miR-376c mimic (Qiagen) or control 
siRNA (Qiagen) was co-transfected with one of the following luciferase vectors:  pEZX-MT01-
Hoxa2, pEZX-MT01-Hoxa2mut1, pEZX-MT01-Hoxa2mut2, pEZX-MT01-Hoxa2mut1+2 or 
blank pEZX-MT01 vector using lipofectamine 2000 (Invitrogen). For each transfection, 3 µl 
lipofectamine 2000 (Invitrogen) was incubated together with 300 ng miRNA mimic/siRNA 
control and 1 µg luciferase vector in 100 µl DMEM for 20 min and then added into cell cultures. 
The vector pEZX-MT01 (Genecopoeia) encoding hLuc and hRLuc was used as negative control 
in luciferase assay. After 24h post-transfection, cells were washed with PBS and lysed using 
LucPair miR Duo-Luciferase Assay Kit (GeneCopoeia). Firefly and Renilla luciferase activities 
were determined for each transfection using a luminometer. The firefly luciferase signals were 
normalized to the Renilla luciferase signal. 
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Figure 4.3. Mechanism of Duo-Luciferase assay. (A) pEZX-MT01 vector map. Hoxa2 3'UTR 
is inserted as miR target. pEZX-MT01 vector encodes firefly luciferase (hLuc) and renilla 
luciferase (hRLuc). hLuc mRNA is merged with Hoxa2 3'UTR and is used as an indicator of 
miRNA effects. hRluc is expressed independently and is used as an internal control. Vector map 
taken from Genecopoeia (B) Mechanism of luciferase assay. Hoxa2 3'UTR is attached to firefly 
luciferase mRNA. If Hoxa2 3'UTR is targeted by miRNAs, the entire mRNA may be cleaved 
and reduced luminescence will be detected.   
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4.2.10. Mouse Hotairm1 (mHotairm1) sequence analysis 
Three pairs of overlapping primers (Mush 147F, Mush 147R, Mush 138F, Mush 138R, 
Mush 245F, Mush 245R) were designed (Fig. 4.4) and PCR were carried out using cDNA 
samples from NIH 3T3 cells. For the PCR amplification (a total of 50µl), 50 ng of cDNA, 
10×EconoTaq buffer, 2.5 units of EconoTaq DNA polymerase (Invitrogen), 50 µM of each 
dNTP and 500 nM of each forward and reverse primer (Table 3.1) were used. The PCR cycle 
started with one cycle at 95°C for 3 min, followed by 30 cycles of 95°C for 30 sec, 52°C for 30 
sec, 72°C for 40 sec and a final extension step at 72°C for 10 min. The PCR fragments were run 
on a 1.2% agarose gel and purified from the gel using QIAquick Gel Extraction kit (Qiagen). The 
DNA samples were then cloned into pGEM T-easy vector as described in 4.2.2.3 for subsequent 
sequence analysis with an ABI PRISMTM system at the National Research Council, Plant 
Biotechnology Institute, Saskatoon, SK. 
 
4.2.11. MHotairm1 silencing in NIH 3T3 cells  
NIH 3T3 cells (6 ×104) were seeded in each well of a 24-well plate in 0.5 ml culture 
medium. siRNA (150 ng of hotairm1 siRNA or control siRNA) and 6 µl HiperFect Transfection 
Reagent (Qiagen) were incubated in 100 µl DMEM medium for 20 min and then added to each 
well. Cells were then incubated under normal growth conditions and RNA samples were isolated 
after 72 h incubation. SYBR green real-time PCR was carried out with mHotairm1 primers mush 
137F and mush138R (Table 4.3). Hoxa1 and Hoxa2 expression were detected using Hoxa1 and 
Hoxa2 SYBR primers (Table 4.1, Integrated DNA Technologies). 
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4.2.12. Effect of all-trans Retinoic acid (ATRA) on mHotairm1 expression 
NIH 3T3 cells were seeded in 100 mm cell culture dish and grown to 70% confluency. 
NIH 3T3 cells were treated with ATRA (10-6M) for 24 h. RNA was isolated, reverse transcribed 
to cDNA, followed by real-time PCR to detect mHotairm1, Hoxa1 and Hoxa2 expression as 
indicated in 4.2.4 and 4.2.5. Protein samples were collected and WDR5 protein was detected 
using western blot analysis as indicated in 4.2.6. 
 
 
 
Figure 4.4. Primer, siRNA and probe design for mHotairm1. Three pairs of primers were 
designed to cover the predicted mouse hotairm1 sequence. Violet: primer Mush 147F/R; Blue: 
primer Mush 138F/R; Green: primer Mush 245F/R. Primer names were marked above sequence. 
Three probes (Probe 1, 2 and 3, underlined sequences in red) were designed against mHotairm1 
for CHART experiment and Probe C is complimentary to Probe 2. CHART Probe names were 
marked below sequence. mHotairm1 siRNA is marked in grey and mHotairm1 in situ probe is 
marked in yellow. 
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4.2.13. In situ hybridization histochemistry 
Mouse head samples were dissected and immediately frozen in isopentane on dry ice. In 
situ hybridization histochemistry was carried out using IsHyb In Situ Hybridization (ISH) Kit 
(BioChain) as per manufacture’s protocol. Frozen palatal sections (20 µm) were collected on 
slides and fixed immediately in 4% paraformaldehyde in PBS for 10 min. The samples were then 
rinsed with RNase free PBS and treated with proteinase K digestion (10 µg/ml in PBS) for 5 sec. 
When the slides were dry, pre-hybridization solution was added and slides were incubated for 3h 
at 50°C. Slides were then washed with 2x Saline Sodium Citrate (SSC) for 10 min at 45°C, 1.5x 
SSC for 10 min at 45°C and 0.2x SSC twice for 20 min at 37°C. Slides were blocked with 1x 
blocking solution for 1 h at room temperature. Labeled 100 ng of digoxigenin (DIG) tagged 
mhotairm1 probe (Fig. 4.4, Table 4.3, IDT) or random control probe was added to the slides, 
respectively and incubated over night at 37°C. Slides were then rinsed with SSC buffer and PBS 
and blocked for 30 min at room temperature with 0.1% Triton 100, 1% sheep serum in PBS. The 
anti-DIG-fluorescein, Fab fragments (1:50, Roche) was added and incubated for 3h at room 
temperature and washed 3 times with PBS. 
 
4.2.14. Capture hybridization analysis of RNA targets (CHART) 
The genomic binding sites of mHotairm lnc RNA were identified by using the CHART 
technique developed by Simon et al., (2011) and was modified as described here. NIH 3T3 cells 
(107) were collected and cross-linked in 10 ml PBS with 1% formaldehyde for 10 min at room 
temperature. Cells were washed 3 times with PBS and dounce homogenized in 4 ml sucrose 
buffer (0.3M sucrose, 1% Triton X-100, 10mM HEPES pH 7.5, 100 mM KOAc, 0.1 mM EGTA, 
0.5 mM spermidine, 0.15 mM spermine, 1× protease inhibitor, 1 mM DTT, 10 unit/ml RNase 
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inhibitor). The homogenized sample was added to the top of 4 ml glycerol buffer (25% glycerol, 
10 mM HEPES pH 7.5, 100mM KOAc, 1 mM EDTA, 0.1 mM EGTA, 0.5 mM spermidine, 0.15 
mM spermine, 1× Roche protease inhibitor tablet, 1 mM DTT, 10 unit/ml RNase inhibitor) and 
centrifuged at 1000g for 15 min at 4°C. The pellet (nuclei) was collected and cross-linked in 10 
ml PBS with 3% formaldehyde for 30 min at room temperature. Nuclei pellet was then washed 
with PBS for 3 times and resuspended in 1 ml WD100 solution (100mM NaCl, 10Mm Hepes PH 
7.5, 2Mm EDTA, 1Mm EGTA, 0.2% SDS and 0.1% N-Lauroylsarcosine). The resuspended 
nuclei pellet was sonicated using Branson digital sonifier 250 (Branson) with 10% input pulse, 3 
cycles with 2 s pulse “on” and 30 s pulse “off” to shear DNA to 2-3 kb fragments. Sheared 
sample was centrifuged at 16000 g for 10 min at room temperature and 50 µl supernatant was 
collected as 5% input. The rest of supernatant was adjusted to hybridization conditions (20 mM 
HEPES, pH 7.5, 817 mM NaCl, 1.9 M urea, 0.4% SDS, 5.7 mM EDTA, 0.3 mM EGTA, 0.03% 
sodium deoxycholate, 5× Denhardt’s solution) and pre-cleared with ultralink-streptavidin resin 
(Pierce). Three biotin labeled oligo probes against mHotairm1 were designed (Fig. 4.4, Table 4.3) 
and were added (16 nM each) and hybridized with 55 °C for 20 min, 37 °C for 10 min, 45 °C for 
60 min and followed by 37 °C for 30 min. The bound material was captured using streptavidin 
beads overnight at room temperature. The product was rinsed five times with WB250 (250 mM 
NaCl, 10 mM Hepes, pH 7.5, 2 mM EDTA, 1 mM EGTA, 0.2% SDS, 0.1% N-lauroylsarcosine). 
For protein sample detection, beads were suspended in RIPA buffer and boiled with 4x loading 
buffer for SDS-PAGE and western blot analysis as described in 4.2.6. For DNA sample 
detection, 100 µl reverse buffer (1mg/ml proteinase K, 0.5% SDS and 100Mm Tris pH 7.4) was 
added to the beads and incubated at 55°C for 1 h followed by 65 °C for 30 min. DNA was then 
isolated using GeneJET PCR Purification kit (ThermoFisher Scientific) and Hoxa1, Hoxa2, 
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Hoxa3, Hoxa5 and Hoxa13 promoters were identified by PCR using primers listed in Table 4.3 
(Simon et al., 2011). 
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Figure 4.5. Capture hybridization analysis of RNA targets (CHART). Chromatin was 
crosslinked and sheared. Biotin labelled complementary oligonucleotides were used to purify the 
targeted RNA together with its DNA and protein targets using streptavidin beads. Reversibly 
cross-linked CHART-enriched material can then go through different analysis, e.g. DNA 
analysis (left) and protein analysis (right) (taken from Simon et al., 2011 with permission). 
 
 
4.2.15. GST fusion protein pull down experiments 
4.2.15.1 GST fusion protein expression vector construction 
WDR5 and MLL1 (amino acid 3810-3963) were amplified from NIH 3T3 cDNA samples 
using PCR primers containing EcoR I (GAATTC) and BamH1 (GGATCC) restriction enzyme 
digestion sites (Table 4.3, Mouse MLL13810 start, Mouse MLL1 3963 stop, Mouse WDR5 start, 
Mouse WDR5 stop). PCR amplification system (a total of 50 µl) were prepared with 50 ng 
cDNA, 10×EconoTaq buffer, 2.5 units of EconoTaq DNA polymerase (Invitrogen), 50 µM of 
each dNTP and 500 nM of each forward and reverse primer (Table 4.3). The PCR cycle started 
with one cycle at 95°C for 3 min, followed by 30 cycles of 95°C for 30 sec, 53°C for 40 sec, 
72°C for 1 min and a final extension step at 72°C for 10 min. The PCR products were run on a 
1.0% agarose gel and purified from the gel using QIAquick Gel Extraction kit (Qiagen). The 
DNA samples were then cloned into pGEM T-easy vector (Promega) and sequenced with an ABI 
PRISMTM system at the National Research Council, Plant Biotechnology Institute, Saskatoon, 
SK. The correct clone sequences were then digested from T-easy vector using FastDigestTM 
EcoRI and FastDigestTM BamHI restriction enzymes (Thermo ScientificTM) at 37°C for 20 min. 
The digested DNA fragments were run on a 1% agarose gel and target bands were excised from 
the gel and purified using QIAquick Gel Extraction kit (Qiagen). The purified DNA samples 
were then cloned into pGEX-6p-1 vector (Fig. 4.6. GE Healthcare). This started with the 
incubation of 100 ng pGEX-6p-1 vector with 50 ng of purified DNA fragment (WDR5 or MLL1) 
at 65°C for 5 min. Vector/DNA fragment mix were then placed on ice and a ligation (10 µl) was 
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set up by adding 5 µl of 2x Ligation buffer and 0.5 µl of T4 DNA ligase (Promega) to the mix. 
Ligation was carried at 16°C overnight followed by 5 min incubation at 70°C to inactivate T4 
DNA ligase. Ligation product was then transformed into DH5α™ Competent Cells (Subcloning 
Efficiency™, Invitrogen) as described in 4.2.2.3. Single clone was picked and incubated in 4ml 
LB medium with 1% ampicillin overnight at 37°C. Plasmid was then extracted from bacteria 
culture and target fragment insertion was tested by digesting the plasmid DNA with 
FastDigestTM EcoRI and FastDigestTM BamHI restriction enzymes (Thermo ScientificTM) at 37°C 
for 20 min. The digested DNA fragments were run on a 1% agarose gel. DH5α™ cells with 
correct WDR5 and MLL1 expression vectors were stored at -80°C in LB medium with 25% 
glycerol.  
 
Figure 4.6. pGEX-6p-1 vector map (GE Healthcare). WDR5 and MLL1 (amino acid 3810-
3963) were cloned into pGEX-6p-1 vector using EcoRI and BamHI restriction enzymes to link 
with GST (Figure taken from www.snapgene.com/resources) 
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4.2.15.2 GST fusion protein expression and purification 
The bacterial DH5α™ cells with WDR5 and MLL1 expression vectors were cultured in 4 
ml LB medium with 1% ampicillin overnight at 37°C. The cells were then subcultured (1:100 
v/v) into LB medium with 1% ampicillin for 2 h at 37°C. Protein expression was induced 
following treatment with IPTG (1mM) for 2h at 26°C.  
DH5α™ cells were collected by centrifuging at 3000rpm for 3 min and vortexed with 
1ml lysis buffer (1mM DTT, 0.5 mg/ml lysozyme, 1% triton X-100 and 1x proteinase inhibitor 
in RIPA buffer) and incubated on ice for 20 min. The samples were then sonicated using 
Branson digital sonifier 250 (Branson) (10% input pulse, 5 cycles with 2 s pulse “on” and 30 s 
pulse “off”). Following sonication, samples were centrifuged at 12000 rpm for 10 min at 4°C and 
supernatant was collected. Glutathione agarose beads were washed with RIPA buffer. A 100 µl 
of glutathione agarose beads (PierceTM, ThermoFisher Scientific) were added into each 
supernatant collected from the previous step and incubated for 2 h at room temperature to purify 
GST fused protein. The beads were collected by centrifuging at 3000rpm for 1 min and washed 
for three times with RIPA buffer. The purification of GST fused protein was tested by running 
the purified beads on an SDS-PAGE gel, followed by coomassie blue staining.  
 
4.2.15.3 GST fusion protein pull down 
For protein sample pull down, the purified glutathione agarose beads with protein were 
added to NIH 3T3 cell lysates (in RIPA buffer) and incubated at 4°C overnight. Pull down 
samples were collected by centrifuging at 3000rpm for 2 min and washed three times with RIPA 
buffer. Protein samples pulled down with GST fused MLL1 (amino acid 3810-3963) were tested 
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with WDR5 antibody following western blot analysis as described in 4.2.6. GST was used as a 
negative control. 
For RNA sample pull down, NIH 3T3 cells were lysised in cell lysis buffer with 100mM 
KCl, 5mM MgCl2, 10mM Hepes (PH 7.0), 0.5% Nonidet P-40, 1mM DTT, 2mM Vanadyl 
ribonucleoside complexes solution, 25 µg/ml protease inhibitor and 100 unit/ml RNase inhibitor. 
Lysates were votexed and centrifuged at 12000rpm at 4°C for 10 min. Purified glutathione 
agarose beads with WDR5/MLL1 were added into the supernatant and incubated at 4°C for 3 h. 
Beads were then collected by centrifuging at 3000rpm for 2 min and washed 3 times with cell 
lysis buffer. RNA samples were recovered using RNeasy Protect Mini Kit (Qiagen) and 
converted to cDNA as described in 4.2.4. The existence of mHotairm1 was tested by PCR using 
mush 138 forward and reverse primers as listed in Table 4.3. 
 
4.2.16 Chromatin Immunoprecipitation (ChIP)  
 NIH 3T3 cells transfected with either hotairm1 siRNA or control siRNA were cross 
linked with 1% formaldehyde in cell culture media for 10 min at room temperature.  Glycine was 
added to a final concentration of 125 mM and incubated with shaking for 5 min at room 
temperature. Cells were washed two times with 10 ml cold PBS. Cells were collected and lysed 
with Lysis Buffer (50Mm HEPES-KOH pH7.5, 140Mm NaCl, 1Mm EDTA pH8, 1% Triton X-
100, 0.1% sodium deoxycholate, 0.1% SDS and protease inhibitor cocktail).  Cell lysates were 
sonicated using Branson digital sonifier 250 (Branson) with 20% input pulse, 3 cycles of 5s pulse 
“on” and 30s pulse “off” to shear DNA to lengths between 200 and 1000 bp. Sheared DNA 
samples were centrifuged for 30 s at 8,000 g at 4°C and supernatant was collected. Input 
represents 5% of supernatant. 
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 Samples were then incubated with 10 µg anti-Histone H3 (tri methyl K4) antibody 
(Abcam), 10 µg H3K27trime antibody (Abcam), 10 µg Histone3 antibody (Abcam) or 10µg 
normal rabbit IgG (Santa cruz) respectively, at 4°C overnight. Antibody/histone complex were 
collected with 20 µl protein A agarose slurry (Santa Cruz). Beads were washed three times with 
1 ml wash buffer (0.1% SDS, 1%Triton X-100, 2mM EDTA pH8, 150mM NaCl and 20mM 
Tris-HCl pH8). Histone complex from the antibody was eluted with 100 µl elution buffer (1% 
SDS and 100 mM NaHCO3) and histone-DNA crosslinks were reversed by heating at 65°C in 
5M NaCl for 4 h. Resulting DNA was then recovered by incubating with proteinase K and 
extracted by phenol/chloroform. Samples were resuspended in 20 µl of MiliQ distil water, and 
1:50 was used for qPCR with Hoxa1, Hoxa2 promoter primers listed in Table 4.3. qPCR was 
performed in a final volume of 25 µl containing 50 ng of ChIP DNA or 50 ng of input DNA as 
template, 400 ng of each primer, and 12.5 µl of SYBR green PCR master mix (Applied 
Biosystems). The amplification consisted of 10 min at 95°C followed by 35 cycles of 95°C for 
30 s, 60°C for 1 min, and 72°C for 30 s in 7300 ABI detection system. The fold enrichment of 
each protein at the Hoxa1 and Hoxa2 gene promoter was determined by the 2(-∆∆Ct) method 
described in the Applied Biosystems User Bulletin (ABI PRISM 7700 Sequence Detection 
System, Applied Biosystems, 2001) and are shown as the fold increase relative to input, N=3. 
 
4.2.17 Separation of nucleus and cytoplasm  
NIH 3T3 cells were collected and washed in cold PBS. The cells were homogenized in 0.5 ml 
sucrose buffer (0.3M sucrose, 1% Triton X-100, 10mM Hepes pH 7.5, 100 mM KOAc, 0.1 mM 
EGTA, 0.5 mM spermidine, 0.15 mM spermine, 1× Roche protease inhibitor tablet, 1 mM DTT, 
10 unit/ml RNase inhibitor). The homogenized sample was added to the top of 0.5 ml glycerol 
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buffer (25% glycerol, 10 mM Hepes pH 7.5, 100mM KOAc, 1 mM EDTA, 0.1 mM EGTA, 0.5 
mM spermidine, 0.15 mM spermine, 1× protease inhibitor, 1 mM DTT, 10 unit/ml RNase 
inhibitor) and centrifuged at 1000g for 15 min at 4°C. The supernatant was collected as 
cytoplasm and the pellet was collected as nucleus (Simon et al., 2011).  
 
4.2.18 Immunoprecipitation (IP) 
NIH 3T3 cells were lysed in RIPA buffer with protease inhibitor cocktail (Thermo Fisher 
Scientific) and sumoylation/ubiquitilation protector N-ethylmaleimide (NEM). Cell samples 
were collected and vortexed and kept on ice for 5 min. Agarose protein A beads were pre-
cleaned with RIPA buffer. Cell lysate was centrifuged for 15 min at 12000 g at 4°C and 
supernatant collected. For WDR5 antibody IP, 10µg WDR5 antibody (ab22512, rabbit IgG, 
Abcam) was added to the cell lysate to precipitate WDR5 at 4°C over night. Normal rabbit IgG 
antibody (10µg, Santa Cruz) was used as negative control. Pre-cleaned agarose protein A beads 
were then added and samples were incubated at 4°C on shaker for 1h. Samples were centrifuged 
at 8000 g for 30 s and the precipitates were washed three times with RIPA buffer. The collected 
samples were denatured at 100 °C for 10 min for subsequent SDS-PAGE (10%) separation. 
Protein samples were transferred and immobilized onto a PVDF transfer membrane. Membrane 
was blocked in 3% BSA (in PBS) at 4 °C overnight. SUMO-1 antibody (1:500, Developmental 
Studies Hybridoma Bank) was used to detect sumoylated WDR5. For SUMO1 antibody IP, 10µg 
SUMO1 antibody (mouse IgG, Developmental Studies Hybridoma Bank) was used in IP and 
normal mouse IgG (Santa Cruz) was used as negative control. Western blot analysis was carried 
out using WDR5 antibody (WDR5 A-6, mouse IgM, Santa Cruz). 
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4.2.19 Statistical data analysis 
All statistical analyses were performed using the GraphPad 5.0 software (GraphPad 
Prism). Statistical analysis on qRT-PCR of miRNAs and gene expressions were evaluated using 
one way analysis of variance (ANOVA) followed by Bonferroni post-tests. Student’s T-Tests 
was used in the analysis of ChIP experiment and luciferase assay for the comparison between 
experimental groups and control groups. A significant p-value of less than or equal to 0.05 was 
used to denote significant difference  
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Table 4.3. Sequences of primers and probes used in this study. 
Name Sequence 
Hoxa2 gene 
(Taqman) 
Forward: 5' CTGGATGAAGGAGAAGAAGGC 
Reverse: 5' CGGTTCTGAAACCACACTTTC 
GAPDH gene 
(Taqman) 
Forward: 5' ACCACAGTCCATGCCATCAC 
Reverse: 5' TCCACCACCCTGTTGCTGTA 
b-actin gene (SYBR 
Green) 
Forward: 5' AGAGGGAAATCGTGCGTGAC 
Reverse: 5' CAATAGTGATGACCTGGCCGT 
Methylation specific 
PCR primers 
Msp- CpG1-MF:5'TTTTCGATAGTTTTAAATAATGCGC 
Msp- CpG1-MR:5'TAAATAACAATACCCCGAAAATACG 
Msp-CpG1-UF:5' TTTGATAGTTTTAAATAATGTGTGG 
Msp- CpG1-UR:5'AATAACAATACCCCAAAAATACATA 
Msp- CpG2-MF:5' TAGTTATTTTTGAGAAGTTGATGGC 
Msp- CpG2-MR:5' TATCCAACCCGAAACCTACG 
Msp- CpG2-UF:5'GTTATTTTTGAGAAGTTGATGGTGA 
Msp- CpG2-UR:5' TTAATATCCAACCCAAAACCTACAC 
Msp- CpG3-MF:5' TTTTTGGAAGTCGGAAATATTTATC 
Msp- CpG3-MR:5'AATCCCCGTAACCTAAACGAC 
Msp-CpG3-UF: 5' TTTTGGAAGTTGGAAATATTTATTGT  
Msp-CpG3-UR:5' CAAATCCCCATAACCTAAACAAC 
Bisulfite specific  
PCR primers 
Bsp-CpG3-F: 5' GTTAGGTTGAGGTGTTTAAAT 
Bsp-CpG3-R: 5' ACCACTATCTATTTAATTAATCC 
mHotairm1 primers 
mush138-F: 5'CCCACCCAGCCCAGAAAG  
mush138-R: 5'GTTTCAAACATCTACGTTCC  
mush 147-F: 5'TGACTTGGAGCACTGGGA 
mush 147-R: 5'CTCTTGCCAGTTCAGCTTTCT 
mush 245-F: 5' GAAAGGAAGAGTTGGAACGTAGA 
mush 245-R: 5' TGAGACTCAGGCCATAGAGTTA 
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Hoxa2 3' UTR 
mutation primers 
669b1F: 5' CACACGACAAAACGCCTTTGACC 
669b1R: 5' GGTCAAAGGCGTTTTGTCGTGTG 
669b2F: 5' CTATGTGATTTTCCTGAAAAACACGACAGGAGGCCTGC 
669b2R: 5' GCAGGCCTCCTGTCGTGTTTTTCAGGAAAATCACATAG 
GST fusion protein 
Mouse MLL1 
primers 
3810start: 5'GGATCCATGCCCATGAGATTCCGGCACTTG 
3963stop: 5'GAATTCTTAGTTCAGGAACTTGCGGCA 
GST fusion protein 
Mouse WDR5 
primers 
start: 5' GGATCCTTCAGAGCCATGGCCACAGAGG 
stop: 5' GAATTCTTAGCAGTCACTCTTCCACAGT 
Promoter primers 
Hoxa1 
Forward: 5' TTTGGTCCCAGTGCTCCAAG 
Reverse: 5' ATGTACAGTGCGCAAGAGGC 
Hoxa2 Forward: 5' GTTGTCTTTTGAATCCTTCAGCC 
Reverse: 5' GGCACTCTGGGTTTCATACC 
Hoxa3 
Forward: 5' CTCAAAAGGGCAAAGGGTCG 
Reverse: 5' GGTTGGTCCTCTTCCCTGAAC 
Hoxa5 
Forward: 5' TCCTAATGGAACTGCGAGGG 
Reverse: 5' CTAATGGGGGAGTTGGGTGG 
Hoxa13 
Forward: 5' AACCAACAGGAAACAAACGCC 
Reverse: 5' GGTCGTGGGGACAAGTCAG 
CHART probes 
Probe 1: Biotin-5' GGCGCGCGCAGAAGGCAGTCTCG 
Probe 2: Biotin-5' TCAAACATCTACGTTCCAACTCT 
Probe 3: Biotin-5' AGACTCAGGCCATAGAGTTACAT 
Probe C: Biotin-5' AGAGTTGGAACGTAGATGTTTGA (Antisense 
to Probe 2) 
mHotairm1 siRNA 5' GGAAGAGUUGGAACGUAGAUGUUTG 
In situ Probes 
mHotair1 
5' DigN/ACTCCGTTATTGACCTAGAAACTAGCAGCTTGGTAAGGGAAC 
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CHAPTER 5 
5. Results and analysis of data 
5.1 Methylation status of Hoxa2 promoter region in developing mouse palate, NIH 3T3 
cells and EG7 cells. 
DNA methylation was the first epigenetic mechanism that I investigated in the regulation 
of Hoxa2 gene expression in mouse palate development. Analysis of the Hoxa2 promoter 
revealed the presence of three CpG islands (Fig. 5.1). The three sets of methylation specific 
primers used for the analysis of the CpG islands are listed in the materials and methods section 
(Table 4.3). Methylation specific PCR (MSP) carried out for all three CpG rich regions showed 
that all three CpG regions in the Hoxa2 promoter were unmethylated in developing palate as well 
as in NIH 3T3 cells, while these regions remained methylated in EG7 cells, (Fig. 5.2). A further 
bisulfite specific PCR (BSP) amplification and sequencing was carried out to examine the 
methylation status of each CpG site. A region close to the transcription start site (Region 1, Fig. 
5.1) with 14 CpG sites was selected for further analysis. I found that all 14 CpG sites were 
unmethylated in both NIH 3T3 cells and in developing palate samples (Fig. 5.3A, Appendix 1-
5); however, in the same CpG rich region 1 of the Hoxa2 promoter in EG7 cells, 10 of the 14 
sites were methylated (Fig. 5.3B, Appendix 6).  
Since Hoxa2 is expressed in both the developing mouse palate (Smith et al., 2009) and 
NIH 3T3 cells but not in EG7 cells (X. Wang, PhD Thesis, 2013), my results indicate that an 
unmethylated promoter of Hoxa2 may be required for its expression. However, since Hoxa2 
expression changes temporally at different stages of mouse palate development (Smith et al., 
2009), and that the Hoxa2 promoter remains unmethylated throughout mouse palate 
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development, DNA methylation does not appear to be a regulator for Hoxa2 expression during 
mouse palatogenesis, therefore, I focused on other epigenetic regulators, such as miRNAs and 
lncRNAs. 
 
 
Region 1 (-489 -- -624bp 136bp) 
CTGCAGGCGTCAGGCTGAGGTGCTTAAATGATTTGTGAGGTGCGAGGCGTCTTCCCG
ACAGTCCCAAACAATGCGCGGAGTGTGCGGGGGAGGCAGAGGGCAGCCACTGGCG
GGACGGCAGCAGGGCTCACACGCA 
 
Region 2 (-1019 -- -1169bp 151bp) 
GTTGATGGCGAAGGAAGATCAGCAGGCTTCGAGAGCCGCCTCTCGTTTTCCGCTGCC
CGCAGGAGTCAGATGCAAAGCTGCCGTGGAAAAGCCGGCTAACAATGGGCCAGGG
GCGCAGGTCCCGGGCTGGACATTAAGAGGAGGCGAGAGG 
 
Region 3 (-1244 -- -1360bp 117bp) 
AAGTCGGAAATACTCACCGCACCCGAGCCCTACGGGTATGAAACCCAGAGTGCCAG
GAGCCGCACGAGCCTGCTCGGGACGGCATTGTTTTGGCTGGCCGCCGCCCAGGCTAC
GGGG 
 
Figure 5.1. Analysis of CpG rich regions in Hoxa2 gene promoter. All the predicted CpG 
sites in the region 2000 bp upstream of the transcriptional start site were separated into three 
methylation specific regions: region 1 from -489 to -624, region 2 from -1019 to -1169, and 
region 3 from -1244 to -1360 (transcriptional start site begins at 0). CpG sites are highlighted 
with light grey. Predicted methylated cytosines of CpG dinucleotides are shown as red letters 
(predicted with Methylator, Bhasin et al., 2005, http://bio.dfci.harvard.edu/Methylator/).  
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Figure 5.2. MSP amplification for three CpG islands in Hoxa2 promoter. MSP was done for 
DNA samples collected form NIH 3T3 cells, EG7 cells and developing mouse palatal tissue 
(E12-E15). M = PCR fragment amplified with designed methylated primers. U = PCR fragment 
amplified with designed unmethylated primers. The presence of a PCR band in M indicates the 
region is methylated and PCR band in U indicates the region is unmethylated. 
 
 
 
 
 
 
 
Figure 5.3. BSP and sequencing results for the CpG rich region 1. (A). Schematic of CpG 
methylation status in NIH 3T3 cells and in E12 to E15 palatal samples. All 14 CpG sites 
remained unmethylated. (B). Schematic of CpG methylation status in EG7 cells. 10 out of 14 
CpG sites were methylated in EG7 cells. Each circle represents a CpG site. The number under 
each circle represents the position of each CpG site on mouse Hoxa2 promoter (transcriptional 
start site begins at 0). Blank circles: unmethylated CpG site; Black circles: methylated CpG site.  
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5.2 Regulation of Hoxa2 gene expression by miRNAs 
5.2.1 miRNA binding sites prediction and sequence analysis. 
MicroRNAs play an important role in the regulation of Hox gene expression in several 
biological and pathological processes, mainly via binding to the 3' UTR of Hox genes (reviewed 
in section 1.2.3). To study the regulation of Hoxa2 gene expression by miRNAs, I first used an 
online software (http://www.microrna.org) to predict miRNAs that bind to mouse Hoxa2 3' UTR. 
Six miRNAs were predicted to bind to mouse Hoxa2 3' UTR as shown in Figure 5.4. The stem-
loop sequence and mature sequence of all six miRNAs are shown in Table 5.1. Detailed 
predicted binding sequences and structures between miRNAs and mouse Hoxa2 3' UTR are 
shown in Figures 5.5-5.10 (A, B) for each individual miRNA. I also analyzed the sequence 
similarity for each miRNA binding site among several species (Figs. 5.5–5.10C). Most predicted 
miRNA binding sites are evolutionally conserved except the binding site 2 of miR-669b (Fig. 
5.5C) 
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Figure 5.4. Predicted binding sites of miRNA on mouse Hoxa2 3' UTR (prediction from 
http://www.microrna.org). Full length mouse Hoxa2 3' UTR sequence is shown (5' to 3'). Colour 
lines beneath the nucleotide sequence represents binding sites of respective miRNAs.  
 
 
 
Table 5.1. Mouse miRNA stem-loop sequence and mature sequence. The sequence data is 
from miRBase (http://www.mirbase.org/). 
 
 Stem-loop sequence 5'-3' Mature sequence 5'-3' 
miR-669b AUGAAUGUAUGUGCAUGUGUA
UAUAGUUUUGUGUGCAUGUGC
AUGUGUGUCUAUUAAUGUACA
UAUACAUACACACAAACAUAU
ACACGCAUGCGCA 
AGUUUUGUGUGCAUGUGCAU
GU 
miR-431 CGUCCUGCGAGGUGUCUUGCA
GGCCGUCAUGCAGGCCACACUG
ACGGUAACGUUGCAGGUCGUC
UUGCAGGGCUUCUCGCAAGAC
GACAUC 
UGUCUUGCAGGCCGUCAUGCA 
 
miR-298 CCAGGCCUUUGGCAGAGGAGG
GCUGUUCUUCCCUUGAGUUUU
AUGACUGGGAGGAACUAGCCU
UCUCUCAGCUUAGGAGUGG 
GGCAGAGGAGGGCUGUUCUU
CCC 
miR-376c UUUGGUAUUUAAAAGGUGGAU
AUUCCUUCUAUGUUUAUGCUU
UUUGUGAUUAAACAUAGAGGA
AAUUUCACGUUUUCAGUGUCA
AA 
AACAUAGAGGAAAUUUCACG
U 
miR-19a GCAGCCCUCUGUUAGUUUUGC
AUAGUUGCACUACAAGAAGAA
UGUAGUUGUGCAAAUCUAUGC
AAAACUGAUGGUGGCCUGC 
UGUGCAAAUCUAUGCAAAAC
UGA 
 
miR-878-3p UGCAAUGCUUUAUCUAGUUGG
AUGUCAAGACACGUGAAACUU
AAGUGCAUGACACCACACUGG
GUAGAGGAGGGCUCA 
GCAUGACACCACACUGGGUAG
A 
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Figure 5.5. Prediction and analysis of miR-669b binding sites on Hoxa2 3' UTR. (A) The 
predicted target seed sequences for miR-669b in mouse Hoxa2 3' UTR is marked in red 
(http://www.microrna.org). The underlined “AA” in blue in both binding sites were mutated to 
“CG” for luciferase assays. (B) Predicted binding structures of miR-669b to mouse Hoxa2 3' 
UTR (RNAhybrid, Rehmsmeier et al., 2004). mfe: minimal free energy. Hoxa2 3' UTR sequence 
is labelled in red and miR-669b is labelled in green. (C) The degree of sequence similarity within 
the seed targets for miR-669b were shown for Hoxa2 genes from five different species. 
Complementary regions between miR-669b and Hoxa2 3' UTR were highlighted in red. 
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Figure 5.6. Prediction and analysis of miR-376c binding site on Hoxa2 3' UTR. (A) The 
predicted target seed sequences for miR-376c in mouse Hoxa2 3' UTR is marked in red 
(http://www.microrna.org). (B) Predicted binding structures of miR-376c to mouse Hoxa2 3' 
UTR (RNAhybrid, Rehmsmeier et al., 2004). mfe: minimal free energy. Hoxa2 3' UTR sequence 
is labelled in red and miR-376c is labelled in green. (C) The degree of sequence similarity within 
the seed targets for miR-376c were shown for Hoxa2 genes from five different species. 
Complementary regions between miR-376c and Hoxa2 3' UTR were highlighted in red.  
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Figure 5.7. Prediction and analysis of miR-431 binding site on Hoxa2 3' UTR. (A) The 
predicted target seed sequences for miR-431 in mouse Hoxa2 3' UTR is marked in red 
(http://www.microrna.org). (B) Predicted binding structures of miR-431 to mouse Hoxa2 3' UTR 
(RNAhybrid, Rehmsmeier et al., 2004). mfe: minimal free energy. Hoxa2 3' UTR sequence is 
labelled in red and miR-431 is labelled in green. (C) The degree of sequence similarity within the 
seed targets for miR-431 were shown for Hoxa2 genes from five different species. 
Complementary regions between miR-431 and Hoxa2 3' UTR were highlighted in red.  
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Figure 5.8. Prediction and analysis of miR-19a binding site on Hoxa2 3' UTR. (A) The 
predicted target seed sequences for miR-19a in mouse Hoxa2 3' UTR is marked in red 
(http://www.microrna.org). (B) Predicted binding structures of miR-19a to mouse Hoxa2 3' UTR 
(RNAhybrid, Rehmsmeier et al., 2004). mfe: minimal free energy. Hoxa2 3' UTR sequence is 
labelled in red and miR-19a is labelled in green. (C) The degree of sequence similarity within the 
seed targets for miR-19a were shown for Hoxa2 genes from five different species. 
Complementary regions between miR-19a and Hoxa2 3' UTR were highlighted in red.  
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Figure 5.9. Prediction and analysis of miR-878-3p binding site on Hoxa2 3' UTR. (A) The 
predicted target seed sequences for miR-878-3p in mouse Hoxa2 3' UTR is marked in red 
(http://www.microrna.org). (B) Predicted binding structures of miR-878-3p to mouse Hoxa2 3' 
UTR (RNAhybrid, Rehmsmeier et al., 2004). mfe: minimal free energy. Hoxa2 3' UTR sequence 
is labelled in red and miR-878-3p is labelled in green. (C) The degree of sequence similarity 
within the seed targets for miR-878-3p were shown for Hoxa2 genes from five different species. 
Complementary regions between miR-878-3p and Hoxa2 3' UTR were highlighted in red.  
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Figure 5.10. Prediction and analysis of miR-298 binding site on Hoxa2 3' UTR. (A) The 
predicted target seed sequences for miR-298 in mouse Hoxa2 3' UTR is marked in red 
(http://www.microrna.org). (B) Predicted binding structures of miR-298 to mouse Hoxa2 3' UTR 
(RNAhybrid, Rehmsmeier et al., 2004). mfe: minimal free energy. Hoxa2 3' UTR sequence is 
labelled in red and miR-298 is labelled in green. (C) The degree of sequence similarity within the 
seed targets for miR-298 were shown for Hoxa2 genes from five different species. 
Complementary regions between miR-298 and Hoxa2 3' UTR were highlighted in red. 
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5.2.2 The predicted miRNAs are expressed in NIH 3T3 and EG7 cells. 
To study the role of these miRNAs in the regulation of Hoxa2 expression, I first needed 
to determine whether these miRNAs were expressed in the NIH 3T3 cells, EG7 cells and in the 
developing mouse palate. Expressions of all six miRNAs predicted to bind Hoxa2 3' UTR were 
examined in both NIH 3T3 and EG7 cells using specific miRNA primers (QiagenÒ) (Table 4.1). 
miR-298 has the highest expression in NIH 3T3 cells followed by miR-431. Both miR-298 and 
miR-431 have low expression in EG7 cells. miR-669b, miR-376c and miR-19a all have higher 
expression in NIH 3T3 cells than in EG7 cells. In contrast, miR-878-3p is expressed higher in 
EG7 cells than in NIH 3T3 cells (Fig. 5.11). Generally, the miRNA expression levels in EG7 
cells are much lower than in NIH 3T3 cells. One explanation would be because EG7 is a cell line 
with a high degree of DNA methylation (X. Wang, PhD Thesis, 2013), thus transcription 
activities may be relatively low compared to that in NIH 3T3 cells. This result fits with the 
hypothesis that the DNA methylation status can impact the expression of miRNAs (Han et al., 
2007; Bandres et al., 2009; Liu et al., 2013). miR-431 and miR-298 are strongly expressed in 
NIH 3T3 cells, indicating that these miRNAs have a less possibility to regulate Hoxa2 
expression based on the fact that Hoxa2 is also highly expressed in NIH 3T3 cells. 
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Figure 5.11. miRNA expression in NIH 3T3 and EG7 cell lines. miRNA expression levels in 
NIH 3T3 and EG7 cells were measured by qRT-PCR as described in section 4.2.5, p76. miRNA 
expressions were relative to snRNA RNU6B. Relative quantitative expression of miR-431 in 
EG7 cells were normalized to 1. miR-431 and miR-298 had relatively high expressions in NIH 
3T3 cells. Overall, expressions of miRNAs in EG7 cells were relatively low. E - EG7 cells, N -
NIH 3T3 cells.  
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5.2.3 The predicted miRNAs are expressed in the developing mouse palate 
All six miRNAs were expressed in the developing mouse palate (Fig.5.12). Interestingly, 
three of them, miR-669b, miR-376c and miR-431 exhibited gradual increase in expression from 
stages E12 to E15 during palatal development. These miRNAs had a lower expression at E12, 
when Hoxa2 begins its expression in mouse palate (Smith et al., 2009). Their expression 
continued to increase in the developing palate from E13 to E15 (Fig. 5.12) when Hoxa2 
expression gradually declines (Smith et al., 2009). The counter and opposite expression levels of 
these miRNAs to Hoxa2 gene during mouse palatogenesis indicates that these miRNAs may 
have a high potential to regulate Hoxa2 expression during palatal development. For other three 
miRNAs, miR-19a expression also showed significant differences during some of the stages and 
may play a role in palate development; however, miR-298 and miR-878-3p did not show 
significant expression changes during palate development (Fig. 5.12). Taken together with the 
miRNA expression levels during palate development and miRNA expression in NIH 3T3 and 
EG7 cell lines, I speculated that miR-669b and miR-376c had a higher possibility to regulate 
Hoxa2 expression. Hence, I chose these two miRNAs for further investigation. 
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Figure 5.12. miRNA expression in the developing mouse palate. miRNA expression levels in 
wild-type mouse palate shelves from E12 to E15 were measured by qRT-PCR as described in 
section 4.2.5, p76. miRNA expressions were relative to snRNA RNU6B. Relative quantitative 
expression of miRNAs at E12 were normalized to 1. Relative quantitative expression during 
mouse palate development of miRNA: (A) miR-669b; (B) miR-376c; (C), miR-431; (D) miR-
19a; (E) miR-878-3p and (F) miR-298. (G) Expression level of Hoxa2 gene in developing mouse 
palate. Hoxa2 gene expressions were relative to b-actin. Figure taken from Smith et al., 2009 
with permission. RQ: relative quantity of miRNA expression. Bars represent mean ±SEM, n =3. 
*p ≤ 0.05 between bars indicated by brackets. **p ≤ 0.01 between bars indicated by brackets.  
 
5.2.4 miRNA-669b and miR-376c down regulate Hoxa2 expression in NIH 3T3 cells.	  
To investigate whether miR-669b and miR-376c impact Hoxa2 gene expression, I 
transfected NIH 3T3 cell line with the respective miRNA mimic. NIH 3T3 cells transfected with 
miR-669b mimic reduced Hoxa2 mRNA expression by ~30% after 24h of transfection (Fig. 
5.13A). Although miR-376c mimic significantly reduced expression of Hoxa2 after 24h of 
transfection compared to mock treated cells (transfection reagent only), it did not reach 
significance when compared to control miRNA treated cells. These differences were not 
observed after 48h of transfection with either miR-669b or miR-376c mimic, possibly due to the 
degradation of the miRNA mimics. Western blot analysis showed both miR-669b and miR-376c 
mimics down regulated Hoxa2 protein expression after 24h of transfection (Fig. 5.13B). 
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Figure 5.13. Effect of miR-669b and miR-376c mimics on Hoxa2 expression in NIH 3T3 
cells. NIH 3T3 cells were transfected with miR-376c mimic, miR-669b mimic, control miRNA 
and mock treatment, respectively. (A) After 24h and 48h of transfection, total RNAs were 
isolated and qRT-PCR was carried out using Hoxa2 Taqman primers as described in 4.2.5. Bars 
represent mean ±SEM, n =3. *p ≤ 0.05 between bars indicated by brackets. (B) NIH 3T3 cells 
were transfected with miR-376c mimic, miR-669b mimic, control miRNA or mock treatment, 
and whole cell lysates were collected for western blot analysis after 24h. GAPDH was used as a 
loading control. 
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5.2.5 miR-669b binds directly to mouse Hoxa2 3'UTR 
Since both miR-669b and miR-376c repress Hoxa2 expression in NIH 3T3 cells (Fig. 
5.13), I further investigated whether this effect on Hoxa2 expression is due to direct binding of 
miRNAs to Hoxa2 3' UTR. To answer this question, I carried out dual-luciferase assays in NIH 
3T3 cells. The vectors pEZX-MT01 (GenecopoeiaÒ) encoding firefly luciferase (hLuc) and 
renilla luciferase (hRLuc) pEZX-MT01-Hoxa2 (GenecopoeiaÒ) containing full length mouse 
Hoxa2 3' UTR were used in these experiments. If Hoxa2 3' UTR was being targeted by the 
miRNAs, the translation of firefly luciferase will be affected and any change in enzyme activities 
will be detected (Fig. 4.3). Renilla luciferase was used as an internal control to normalize firefly 
luminescence. In the experimental group, pEZX-MT01-Hoxa2 was co-transfected with miR-
669b mimic, miR-376c mimic or control miRNA, respectively. A significantly reduced 
luminescence signal was observed in cells transfected with miR-669b mimic, indicating miR-
669b can bind directly to mouse Hoxa2 3' UTR (Fig. 5.14). No significant down regulation of 
firefly luciferase activity was observed in samples transfected with miR-376c (Fig. 5.14). Hence, 
the down regulation of Hoxa2 expression in NIH 3T3 cells following transfection of miR-376c 
mimic does not appear to be through direct binding of miR-376c to Hoxa2 3'UTR. For the 
control group, I used pEZX-MT01 blank vector without Hoxa2 3'UTR and found no significant 
difference in NIH 3T3 cells transfected with miR-669b mimic, miR-376c mimic or control 
miRNA (Fig. 5.14).   
miR-669b has two predicted binding sites on Hoxa2 3'UTR and a AA-CG mutation was 
engineered in the predicted seed sequences (Fig. 5.5A) on pEZX-MT01-Hoxa2 vector (pEZX-
MT01- Hoxa2 mut1 and pEZX-MT01- Hoxa2 mut2, Fig. 5.5A). A construct with both predicted 
binding sites that were mutated was also generated (pEZX-MT01-Hoxa2 mut1+2). Luciferase 
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assay showed that mutation at single binding site alone was not sufficent to block the effect of 
miR-669b on Hoxa2 3'UTR, only after both binding sites were mutated, miR-669b mimic could 
no longer reduce the luciferase activity, suggesting that both predicted binding sites are required 
for the effective miR-669b function (Fig. 5.15). 
 
 
 
 
Figure 5.14. Luciferase assay revealed direct interactions between miR-669b and mouse 
Hoxa2 3'UTR. NIH 3T3 cells co-transfected with luciferase vector and miRNA mimics. 
Luciferase reporter vectors with (pEZX-MT01-Hoxa2) or without Hoxa2 3’UTR (pEZX-MT01) 
were co-transfected with miR-669b mimic, miR-376c mimic or control miRNA, respectively 
Firefly luminescence signal was normalized to renilla luminescence signal. Y-axis shows ratio of 
firefly and renilla luminescence signal. Bars represent mean ±SEM, n =4. ***p ≤ 0.001 
compared to control miRNA. 
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Figure 5.15. Luciferase assay revealed that seed sequence mutations affect miR-669b 
binding capacity to Hoxa2 3' UTR. Firefly luminescence signal was normalized to renilla 
luminescence signal. Y-axis shows ratio of firefly and renilla luminescence signal. Three 
different vectors with mutations in seed binding sites of Hoxa2 3' UTR (pEZX-MT01- Hoxa2 
mut1, pEZX-MT01- Hoxa2 mut2 and pEZX-MT01-Hoxa2 mut1+mut2) were tested for the 
luciferase assay. Bars represent mean ±SEM, n =3. ***p ≤ 0.001 compared to control miRNA . 
 
 
The findings above show that the overexpression of both miR-669b and miR-376c 
decreases the expression of Hoxa2 at transcriptional and translational level. Using luciferase 
reporter assay, two direct miR-669b binding sites were revealed in mouse Hoxa2 3'UTR and 
both sites proved to be functional. miR-376c does not have direct binding sites on Hoxa2 3'UTR. 
The effect of miR-376c on Hoxa2 expression may be due to the binding of miR-376c to another 
part of the Hoxa2 gene, or due to an indirect effect.  
 
 
	   117	  
5.3 mHotairm1 lncRNA regulates Hoxa1 and Hoxa2 gene expression via an epigenetic 
mechanism 
HOTAIRM1 is known to activate 3' HOXA genes (HOXA genes located at the 3' end of 
HOXA loci) in human cells (Zhang et al., 2009), yet no similar transcript has been reported in 
other species and little is known about how 3' HOXA genes are regulated by HOTAIRM1. In the 
following study, I identified the existence of a noncoding transcript in mouse that shares 
sequence similarity with human HOTAIRM1, and referred it as the mouse Hotairm1 
(mHotairm1). I further investigated the roles and mechanisms of mHotairm1 in regulating the 
expression of two 3' Hoxa genes in mice, namely Hoxa1 and Hoxa2.  
 
5.3.1 Predicted mouse Hotairm1 sequence analysis   
To investigate the existence of mHotairm1 noncoding transcript in mouse, first I analyzed 
the human HOTAIRM1 sequence using BLAST with mouse RefSeq RNA, and found a predicted 
transcript in mouse that shared some sequence similarity with human HOTAIRM1 (Fig. 5.16C). 
This transcript in mouse is transcribed between Hoxa1 and Hoxa2 (Fig. 5.16A), and it is 522 nt 
long (Fig. 5.16B) with two exons and one intron that undergoes splicing during transcription (Fig. 
5.16D). Next, three pairs of overlapping primers were designed (Fig. 4.4, Table 4.3) and PCR 
was carried out for a cDNA library that was generated from NIH 3T3 cells. The amplied DNA 
fragments were sequenced and a 462 nt sequence was identified, hereafter I refered it as 
mHotairm1 [Fig. 5.16B (sequence in orange), Appendix 7-9]. 
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A 
 
B 
CGGCCGCTCCCGGAGCTGACTTGGAGCACTGGGACCAAAGGGAGTCGAGACTGC
CTTCTGCGCGCGCCCGGCTTTGCGCGCCTCCGCCACCAGATGTGGGGGGATGGGA
GGCCCCCTCCGCGGCCCCTTCCCCACCCAGCCCAGAAAGCTGAACTGGCAAGAG
GTCTGTTTTTCCTGAACCCATCCACAGCTGGGAGATTAATCAACCACACTGAAAAT
GGGGGTGTGGGGGAGGGAAAGGAAGAGTTGGAACGTAGATGTTTGAAACAAATG
TGTATAAATAAATGAATTTTTGATAACTCCGTTATTGACCTAGAAACTAGCAGCTTG
GTAAGGGAACTCCATTCCACTCCACTCGTCCTAGAACTGGAAGTTTTTGTAGGCA
CTTTTCCTCTCCACACTCAAAAGCTTGGGCTAGGGCCAACTCAGGCTGCCCAAGC
CCATTTCTATTACTAATGTAACTCTATGGCCTGAGTCTCAACACTGAAAACCAAATT
CATTCCCTTAGGGGGGAAAAATCCA 
 
 
 
C. Sequence similarity between human and mouse Hotairm1. 
 
        Mouse  51   CTGCCTTCTGCGCGCGCCCGGCTT---TGCGCGCCTCCGCCA-----CCAGATGTGGGGG  102 
                     |||| ||||||||||||||| ||    ||| |||| ||||||     || |  |  |||| 
        Human  173  CTGCGTTCTGCGCGCGCCCGACTCCGCTGCCCGCC-CCGCCAGGCCTCCGGGAGGTGGGG  231 
 
        Mouse  103  GATGGGAGGCCCCCTCCGCG---GCCCCTTCCCCACCCAGCCCAGAAAGCTGAACTGGCA  159 
                    | ||||||||  || ||||    ||||| ||||||||   |   ||||| |||||||||  
        Human  232  GCTGGGAGGCGTCCCCCGCTCCCGCCCCCTCCCCACCGTTCAATGAAAGATGAACTGGCG  291 
 
        Mouse  160  AGAGGTCTGTTTTTCCTGAACCCATCCACAGCTGGGAGATTAATCAACCACACTGAAAAT  219 
                    ||||||||||||| |||||||||||| ||||||||||||||||||||||||||||||||| 
        Human  292  AGAGGTCTGTTTTGCCTGAACCCATCAACAGCTGGGAGATTAATCAACCACACTGAAAAT  351 
 
        Mouse  220  GGGG------GTGTGGGGGAGGGAAAGGAAGAGTTGGAACGTAGATGTTTGAAACAAATG  273 
                    | ||       | |||||||||        | |||| || || | ||||||||||||| | 
        Human  352  GTGGAGGGATTTATGGGGGAGG--------GGGTTGAAATGTGGGTGTTTGAAACAAAAG  403 
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        Mouse  274  TGTATAAATAAATGAATTTTTGATAACTCCGTTATTGACCTAGAAACTAGCAGCTTGGTA  333 
                    |||||||| ||||||||| |||||||||  ||||||||||| || ||| | |||||  || 
        Human  404  TGTATAAACAAATGAATTGTTGATAACTTAGTTATTGACCTGGAGACTGGTAGCTTATTA  463 
 
        Mouse  334  AGGGAACTCCATTCCACTCCACTCGTCCTAGAACTGGAAGTTTTTGTAGGCACTTTTCCT  393 
                    | | |||||| |   ||||      |||| ||  |||  |||| ||||||||||||   | 
        Human  464  AAGAAACTCCGTGTTACTC----ATTCCTGGAGTTGGGGGTTTCTGTAGGCACTTTATTT  519 
 
        Mouse  394  CTCCACACTCAAAAGCTTGGGCTAGGGCCAA--CTCAGGCTGCCCAAGCCCATTTCTATT  451 
                    ||||||  |||| |||||||||| || ||||  || || ||| ||||  |    |||||| 
        Human  520  CTCCACTTTCAAGAGCTTGGGCTTGGCCCAAATCTTAGACTGTCCAATTCTGCCTCTATT  579 
 
        Mouse  452  ACTAATGTAACTCTATGGCCTGAGTCTCAACACTGAAAACCAAAT  496 
                    || ||| ||| |||||||| |||  ||   ||||||||| ||||| 
        Human  580  ACCAATTTAAATCTATGGCTTGAACCTGTGCACTGAAAATCAAAT  624 
 
D. Comparation of mHotairm1 RNA sequence to mouse genome. 
(a) 
     mHotairm1  162         AGGTCTGTTTTTCCTGAACCCATCCACAGCTGGGAGATTAATCAACCACACTGAAAATGG 221 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52161929  AGGTCTGTTTTTCCTGAACCCATCCACAGCTGGGAGATTAATCAACCACACTGAAAATGG 52161988 
 
     mHotairm1  222         GGGTGTGGGGGAGGGAAAGGAAGAGTTGGAACGTAGATGTTTGAAACAAATGTGTATAAA  281 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52161989  GGGTGTGGGGGAGGGAAAGGAAGAGTTGGAACGTAGATGTTTGAAACAAATGTGTATAAA 52162048 
 
     mHotairm1  282         TAAATGAATTTTTGATAACTCCGTTATTGACCTAGAAACTAGCAGCTTGGTAAGGGAACT  341 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52162049  TAAATGAATTTTTGATAACTCCGTTATTGACCTAGAAACTAGCAGCTTGGTAAGGGAACT 52162108 
 
     mHotairm1  342         CCATTCCACTCCACTCGTCCTAGAACTGGAAGTTTTTGTAGGCACTTTTCCTCTCCACAC  401 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52162109  CCATTCCACTCCACTCGTCCTAGAACTGGAAGTTTTTGTAGGCACTTTTCCTCTCCACAC 52162168 
 
     mHotairm1  402         TCAAAAGCTTGGGCTAGGGCCAACTCAGGCTGCCCAAGCCCATTTCTATTACTAATGTAA  461 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52162169  TCAAAAGCTTGGGCTAGGGCCAACTCAGGCTGCCCAAGCCCATTTCTATTACTAATGTAA 52162228 
 
     mHotairm1  462         CTCTATGGCCTGAGTCTCAACACTGAAAACCAAATTCATTCCCTTAGGGGGGAAAAATCC  521 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52162229  CTCTATGGCCTGAGTCTCAACACTGAAAACCAAATTCATTCCCTTAGGGGGGAAAAATCC 52162288 
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     mHotairm1  522          A  522 
                             | 
     Mouse genome  52162289  A  52162289 
 
（b） 
     mHotairm1  1           CGGCCGCTCCCGGAGCTGACTTGGAGCACTGGGACCAAAGGGAGTCGAGACTGCCTTCTG  60 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52158524  CGGCCGCTCCCGGAGCTGACTTGGAGCACTGGGACCAAAGGGAGTCGAGACTGCCTTCTG 52158583 
 
     mHotairm1  61          CGCGCGCCCGGCTTTGCGCGCCTCCGCCACCAGATGTGGGGGGATGGGAGGCCCCCTCCG  120 
                            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52158584  CGCGCGCCCGGCTTTGCGCGCCTCCGCCACCAGATGTGGGGGGATGGGAGGCCCCCTCCG 52158643 
 
     mHotairm1  121         CGGCCCCTTCCCCACCCAGCCCAGAAAGCTGAACTGGCAAGAGGT  165 
                            ||||||||||||||||||||||||||||||||||||||||||||| 
     Mouse genome 52158644  CGGCCCCTTCCCCACCCAGCCCAGAAAGCTGAACTGGCAAGAGGT 52158688 
 
 
 
Figure 5.16. Sequence analysis of mouse Hotairm1. A. Mouse Hotairm1 is transcribed 
between Hoxa1 and Hoxa2. It has two exons, and one intron that is spliced during transcription. 
B. The 522 nt predicted transcript in mouse that shared sequence similarity with human 
HOTAIRM1 was listed. Sequence identified by cloning and sequencing of mouse Hotairm1 
transcript (462 nt) is shown in orange. Splicing happen at nucleotide 163, with AG (marked in 
blue) the 5’ splicing signal and G (marked in green) the 3’ splicing signal. C. Analysis of 
sequence similarity between human and mouse Hotairm1. mHotairm1 RNA sequence was 
blasted with human HOTAIRM1 RNA sequence. D. mHotairm1 RNA sequence was blasted with 
mouse genomic DNA. Two ranges were found (a) and (b), indicating that mHotairm1 is spliced. 
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5.3.2 Expression of mHotairm1 in mouse tissues and cell lines  
To further confirm the existence of mHotairm1 and to study its function, I investigated 
the expression of mHotairm1 in mouse embryonic tissues. Also, I investigated whether the 
expression of mHotairm1 in NIH 3T3 cells is induced by an activator of Hox gene expression, 
namely, the all-trans retinoic acid (ATRA) (Bertani et al., 2011). 
 
5.3.2.1 mHotairm1 is expressed in several different mouse tissues  
The expression of mHotairm1 was examined in the mouse developing palate using real-
time PCR. In the mouse, palatogenesis occurs between E12 to E15 (Smith et al., 2009; 2013) and 
my findings showed that mHotairm1 expression exhibited the highest expression at E12, and 
gradually decreased with the lowest expression at E15 (Fig. 5.17A). mHotairm1 is also expressed 
in the head, forelimbs, hindlimbs and tail region of E13 embryos with the highest expression in 
the tail (Fig. 5.17B).  
 
5.3.2.2 In situ hybridization histochemistry of mHotairm1 in mouse palate  
To determine precisely where the mHotairm1 transcript is being expressed in the 
developing mouse palate, I utilized in situ hybridization histochemistry (ISH). The mHotairm1 
transcript appeared to be primarily expressed in the medial edge epithelial cells of the developing 
palate at E14 and E15 (Fig. 5.18). The location of its expression at the seam of the medial edge 
epithelia prior to palatal fusion may indicate its role in facilitating palatal fusion. Further 
experiments will need to be carried out to identify the role of mHotairm1 in palatal development. 
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Figure 5.17. Mouse Hotairm1 expression in the developing palate (E12 to E15) and mouse 
tissues from E13 embryos. A. mHotairm1 expression levels in wild-type mouse palatal shelves 
from E12 to E15 were quantitated with qRT-PCR. B. mHotairm1 expression detected in head, 
forelimbs, hindlimbs and tail region from E13 embryos by qRT-PCR. Bars represent mean 
±SEM, n =3. 
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Figure 5.18. In situ hybridization histochemistry of mHotairm1 in mouse palate. A-B:  
Schematic diagram of E14 and E15 mouse palatal shelvies. PS: palatal shelvies. MES: middle 
edge seam. C: Distribution of mHotairm1 in E14 and E15 mouse palate detected by in situ 
hybridization histochemistry. Green staining represents the expression of mHotairm1 transcript 
at E 14 (a,b), and E15 (d,e). (c,f): control in situ probes were used and no staining was observed. 
Scale bar indicate 5 microns. 
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5.3.2.3 ATRA induces mHotairm1 expression  
ATRA is a known inducer for the expression of Hox genes and has also been reported to 
induce lncRNA transcription (Bertani et al., 2011). To determine how mHotairm1 is regulated, 
NIH 3T3 cells were treated with ATRA. Results showed that the expression of mHotairm1 as 
well as that of Hoxa1 and Hoxa2 were significantly increased after 24 h treatment with ATRA 
(Fig. 5.19). These results confirmed that mHotairm1 is a mouse noncoding transcript that is 
present in mouse embryonic tissues and that its expression can be induced by ATRA in the NIH 
3T3 cell line 
 
Figure 5.19. All-trans retinoic acid induces mHotairm1, Hoxa1 and Hoxa2 expression. NIH 
3T3 cells were treated with 10-6M ATRA. After 24h, RNA was isolated and mHotairm1 (A), 
Hoxa1 (B) and Hoxa2 (C) expression were quantified using qRT-PCR. Bars represent mean 
±SEM, n =3. *p ≤ 0.05, **p ≤ 0.01 compared to DMSO treated control group. 
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These findings show that mHotairm1 is expressed differently in different mouse 
embryonic tissues. It is also expressed in NIH 3T3 cells and its expression can be induced by 
ATRA, which agrees with the findings of Zhang et al (2009) that human HOTAIRM1 can be 
induced by ATRA in myeloid differentiation. 
 
5.3.3 mHotairm1 regulates Hoxa1 and Hoxa2 expression via histone methylation 
The confirmation of the existence of mHotairm1 led to my next research question: what 
is the function of this lncRNA? The human HOTAIRM1 is known to regulate 3¢ HOXA genes, 
and several lncRNAs transcribed within Hox cluster genes are also known to regulate expression 
of nearby Hox genes (Wang et al., 2011, Bertani et al., 2011). Hence, I further investigated 
whether mHotairm1 regulates the expression of nearby Hoxa1 and Hoxa2 genes and what if any, 
were regulatory mechanisms involved.  
 
5.3.3.1 Knockdown expression of mHotairm1 leads to decreased expression of Hoxa1 and 
Hoxa2  
To determine what impact mHotairm1 had on mouse Hoxa1 and Hoxa2 expression, NIH 
3T3 cells were transfected with mHotairm1 siRNA. Exposure to mHotairm1 siRNA decreased 
mHotairm1 expression in NIH 3T3 cells after 72h, and resulted in significantly decreased 
expression of both Hoxa1 and Hoxa2 genes (Fig. 5.20). 
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Figure 5.20. Knockdown of mHotairm1 leads to decreased expression of Hoxa1 and Hoxa2. 
NIH 3T3 cells were transfected with 150 ng of mHotairm1 siRNA and control siRNA, 
respectively. After 72 h of transfection, total RNAs were isolated, reverse transcribed and 
quantified using qRT-PCR with Hoxa1, Hoxa2 and mHotairm1 primers. Bars represent mean 
±SEM, n =3. **p ≤ 0.01 compared to respective control. 
 
 
 
5.3.3.2 mHotairm1 interacts with promoters of 3' HoxA genes and WDR5. 
To determine the potential mechanism of how blocking the expression of mHotairm1 
causes the down expression of Hoxa1 and Hoxa2 expression, I carried out a “CHART” 
experiment (Simon et al., 2011) to investigate any interactions between mHotairm1, Hoxa1 and 
Hoxa2 promoter and the H3K4 methyltransferase complex MLL1/WDR5. DNA samples bound 
to mHotaim1 probes were collected from the “CHART” experiment and tested using PCR. Probe 
1, 2, 3 were designed to detect mHotairm1 and Probe C (anti-sense to Probe 2) was used as the 
control probe (Fig. 4.4, Table 4.3). Probe 2 showed much stronger interaction with mHotairm1 
(Fig. 5.21 and Fig. 5.22) compared to the control probe, indicating a specific recognition of 
	   127	  
mHotairm1 by Probe 2. PCR results from the DNA fragments pulled down by Probe 2 showed a 
strong interaction between mHotairm1 and the promoters of 3' HoxA genes (Hoxa1, Hoxa2, 
Hoxa3 and Hoxa5) but not with 5' HoxA gene (Hoxa13) when compared to Probe C (Fig. 5.21). 
Protein samples pulled down by Probe 2 also showed strong interaction between mHotairm1 and 
WDR5, a subunit in TrxG complex (Fig. 5.22A). No interaction was observed between 
mHotairm1 and CBP (CREB-binding protein), a histone acetyltransferase. These results indicate 
that there is strong interaction between mHotairm1 and promoters of 3' HoxA genes including 
Hoxa1 and Hoxa2, and the TrxG complex MLL1/WDR5. 
 
 
Figure 5.21. PCR amplification of CHART enriched DNA fragments. DNA fragments that 
can interact with mHotairm1 were pulled down together with mHotairm1 using gene specific 
Probe 1, 2, 3. Probe C was used as control. Each pull down sample was PCR tested with Hoxa1, 
Hoxa2, Hoxa3, Hoxa5 and Hoxa13 promoter primers (see Table 4.3 for probe and primer 
sequences).  
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Figure 5.22. Western blot of CHART enriched protein samples. A. Protein samples 
interacting with mHotairm1 was pulled down together with it using gene specific Probe 1, 2, 3. 
Probe C was used as control. Each pull down sample was tested with WDR5 antibody in western 
blot. NIH 3T3 cell lysate was used as a positive control. Two WDR5 bands were observed in 
NIH 3T3 cell lysate, a WDR5 band at ~37KDa and a modified WDR5 band at ~ 50KDa. Only 
~50KDa bands were seen in CHART enriched protein samples. B. No CBP band was detected in 
western blot in samples pulled down by mHotairm1 specific probe 2. 
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5.3.3.3 mHotairm1 binds directly to MLL1/WDR5 complex. 
5.3.3.3.1 Construction of GST fusion protein vectors. 
To further confirm the interaction between mHotairm1 and MLL1/WDR5 complex, GST 
pull down assay was used. WDR5 and MLL1 (amino acid 3810-3963) coding cDNAs were 
successfully amplified from NIH 3T3 cDNA samples, and cloned into T-easy vectors and further 
confirmed with sequencing (Fig. 5.23, Appendix 10-11). From T-easy vectors, the two fragments 
were then cloned into pGEX-6p-1 vector that contains a GST tag. MLL1 (3810-3963), WDR5 
and GST protein expression were successfully induced with IPTG in DH5ɑ E. coli (Fig. 5.24A-
C). All GST fused proteins were purified with Glutathione agarose beads. Single bands were 
observed in purified samples (Fig. 5.24D). 
 
5.3.3.3.2 Binding of mHotairm1 to MLL1/WDR5 complex 
To confirm the interaction between mHotairm1 and MLL1/WDR5 complex, I carried out 
GST pull down experiments. Using GST fused MLL1 (3810-3963) and WDR5 proteins, the 
RNA pulled down were converted into cDNA and amplified with mHotairm1 primers mush138 
F and mush138 R (Table 4.3). PCR results indicated that mHotairm1can be pulled down with 
both GST-MLL1 (3810-3963) and GST-WDR5, but not with control GST (Fig. 5.24E). 
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A. DNA and protein sequence of full length mouse WDR5 
 
ATG GCC ACA GAG GAG AAG AAG CCA GAG ACA GAG GCT GCA AGA GCA CAG 
 M   A   T   E   E   K   K   P   E   T   E   A   A   R   A   Q  
CCC ACT CCT TCC TCA TCA GCC ACA CAG AGC AAG CCC ACA CCA GTT AAG  
 P   T   P   S   S   S   A   T   Q   S   K   P   T   P   V   K 
CCA AAC TAT GCC CTG AAG TTC ACC CTG GCT GGC CAC ACC AAA GCT GTG  
 P   N   Y   A   L   K   F   T   L   A   G   H   T   K   A   V 
TCC TCT GTG AAG TTC AGC CCC AAT GGG GAA TGG TTG GCA AGT TCA TCT  
 S   S   V   K   F   S   P   N   G   E   W   L   A   S   S   S 
GCT GAT AAA CTC ATT AAA ATT TGG GGA GCA TAT GAT GGA AAG TTT GAG  
 A   D   K   L   I   K   I   W   G   A   Y   D   G   K   F   E 
AAA ACT ATA TCT GGT CAC AAA CTG GGA ATA TCT GAT GTA GCG TGG TCA  
 K   T   I   S   G   H   K   L   G   I   S   D   V   A   W   S 
TCA GAT TCT AAC CTC CTT GTG TCT GCC TCT GAT GAT AAA ACT TTG AAG  
 S   D   S   N   L   L   V   S   A   S   D   D   K   T   L   K 
ATT TGG GAC GTG AGT TCC GGG AAG TGT CTG AAG ACC CTG AAG GGC CAC  
 I   W   D   V   S   S   G   K   C   L   K   T   L   K   G   H 
AGT AAC TAC GTC TTC TGC TGC AAC TTC AAC CCC CAG TCC AAC CTC ATC  
 S   N   Y   V   F   C   C   N   F   N   P   Q   S   N   L   I 
GTC TCA GGG TCT TTT GAT GAA AGT GTG AGG ATA TGG GAC GTG AAG ACA  
 V   S   G   S   F   D   E   S   V   R   I   W   D   V   K   T 
GGG AAG TGC CTC AAG ACT TTG CCT GCC CAT TCG GAC CCA GTC TCA GCC  
 G   K   C   L   K   T   L   P   A   H   S   D   P   V   S   A 
GTT CAT TTC AAC CGT GAT GGA TCA TTG ATT GTT TCC AGT AGC TAT GAT  
 V   H   F   N   R   D   G   S   L   I   V   S   S   S   Y   D 
GGC CTC TGC CGA ATC TGG GAC ACC GCC TCT GGC CAG TGT CTG AAG ACA  
 G   L   C   R   I   W   D   T   A   S   G   Q   C   L   K   T 
CTC ATT GAT GAT GAC AAT CCT CCA GTG TCC TTC GTG AAG TTC TCT CCA  
 L   I   D   D   D   N   P   P   V   S   F   V   K   F   S   P 
AAT GGC AAA TAC ATC CTG GCT GCA ACT TTG GAC AAC ACA CTG AAG CTC  
 N   G   K   Y   I   L   A   A   T   L   D   N   T   L   K   L 
TGG GAC TAC AGC AAG GGG AAG TGC CTG AAG ACA TAC ACT GGC CAC AAG  
 W   D   Y   S   K   G   K   C   L   K   T   Y   T   G   H   K 
AAT GAG AAG TAC TGC ATA TTT GCC AAC TTC TCC GTG ACA GGC GGG AAG  
 N   E   K   Y   C   I   F   A   N   F   S   V   T   G   G   K 
TGG ATT GTG TCT GGT TCT GAA GAT AAC CTG GTG TAT ATC TGG AAT CTG  
 W   I   V   S   G   S   E   D   N   L   V   Y   I   W   N   L 
CAG ACC AAG GAG ATT GTG CAG AAG TTG CAG GGT CAC ACA GAT GTT GTG  
 Q   T   K   E   I   V   Q   K   L   Q   G   H   T   D   V   V 
ATT TCC ACG GCT TGT CAC CCG ACA GAG AAC ATC ATT GCC TCA GCA GCG  
 I   S   T   A   C   H   P   T   E   N   I   I   A   S   A   A  
TTA GAG AAC GAC AAA ACA ATC AAA CTG TGG AAG AGT GAC TGC TAA 
 L   E   N   D   K   T   I   K   L   W   K   S   D   C 
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B. DNA and protein sequence of mouse MLL1 (amino acid 3810-3963) 
 
ATG CCC ATG AGA TTC CGG CAC TTG AAG AAG ACT TCT AAG GAG GCG GTT  
 M   P   M   R   F   R   H   L   K   K   T   S   K   E   A   V 
GGT GTC TAC AGG TCT CCC ATC CAT GGT CGG GGT CTT TTC TGT AAG AGA  
 G   V   Y   R   S   P   I   H   G   R   G   L   F   C   K   R 
AAC ATC GAT GCA GGA GAG ATG GTG ATT GAA TAC GCC GGC AAC GTC ATC  
 N   I   D   A   G   E   M   V   I   E   Y   A   G   N   V   I 
CGC TCC ATC CAG ACA GAC AAG CGT GAG AAG TAC TAT GAC AGC AAG GGC  
 R   S   I   Q   T   D   K   R   E   K   Y   Y   D   S   K   G 
ATT GGT TGC TAC ATG TTC CGA ATT GAT GAC TCG GAG GTA GTG GAT GCC  
 I   G   C   Y   M   F   R   I   D   D   S   E   V   V   D   A 
ACC ATG CAT GGA AAT GCT GCA CGC TTC ATC AAT CAC TCT TGT GAG CCT  
 T   M   H   G   N   A   A   R   F   I   N   H   S   C   E   P 
AAC TGC TAC TCC CGG GTC ATC AAT ATT GAT GGG CAG AAG CAC ATT GTC  
 N   C   Y   S   R   V   I   N   I   D   G   Q   K   H   I   V 
ATC TTC GCC ATG CGT AAG ATC TAC CGG GGG GAG GAG CTC ACC TAT GAC  
 I   F   A   M   R   K   I   Y   R   G   E   E   L   T   Y   D 
TAT AAG TTC CCC ATT GAG GAC GCC AGC AAC AAG CTA CCC TGC AAC TGT  
 Y   K   F   P   I   E   D   A   S   N   K   L   P   C   N   C 
GGC GCC AAA AAA TGC CGC AAG TTC CTG AAC TAA 
 G   A   K   K   C   R   K   F   L   N   
 
 
Figure 5.23. Coding sequence of WDR5 and MLL1 (amino acid 3810-3963). DNA seuqences 
were grouped in triplets with correlating ammino acids marked under DNA sequences in bold 
letters. DNA sequencing confirmed successful cloing of WDR5 (A) and MLL1 (amino acid 
3810-3963) (B). 
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Figure 5.24. GST fusion protein pull down of mHotairm1. (A-C) Coomassie blue staining 
show expressions of GST and GST fused MLL1 (3810-3963) and WDR5 induced with IPTG in 
DH5ɑ (Pointed with red arrow). Lane numbers indicate different clones. (D) GST fusion proteins 
were purified with Glutathione agarose beads. P- protein samples from the pellet of E coli cell 
lysate, S- protein samples from the supernatant of E coli cell lysate, BP- beads purified protein 
sample from the supernatant of E coli cell lysate. Target bands are pointed with red arrow. (E) 
PCR amplicant of mHotairm1 (pointed with red arrow) from GST fusion protein pull down. 
Bands in MLL1 (3810-3963) and WDR5 pull down indicate direct interaction between 
mHotairm1 and MLL1/WDR5 complex. NIH 3T3 cDNA sample was used as a positive control. 
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5.3.3.4 mHotairm1 can affect H3K4me3 and H3K27me3 marks on Hoxa1 and Hoxa2 
chromatin. 
Results above confirmed an interaction between mHotairm1 and TrxG MLL1/WDR5 
complex, next, I wanted to determine whether this interaction also impacts the bivalent domain 
marks H3K4me3 and H3K27me3. H3K4me3 is an activation mark and its occupancy on the 
promoters of some Hox genes is enhanced when expression of the Hox gene is increased, while 
at the same time, gene repressive mark H3K27me3 has decreased occupancy (Wang et al., 2011; 
Bertani et al., 2011). The reverse occurs when Hox gene expression is inhibited resulting in a 
lower occupancy of H3K4me3 and higher occupancy of H3K27me3. Chromatin 
immunoprecipitation (ChIP) were carried out as described in 4.2.16 (p. 90) and experiments 
showed that siRNA induced suppression of mHotairm1 expression in NIH 3T3 cells (Fig. 5.20), 
resulted in a decreased occupancy of the activating mark H3K4me3 and an increased occupancy 
of repressive mark H3K27me3 in both Hoxa1 and Hoxa2 chromatin samples (Fig. 5.25 A-D). 
The occupancy of Histone 3 (H3) on both Hoxa1 and Hoxa2 gene chromatin samples was not 
affected by the down regulation of mHotairm1 (Fig. 5.25 E, F). These results confirmed that 
mHotairm1 does indeed regulate the expression of Hoxa1 and Hoxa2 via histone methylation 
impacting bivalent domain marks H3K4me3 and H3K27me3. 
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Figure 5.25. mHotairm1 affects the bivalent histone methylation marks, H3K4me3 and 
H3K27me3, at Hoxa1 and Hoxa2 chromatin sites. qChIP was carried out as described in 
4.2.16. Relative occupancy repreasts the fold enrichment of H3K4me3 (A,B),  H3K27me3 (C,D) 
and H3 (E,F) on both Hoxa1 and Hoxa2 chromatin relative to input. Histone 3 was used as a 
positive control (E,F). Bars represent mean ±SEM, n =3. *p ≤ 0.05 compared to respective 
control. 
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The above findings demonstrate that mHotairm1 can recruit histone methyltransferase 
complex MLL1/WDR5 to Hoxa1 and Hoxa2 gene and induce H3K4me3 to activate their 
expression. These findings are similar to the findings of HOTTIP (Wang et al., 2011) and Mistral 
(Bertani et al., 2011), which can positively regulate neighbouring Hox genes through the 
recruitment of MLL1/WDR5 complex.  
 
5.3.4 WDR5 is sumoylated and this modification maybe important for the function of 
WDR5.  
5.3.4.1 MLL1 specifically interacts with 50 kDa WDR5. 
Using a WDR5 antibody in western blot, two distinct WDR5 bands at ~37KDa and at ~ 
50KDa were observed in NIH 3T3 cell lysates (Fig. 5.22). In addition, GST-MLL1 (3810-3963) 
protein pull down of WDR5 confirmed a direct interaction between MLL1 and WDR5 but 
interestingly, only predominantly with the ~50 kDa isoform (Fig. 5.26). This ~50 kDa band was 
suspected to represent a modification of WDR5 and since only the ~50 kDa band co-precipitated 
with MLL1, this modification may be biologically important. The size difference between the 
~50 kDa band and the unmodified WDR5 (~37 kDa) suggested the modification might be 
sumoylation, which is ~ 12 kDa in size (Kumar and Zhang, 2015). Indeed, in the presence of the 
ubiquitin/SUMO protector NEM, protein samples showed a stronger band intensity further 
supporting this hypothesis (Fig. 5.26A). Thus I hypothesized this post-translation modification to 
be sumoylation and additional experiments were carried out to test this hypothesis. 
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Figure 5.26. GST fused MLL1 (3810-3963) pull down of modified WDR5. A. Western blot 
showing modified WDR5 bands at ~ 50kDa in samples pulled down with GST fused MLL1 
(3810-3963). The unmodified WDR5 band (~37kDa) was not observed. NEM: ubiquitin/SUMO 
protector N-ethylmaleimide. GST was used as a negative control. B. Loading control of GST and 
MLL1 (3810-3963). Coomassie blue staining showing equal loading of GST and GST fused 
MLL1 used in the pull down experiment above. 
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5.3.4.2 Sumoylated WDR5. 
I carried out immunoprecipitation assays and established that the protein samples 
precipitated with WDR5 antibody could be detected with a SUMO1 antibody in Western blot 
assays (Fig. 5.27A). Similarly, protein samples precipitated with SUMO1 antibody could also be 
identified with the WDR5 antibody (Fig. 5.27B). Hence, the modification of WDR5 as it exists 
in NIH 3T3 cells is most likely sumoylation. Experiments using mass spectrometry to confirm 
sumoylation of WDR5 will be needed to characterize this further.  
 
Figure 5.27. Reciprocal co-immunoprecipitation of WDR5 and SUMO1. A. SUMO1 
antibody detected a band in protein samples immunoprecipitated with WDR5 antibody at the 
exact size as modified WDR5 seen in NIH 3T3 nucleus. B. WDR5 antibody also detected a band 
in protein samples immunoprecipitated with SUMO1 antibody at the size of modified WDR5. 
IgG antibody was used as the negative control. 
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5.3.4.3 Cellular distribution of WDR5 in NIH 3T3 cells.  
Although SUMO modification of proteins has multiple functions, one important function 
is their role in nuclear-cytosolic transport (Eun Jeoung et al., 2008; Berndt et al., 2012; 
Lamoliatte et al., 2014). I investigated this further by first performing immunocytochemistry to 
determine the distribution profile of WDR5 in NIH 3T3 cells. Immunocytochemistry revealed 
that WDR5 is distributed throughout the cell in both cytoplasm and nuclei (Fig. 5.28).  
Subsequently, nuclei and cytoplasm were isolated from the NIH 3T3 cells using the method 
described in section 4.2.17. Western blot analysis showed that the modified WDR5 protein is 
present in the nuclei whereas both forms of WDR5 exist in the cytoplasm (Fig 5.29). The 
proteins b-actin (only expressed in cytoplasm) and Histone 3 (H3, only expressed in nucleus) 
were used to verify the separation of nuclei and cytoplasm.  
We can speculate that since only the modified WDR5 is present in the nuclei, this SUMO 
modified WDR5 may play a role in translocation of the protein from the cytoplasm to the nuclei.  
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Figure 5.28. WDR5 is present in both cytoplasm and nuclei in NIH 3T3 cells. NIH 3T3 cells 
were fixed and immunostained with a WDR5 antibody (shown in red, a and c). Nuclei were 
labelled with DAPI (shown in blue, b-c, e-f). A blank group without primary antibody (WDR5 
antibody) is used as negative control (d). Arrows point to nuclei and arrowheads point to 
cytoplasm. Scale bars = 3 microns.  
 
 
 
Figure 5.29. WDR5 proteins in NIH 3T3 cell cytoplasm and nuclei. Western blot analysis 
shows modified WDR5 protein band (~50kD) in nuclei, cytoplasm and NIH 3T3 whole cell 
lysates. Unmodified WDR5 protein band (~37kD) was only observed in the cytoplasm and NIH 
3T3 cell lysates. b-Actin protein was observed only in cytoplasm and NIH 3T3 whole cell 
lysates. H3 protein was observed in nuclei and NIH 3T3 whole cell lysates.  
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5.3.4.4 Sumoylated WDR5 is responsive to ATRA induction. 
Since ATRA induces the expression of mHotairm1 as well as Hoxa1 and Hoxa2 (Fig. 
5.19), I further investigated whether ATRA would have any effect on post-translation 
modification of WDR5. Interestingly, ATRA treatment appeared to show a stronger band 
intensity of the modified WDR5 (~50 kDa) protein in the nuclei of NIH 3T3 cells (Fig 5.30). As 
mHotairm1 can positively regulate Hoxa1 and Hoxa2 expression through the regulation of 
H3K4me3 occupancy on their promoters, it is highly possible that exposure to ATRA which 
induces Hoxa1 and Hoxa2 expression is through the increase of both modified WDR5 and 
mHotairm1 expression. In summary, my results reveal a new a gene regulatory pathway in which 
mHotairm1 working closely with H3K4 methylation complex and sumoylated WDR5, regulates 
Hoxa1 and Hoxa2 expression.  
 
Figure 5.30. Effect of ATRA on the expression sumoylated WDR5. After ATRA treatment, 
an increased sumoylated WDR5 in NIH 3T3 nuclei was observed. b-actin bands were observed 
in cytoplasm and NIH 3T3 cell lysates. Histone 3 bands were observed in the nuclei and NIH 
3T3 cell lysates. 
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These findings suggest that WDR5 is sumoylated and this modification plays an 
important role in its interaction with mHotairm1 and MLL1. This modification may help WDR5 
to translocate from cytoplasm to the nucleus. Further experiments are needed to study the 
function of sumoylated WDR5.  
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CHAPTER 6 
6. Discussion 
6.1 DNA methylation 
DNA methylation is an important epigenetic mechanism in mammalian embryo 
development (Bird, 2002; Santos et al., 2005; Bartolomei and Ferguson-Smith, 2011; Lomvardas 
and Maniatis, 2016). DNA methylation which primarily occurs on cytosine bases in GpG rich 
sequences of the promoter regions leads to gene silencing through the inhibition of transcription 
factor binding and the changing of chromatin structure into a repressive state (Domcke et al., 
2015). Our lab has been interested in Hoxa2 regulation in mouse palatal development and has 
revealed a spatio-temporal expression pattern of Hoxa2 during palatogenesis (Nazarali et al., 
2000; Smith et al., 2009, 2013). It is not known whether this differential expression of Hoxa2 is 
regulated by a specific epigenetic mechanism(s). The genome is comprised of many CpG rich 
regions and many are located near 5′ regulatory regulatory regions of genes. My analysis of 
Hoxa2 promoter revealed three CpG islands close to Hoxa2 5′ regulatory regulatory region. I 
have used several approaches to study these CpG islands. First I used MSP to study the three 
CpG islands within the Hoxa2 promoter region. The advantage of this method is that by 
designing methylated and unmethylated specific primers, the methylation status can be tested by 
a simple PCR. However, since PCR primers are usually only 18-24nt long, the CpG sites that can 
be covered by forward and reverse primers are limitied. This also resulted in higher degree of 
primer sequence similarity between methylated and unmethylated primers. A critical PCR 
condition is needed for MSP primers to selectively bind and amplify specific 
methylated/unmethylated target sequences. To develop optimal PCR conditions for all sets of 
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MSP primers, DNA samples from NIH 3T3 cells and EG7 cells were used as unmethylated and 
methylated control, respectively. It has previously been shown in our lab that the Hoxa2 
promoter is unmethylated in NIH 3T3 cells and that it remains highly methylated in the EG7 
cells (Wang and Nazarali, unpublished). After testing several different annealing temperatures, I 
was able to develop optimal PCR cycle conditions for each pair of MSP primer set. In the 
developing mouse palate, DNA samples collected at all four stages of palatogenesis were 
recognized by unmethylated primers but not with methylated primers, suggesting Hoxa2 
promoter is most likely unmethylated during palate development.  
The limitation of using MSP is that only CpG sites recognized by the primers can be 
tested. To examine the methylation status of each single CpG site, a BSP method was used. BPS 
is a method that uses PCR to amplify a certain CpG island, whether methylated or unmethylated, 
and the methylation status of each individual CpG site can then be analyzed by DNA sequencing. 
This method requires a longer experimental process but the advantage is that each GpG site 
within the CpG island can be analyzed. Since the CpG region-1 is closest to Hoxa2 transcription 
start site and likely most relevant to Hoxa2 expression, this region was selected for further BSP 
analysis. The results of BSP showed that all 14 CpG sites tested in the CpG region-region 1 were 
unmethylated in NIH 3T3 cells and in developing mouse palate from E12 to E15, whereas 10 of 
the 14 CpG sites were found to be methylated in EG7 cells. These results supported my findings 
from the MSP experiments. From these observations we can conclude that during mouse palate 
development the Hoxa2 promoter within the CpG-region 1 primarly remains unmethylated and 
that the DNA methylation status of the Hoxa2 promoter does not change with the spatio-
temporal expression of Hoxa2 during palatogenesis.  
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6.2 Regulation of Hoxa2 gene expression by miRNAs 
Currently, there are several studies that focus on miRNA regulation of gene expression 
(Yan and Jiao, 2016; Green et al., 2015; He et al., 2015; Usmani et al., 2016). Regulation of 
gene expression by miRNAs is complex because a specfic gene can be regulated by many 
different miRNAs and whereas a specific miRNA can also regulate expression of several 
different genes (Doench and Sharp, 2004; Felekkis et al., 2010). Generally, miRNAs bind to the 
3'UTR of a gene, hence I performed in-silico analysis and identified six miRNAs that had the 
potential to bind 3'UTR of the Hoxa2 gene. Following this, I investigated expression profiles of 
these miRNAs in mouse palatal tissues, and in cell lines in which Hoxa2 expression is already 
studied (Smith et al., 2009; Wang and Nazarali unpublished).  Since these predicted miRNAs 
were considered to downregulate Hoxa2 expression, I primarily focused on miRNA expression 
patterns that were complementary to that of the Hoxa2 expression. The two miRNAs: miR-431 
and miR-298 showed high expressions in NIH 3T3 cells at the same time as Hoxa2 expression. 
Thus these two miRNAs are unlikely to down regulate Hoxa2 in NIH 3T3 cells. All six miRNAs 
exhibited low expression levels in EG7 cells, possibly due to globally repressed transcription 
activity and high DNA methylation status of gene promoters in EG7 cells (Wang and Nazarali 
unpublished). I then investigated the expression of of all six miRNAs in developing mouse palate 
at stages E12 to E15. Three miRNAs (miR-669b, miR-376c and miR-431) exhibited increased 
expression from E13 to E15 in mouse palate, during the same period when Hoxa2 expression is 
declining (Smith et al., 2009). Since miR-431 showed high expression in NIH 3T3 cells, I 
continued further investigations with only miR-669b and miR-376c.  
To investigate whether miR-669b and miR-376c are able to down regulate the expression 
of Hoxa2, I transfected synthesized mature miRNAs: miR-669b mimic and miR-376c mimic into 
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NIH 3T3 cell cultures. Overexpression of both miRNAs by miRNA mimics resulted in the 
downregulation of Hoxa2 expression at both transcriptional and translational level. At this stage, 
it was not known whether miR-669b and miR-376c miRNAs bound directly to the 3¢UTR of 
Hoxa2 or had an indirect effect on Hoxa2 expression via regulation of upstream genes that may 
control Hoxa2 expression. A luciferase expressing vector carrying the 3¢UTR of Hoxa2 was used 
in luciferase assays to determine whether miR-669b and miR-376c miRNAs bound to the Hoxa2 
3¢UTR. Luciferase assays showed that miR-669b appears to directly bind to Hoxa2 3'UTR since 
mutations within the seed sequences abrogated luciferase activity, however miR-376c had no 
effect on luciferase assay and so its effect on Hoxa2 expression may likely be via an indirect 
effect. Although most miRNAs bind to the 3'UTR of their target genes, some miRNAs are also 
known to bind to coding regions of mRNA (Hu et al., 2011). Hence, it is possible that miR-376c 
may affect Hoxa2 expression by interacting with other regions of the Hoxa2 mRNA. An 
additional possibility is that miR-376c may be regulating genes upstream of Hoxa2 which in turn 
is regulating Hoxa2 expression. One such possibility is the Krox20 gene that is upsteam of 
Hoxa2 (Nonchev et al., 1996). In human pluripotent stem cells, miR-376c has been reported to 
inhibit the expression of SMAD4 gene in the TGF-β (transforming growth factor β) pathway 
(Liu et al., 2014). SMAD4 is known to bind directly to PAX6 (paired box 6) gene promoter and 
suppress its expression (Liu et al., 2014). Thus, overexpression of miR-376c would lead to the 
downregulation of SMAD4 expression which inturn would lead to an upregulation of PAX6 
expression. Pax6 has been reported to induce the expression of Nab1 (NGFI-A Binding Protein 
1), a Krox20 repressor in the chick embryo (Kayam et al., 2013). Hence, overexpression of miR-
376c could lead to an upregulation Nab1 expression via Pax6 and subsequent downregulation of 
Krox20 expression. Krox20 is a known upstream gene of Hoxa2 and can directly activate its 
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expression (Nonchev et al., 1996). Thus, downregulation of Krox20 would induce 
downregulation of Hoxa2 expression. Hence, an indirect link between miR-376c and Hoxa2 gene 
expression may exist via genes upstream of Hoxa2 (Fig 6.1). 
 
 
Figure 6.1. A putative indirect link between miR-376c and Hoxa2 expression. miR-376c can 
directly inhibit the expression of Smad4 which in turn activates Pax6 expression. Pax6 induces 
the expression of Nab1 which in turn inhibits the expression of Krox20, an upstream Hoxa2 
activator.  
 
Researchers in the past have generally put a higher emphasis on comparing differences 
within coding regions of genes between various species. However, many researchers are 
beginning to realize that the non-coding regions have important regulatory roles and sequence 
differences in these regions could lead to differentially regulated gene expression between 
various species (Barrett et al., 2012). There are two predicted miR-669b binding sites on mouse 
Hoxa2 3'UTR. My mutation experiments showed that the two binding sites appear to work 
independently from each other. I analyzed the degree of sequence similarity for both miR-669b 
binding sites and found that the binding site 1 is evolutionally conserved among the five species 
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examined, human, mouse, rat, chimpanzee and dog. However, the binding site 2 in mouse only 
exibited sequence similarity with that in rat and not with the other three species examned (Fig. 
5.5). Since the binding site 1 is present in all five species examined, it is possible that miR-669b 
has more conserved role in regulating Hoxa2 gene expression via this binding site.  While it is 
known that one miRNA may have hundreds of gene targets, having a single miRNA binding site 
may not be sufficient to strongly inhibit gene expression (Stark et al., 2005). Thus, it is also 
possible that the regulation of Hoxa2 by miR-669b would not be as strong in other species 
compared to mouse or rat which has two miR-669b binding sites on Hoxa2 3¢UTR.  
Interestingly, evidences support genomic evolution of 3'UTR region to mitigate and 
augment the effects of miRNA on gene expression regulation (Stark et al., 2005; Thomsen et al., 
2010). Some mRNAs have evolved to have different lengths of 3'UTRs so that they have 
different ‘visibilities’ to miRNAs in different tissues (Stark et al., 2005; Thomsen et al., 2010). 
Thomsen and colleagues found different 3' UTR splicing exist in several Hox genes in 
Drosophila (Thomsen et al., 2010). For example, the longer form of Ubx mRNA has eight miR-
iab4/8 binding sites and is expressed mainly in the developing CNS. Expression levels of the 
longer Ubx mRNA with multiple miR-iab4/8 binding sites is very sensitive to miR-iab4/8 
regulations. The shorter form of Ubx mRNA with only three miR-iab4/8 binding sites in the 
3'UTR is mainly expressed in germ band elongation and removal of miR-iab4/8 binding 
sequence did not have a significant effect on the expression of the short form of the Ubx 
transcript (Thomsen et al., 2010). Differential splicing of Hoxa2 3'UTR has not been reported; 
however, bioinformatic analysis has revealed high frequency of alternative polyadenylation in 
mammals (Brett et al., 2000; Di Giammartino et al., 2011). Hence, it is still possible that Hoxa2 
may also have differentially spliced 3'UTR. Having a single miR-669b binding site in human 
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HOXA2 3'UTR may make it less ‘visible’ to miR-669b, although my experiments showed that 
each single miR-669b binding site on Hoxa2 3'UTR is sufficient to confer the repression of 
Hoxa2 expression when miR-669b was over expressed. Possessing two binding sites may 
enhance the regulatory role of miR-669b on Hoxa2 expression under normal biological 
conditions. 
In my study, I have also found that in the developing mouse palate (from E13 to E15), 
miR-669b has a complementary expression to that of Hoxa2. At the E12 stage, both Hoxa2 and 
miR-669b have relatively low expression in palate indicating that miR-669b may not be 
responsible for regulating Hoxa2 expression at this stage in mouse palate. However, it is highly 
probable that miR-669b may play a role in down regulating Hoxa2 expression towards the end of 
mouse palate development when Hoxa2 palatal expression declines and miR-669b expression is 
the highest. Since Hoxa2 can also regulate ear and nervous system development (Minoux et al., 
2013; Cox et al., 2014; Gavalas et al., 1997; Wang et al., 2011), it may be of interest to 
investigate whether miR-669b plays a role in these developmental processes. Many pathological 
processes, including cancer, neurological diseases and cardiovascular diseases impact specific 
miRNA expression changes, making them a promising biomarker and potential diagnostic tool 
for a variety of diseases (Chi and Zhou, 2016; Stoicea et al., 2016; Wallace et al., 2016). The 
regulatory roles of miRNAs also render them promising therapeutic targets in many diseases 
(Broderick and Zamore, 2011). The mechanisms by which miRNAs regulate gene expression are 
still not fully understood and further studies on miRNAs will lead to a better understanding of 
biological processes.  
In summary, my investigations identified two miRNAs, miR-669b and miR-376c, that 
regulate Hoxa2 expression in mouse NIH 3T3 cells. MiR-669b directly binds to mouse Hoxa2 
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3'UTR to down regulate its expression, also two functional miR-669b binding sites were 
identified on Hoxa2 3'UTR. No direct interactions between miR-376c and Hoxa2 3'UTR was 
identified. miR-376c possibly binds to other regions of Hoxa2 mRNA or other regulatory genes 
upstream to Hoxa2 which in turn may regulate Hoxa2 expression (Fig. 6.1). miR-669b is 
expressed in developing mouse palate with a complemenatry expression profile to Hoxa2 and 
may have regulatory role in mouse palate development.  
 
6.3 lncRNA mHotairm1 regulation of Hoxa1 and Hoxa2 expression 
Following the discovery of the lncRNA:Polycomb repressive complex 2 (PRC2) 
interaction (Zhao et al., 2008), significant interest has been generated to characterize the role of 
lncRNAs in epigenetic activation/inactivation of gene expression (Cao, 2014). Additionally, 
investigation on the transcriptional activity of the human HOX loci showed that many of the 
intergenic regions are actively transcribed and most of transcripts from the intergenic regions are 
lncRNAs (Rinn et al., 2007). Hox lncRNAs likely play important biological roles based on the 
fact that: 1) Some lncRNAs are conserved during evolution; 2) Like HOX genes, lncRNAs in 
HOX cluster have different expression patterns along the A-P axes depending on their physical 
location on the chromosome (Rinn et al., 2007). However, very few lncRNAs from Hox clusters 
have been chacterized. In my study, I have found a new lncRNA located between mouse Hoxa1 
and Hoxa2 and further demonstrated its ability to recruit MLL1/WDR5 to nearby target genes 
and to regulate these gene expressions. My results provide additional evidence to support the 
hypothesis raised by Rinn et al. that transcription of lncRNA in cis may recruit TrxG proteins 
such as MLL1 and WDR5 to chromatin, leading to H3K4me3 induction and gene activation 
(Rinn et al., 2007).  
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6.3.1 Identification of mHotairm1 
The existence of HOTAIRM1 in human was reported by Zhang and colleagues in 2009 
(Zhang et al., 2009). In GenBank database that I searched, a similar long non-coding transcript 
was found to potentially exist in the mouse. I made several attempts to identify the full length of 
mHotairm1. First, based on the predicted mHotairm1 sequence provided by GenBank, I designed 
three pairs of PCR primers that covered 462bp of the predicted mHotairm1 sequence in total. 
Each pair of primer set were designed to have overlapping region with the next pair. All three 
pairs of primers successfully amplified DNA fragments from cDNA samples generated from 
total RNA isolated from NIH 3T3 cells. Each amplified fragment was sequenced and matched 
exactly with the predicted sequence (Fig. 5.16B, Appendix 7-9). The analysis of the predicted 
mHotairm1 sequence showed that this transcript has two exons and splicing occurs between 
nucleotide 162 and 165. Primer set Mush-138 covered a length from nucleotide 131 to 268 
(Table 4.3, Appendix 8) which include the splicing site. The fact that primer set Mush-138 is 
only able to amplify DNA fragment from cDNA sample but not from genomic DNA (Appendix 
12) further supported the existence of mHotairm1 and ruled out a possible contamination from 
genomic DNA. This primer set was also used to identify mHotairm1 in further experiments.  
I then tried to identify the 3' and 5' end of mHotairm1 using Rapid Amplification of 
cDNA Ends (RACE) approach. The strategy of RACE experiment is to add special adaptor 
sequences to both 3' and 5' end of mRNAs and construct a cDNA library. Then by using gene 
specific primers and adaptor primers, target gene fragments can be amplified with their 3' and 5' 
ends. Unfortunately, I was not able to successfully amplify either 3' or 5' end of mHotairm1. I 
have tried different mHotairm1 specific primers but none of amplification products turned out to 
be from mHotairm1. The possible reasons are: in RACE experiments, only one gene specific 
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primer is used in target fragment amplification, which reduced the specificity of amplification 
compared to normal PCR, and secondly, lncRNAs usually have significantly lower levels of 
expression compared to protein-coding genes (Cabili et al., 2011; Derrien et al., 2012), which 
makes them even more difficult to amplify in a RACE experiment. However, I was able to 
identify the majority of the mHotairm1 sequence (462nt) and confirm the existence of a new 
long noncoding transcript located between Hoxa1 and Hoxa2 in mouse.  
 
6.3.2 mHotairm1 expression in cell lines and mouse tissues 
Most lncRNAs have tissue specific expression (Derrien et al., 2012). mHotairm1 
expression was identified in different mouse embryonic tissues (Fig 5.17). In the developing 
palate (E14) mHotairm1 expression is localized to the medial edge epithelia (MEE) (Fig 5.18A). 
In the developing mouse palate at E14 the two vertical palate shelves begin elevating above the 
tongue and grow towards each other. The two palate shelves eventually contact each other at the 
MEE. The MEE layers from the two palate shelves then merge together to form the medial edge 
seam (MES) and finally fuse together (Ferguson, 1988). This process is regulated by a series of 
cellular and biochemical reactions and is a very important step in palate development (Ferguson, 
1988; Jin and Ding, 2006, Smith et al., 2013, Lan et al., 2015). In situ hybridization 
histochemistry of E14 developing palate showed the expression of mHotairm1 in MEE (Fig. 
5.18), indicating mHotairm1 may play a role in the palatal fusion. mHotairm1 expression in E15 
palatal shelves was only faintly detected by in situ hybridization histochemistry, which agrees 
with the real-time PCR data where mHorairm1 expression has significantly declined. The 
expression of mHotairm1 in E12 and E13 mouse palatal shelves was not detectable with in situ 
probes, possibly due to a low abundance of lncRNAs at these stages.  
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6.3.3 Regulation of Hoxa1 and Hoxa2 expression by mHotairm1  
Although the presence of non-coding transcripts was initially considered to be “noise” 
and of little consequence, they have gained importance as more information is gathered on their 
important regulatory roles (Rinn and Chang, 2012; Bonasio and Shiekhattar, 2014). As Rinn and 
colleagues (2007) have suggested, the lncRNAs transcribed from Hox loci can either up or down 
regulate target gene expression. Thus to study the function of mHotairm1, I first tested whether a 
change in the expression of mHotairm1 could influence the expression of nearby genes such as 
Hoxa1 and Hoxa2. I chose to down regulate expression of mHotairm1 with siRNA in mouse 
fibroblast cell line NIH 3T3 where Hoxa1, Hoxa2, as well as mHotairm1 are all expressed. My 
results showed that downregulation of mHotairm1 resulted in significant downregulation of 
Hoxa1 and Hoxa2 expression.  
A well characterized activator of Hox gene expression, all-trans retinoic acid (ATRA) 
has also been shown to induce the expression of Hox loci derived lncRNAs (Zhang et al., 2009; 
Bertani et al., 2011). Moreover, the induction of 3¢ HOX gene expression by ATRA is attenuated 
if the regulatory lncRNA HOTAIRM1 is silenced (Zhang et al., 2009). As well Bertani and 
colleagues (2011) have reported that the transcription of lncRNA Mistral precedes its target gene 
Hoxa6 and Hoxa7 expression following ATRA treatment. These evidences support induction of 
Hox genes via the effect of ATRA on lncRNA expression. My results showed that ATRA 
induces the expression of mHotairm1, Hoxa1 and Hoxa2 in NIH 3T3 cells. Based on the findings 
of Bertani et al (2011) and Zhang et al (2009), it is highly probable that ATRA induces the 
expression of mHotairm1 further leads to an increase in the expression of Hoxa1 and Hoxa2. 
Thus my findings indicate that Hoxa1 and Hoxa2 have the same expression trend as that of 
mHotairm1 and that mHotairm1 can positively regulate the expression of Hoxa1 and Hoxa2. 
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6.3.4 mHotairm1 activates Hoxa1 and Hoxa2 expression through histone methylation 
LncRNAs are involved in numerous cellular processes, including ES cell pluripotency, 
cellular pathway regulation and cell-cycle regulation (Rinn and Chang, 2012). They are also 
important during development (Schmitz et al., 2016) and in certain diseases, such as 
cardiovascular disease (Archer et al., 2015), nervous system diseases (Briggs et al., 2015) and 
cancer (Schmitt and Chang, 2016). Despite all the different cellular processes and diseases that 
involve lncRNAs, one fundamental rule has emerged: lncRNAs drive the formation of 
ribonucleic-protein complexes to regulate gene expression (Rinn and Chang, 2012). One large 
group of protein partners that bind to lncRNAs are the chromatin and DNA modification 
complexes. These complexes include DNA methylation complex, PRC1 and PRC2, TrxG 
complex and HDACs (reviewed by Rinn and Chang, 2012), which closely link lncRNA with 
other epigenetic marks. The lncRNAs transcribed from Hox loci have thus far been reported to 
bind to two histone methylation complexes: PRC2 which tri-methylates H3K27 and suppresses 
gene expression (Rinn et al. 2007), and MLL1/WDR5 complex, which belongs to TrxG and tri-
methylates H3K4 to activate gene expression (Wang et al., 2011; Bertani et al., 2011). Since my 
results show that mHotairm1 plays a role in activating the expression of Hoxa1 and Hoxa2, I 
speculated that mHotairm1 may achieve its gene activation role by recruiting MLL1/WDR5 
complex to the chromatin of Hoxa1 and Hoxa2.  
Capture hybridization analysis of RNA targets (CHART) developed by Simon et al (2011) 
is method used to enrich endogenous RNAs along with their associated proteins and their DNA 
targets. Similar to ChIP assays, samples are cross-linked and chromatin is sheared into small 
fragments. Then instead of using antibodies targeting chromatin proteins to enrich target 
fragments as in ChIP, affinity-tagged oligonucleotides are used to enrich target lncRNA together 
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with its protein partners and chromatin targets. In this way, CHART can achieve two goals at the 
same time: to study the genomic binding sites of a lncRNA and to study which protein complex 
is associated with this lncRNA. The advantages of CHART over ChIP in the study of lncRNA 
function are: (1) CHART can allow for the study of protein, DNA and RNA from the same 
coprecipitated sample; (2) CHART is able to identify the genomic target of lncRNA. The key 
step in CHART experiment is to design a lncRNA specific oligo probe to specifically bind to and 
enrich the target RNA. Since lncRNAs have secondary structures and are usually bound to 
proteins, the regions on the lncRNA that can be recognized by a complimentary oligo probe are 
limited. Additionally, the oligo probe still should be long enough to specifically recognize target 
lncRNA. Thus, I designed three 25-mer mHotairm1 specific probes targeting 3¢ (Probe 1), 
middle (Probe 2) and 5¢ (Probe 3) part of mhotairm1 (Fig. 4.4). The samples enriched with three 
mHotairm1 specific probes were compared with samples pulled down with a control probe 
(Probe C) to rule out any background interference and nonspecific binding. Probe 2 showed the 
strongest binding to mHotairm1. The DNA samples retrieved from Probe 2 pull down showed 
that Hoxa1 and Hoxa2 as well as additional 3' HoxA genes are all targets of mHotairm1 while 
the 5' HoxA gene Hoxa13 did not specifically interact with mHotairm1. This result is supported 
by Wang et al’s (2011) finding that in HoxA cluster, 3' lncRNAs primarily interact with 3' HoxA 
genes while 5' lncRNAs primarily interact with 5' HoxA genes. The protein samples retrieved 
from the same pull down sample showed that the TrxG protein WDR5 is associated with 
mHotairm1, suggesting MLL1/WDR5 complex may play a role in the regulation of Hoxa1 and 
Hoxa2 gene expression by mHotairm1. Since histone acetylation is also a gene activation marker, 
I examined the presence of histone acetyltransferase CBP and found no interaction between 
mHotairm1 and CBP. This, however, does not rule out the possibility that histone acetylation is 
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involved in mHotairm1 induced expression of Hoxa1 and Hoxa2, since there are other histone 
acetyltransferases that may be able to interact with WDR5 (Zhao et al., 2013; Dias et al., 2014). 
As CHART probes were DNA probes designed complementary to the sequence of mHotairm1, 
they may also have the abilities to bind to the genomic DNA, especially in region where 
mHotairm1 is transcribed. To reduce the background due to the direct binding of genomic DNA 
to CHART probes, DNA samples can be eluted with RNase-H instead of biotin. In this way, only 
the DNA bound through RNA should be eluted from the resin, but not the DNA that is directly 
bound to the oligo probe (Simon et al., 2011). 
WDR5 is a subunit of MLL1/WDR5 complex and is also involved in other functional 
complexes (Zhao et al., 2013; Dias et al., 2014). Thus, to confirm the involvement of histone 
methylation in the regulation of Hoxa1 and Hoxa2 expression by mHotairm1, I wanted to 
determine whether there is an interaction between mHotairm1 and MLL1. Unfortunately, I was 
not able to find a good antibody that could recognize MLL1 in western blots, partially because 
MLL1 is a very large and complex protein. Thus, I was not able to determine the interaction 
between MLL1 and mHotairm1 in CHART experiment. However, I designed a pull down 
experiment that would confirm the interaction between mHotairm1 and MLL1/WDR5 complex. 
A GST tagged WDR5 (full length) and MLL1 (amino acid 3810-3963) expression vectors were 
constructed and a prokaryotic system (E.coli) was used to produce WDR5 and MLL1 proteins. 
As the mammalian MLL1 cDNA is ~12 kb in length and MLL1 protein contains ~4000 amino 
acids (Zhang et al., 2013), it is almost impossible to produce a full length MLL1 protein in E.coli. 
Bertani and colleagues reported that amino acids 3810 to 3963 is the critical region of MLL1 that 
binds lncRNA Mistral (Bertani et al. 2011), thus I selected this region of MLL1 in the pull down 
experiment. GST tag was used for the purification of proteins produced in E.coli and purified 
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WDR5 and MLL1 (3810-3963) proteins were applied to NIH3T3 whole cell lysate. Both WDR5 
and MLL1(3810-3963) could pull down mHotairm1, which indicates that mHotairm1 is closely 
associated with histone methytransferase complex MLL1/WDR5. However, it is not clear which 
of the two proteins bind directly to mHotairm1, since the fragment of MLL1 used in pull down 
experiments contains the Win motif, which is the region on MLL1 that also binds to WDR5 
(Zhang et al., 2013). Hence possibility exists that the MLL1 pulled down mHotairm1 is due to its 
interaction with WDR5.  
There is also some debate in the literature as to which specific protein in the TrxG 
complex is key for the interaction with lncRNA. Wang and colleagues reported that lncRNA 
HOTTIP can only bind to WDR5 but not MLL1 (Wang et al., 2011). This is supported by Yang 
and colleagues who have identified several critical amino acids of WDR5 that are key in the 
binding of lncRNA HOTTIP (Yang et al., 2014). However, Bertani et al. (2011) demonstrated 
that Mistral binds directly to MLL1 only and not to WDR5. Nevertheless, my findings confirmed 
that mHotairm1 interacts with MLL1/WDR5 complex to target Hoxa1 and Hoxa2 genes. 
To further support the above findings that mHotairm1 can recruit MLL1/WDR5 complex 
to Hoxa1 and Hoxa2 genes and regulate their expression, I downregulated the expression of 
mHotairm1 in NIH 3T3 cells and investigated its impact on H3K4me3 and H3K27me3’s 
occupancy on Hoxa1 and Hoxa2 chromatin using ChIP. The knockdown of mHotairm1 resulted 
in reduced occupancy of gene activation mark H3K4me3 and increased occupancy of gene 
suppression mark H3K27me3, which correlates with my previous finding that downregulation of 
mHotairm1 leads to decreased Hoxa1 and Hoxa2 expression.  
These findings together suggested that mHotairm1 can regulate Hoxa1 and Hoxa2 
expression through the recruitment of histone methytransferase complex MLL1/WDR5. Hence, 
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the regulatory mechanism of mHotairm1 appears to be very similar to Mistral (Bertani et al. 
2011) and HOTTIP (Wang et al., 2011), other two lncRNAs identified within the HoxA cluster.  
 
6.3.5 Modification of WDR5 
Another significant aspect of my work is the finding that WDR5 is sumoylated and this 
modification is important for its function. Several pieces of information led me to suggest that 
WDR5 is being sumoylated. Firstly, the molecular mass difference between the modified and 
unmodified WDR5 is ~13KDa, which is close to the molecular mass of sumoylation (~11KDa) 
(Hay, 2005; Kumar and Zhang, 2015). Secondly, the 50KDa protein identified in my 
experiments is protected by NEM, a ubiquitin/SUMO protector (Fig. 5.26A). To confirm that 
WDR5 is sumoylated, I first used immunoprecipitation (IP) to test whether proteins 
immunoprecipitated by WDR5 antibody can be recognized by SUMO1 antibody, and proteins IP 
by SUMO1 antibody can be recognized by WDR5 antibody. In WDR5 antibody precipitated 
sample, a 50KDa band was detected by SUMO1 antibody, which is at the same molecular weight 
as that of the modified WDR5 in NIH 3T3 cells. To avoid the influence by IgG heavy chain, 
which is also at 50KDa, I used a rabbit WDR5 antibody (IgG) for IP and mouse SUMO1 
antibody (IgG) for western blot. The sample precipitated with SUMO1 antibody can also be 
detected by WDR5 antibody at 50KDa. Again to avoid the influence of IgG heavy chain, a 
mouse SUMO1 antibody (IgG) was used for IP and a mouse WDR5 antibody (IgM) was used in 
western blot. The IP experiment supported the hypothesis that WDR5 is being sumoylated. This 
finding is supported by Nayak et al.’s work demonstrating that WDR5 is sumoylated in an in 
vitro transcription/translation system (Nayak et al., 2014). I further tried to use mass 
spectrometry to confirm my finding and to determine which amino acid is sumoylated to better 
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study the function of sumoylated WDR5. I enriched the modified WDR5 using 
immunoprecipitation and ran the protein sample on a SDS-PAGE gel that was subsequently 
stained with coomassie blue. Unfortunately, the IgG heavy chain from the WDR5 antibody also 
showed up at 50KDa in the coomassie blue stained gel, thus I was not able to distinguish the 
modified WDR5 from IgG.  
Even though I could not conclusively determine which amino acid in WDR5 is 
sumoylated, I was able to show the importance of this modification from my studies. From the 
CHART experiment, only modified WDR5 (~50KDa) was observed in samples pulled down with 
mHotiarm1 specific probes, even when two WDR5 protein (modified and unmodified) bands were 
detected in NIH 3T3 cell lysates. In addition, when I used GST-fused MLL1 (amino acid 3810-
3963) to pull down protein samples from NIH 3T3 cell lysates, again only the modified WDR5 
band was observed in western blot assays. Immunocytochemistry showed that WDR5 proteins 
were present in both cytoplasm and nucleus of NIH 3T3 cells. I then analyzed the distribution of 
modified and unmodified WDR5 in NIH 3T3 cells. Results indicated that there is only modified 
WDR5 in the nucleus while both forms exist in the cytoplasm. This result further supported the 
importance of the modification of WDR5 and indicated that this modification may facilitate 
WDR5 translocation to the nucleus. Sumoylation have multiple functions for proteins and 
translocation of proteins to nucleus is one of its key functions (Kumar and Zhang, 2015), which 
further supports my findings. During the separation of cytoplasm and nucleus, only weak 
unmodified protein band of WDR5 could be observed in cytoplasm (Fig. 5.28, Fig. 5.29), which is 
possibly due to the dilution of sample during the separation. Because for the separation method I 
used, protein samples in the cytoplasm are much more diluted compared to nucleus samples and 
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may be the reason why I observed a lower concentration of the unmodified WDR5 in the 
cytoplasm.  
Treatment with ATRA (all-trans retinoic acid) also impacted sumoylated WDR5, 
appearing to increase the quantity of sumoylated WDR5 in the cell nucleus but not influence the 
total quantity of WDR5 protein in NIH 3T3 cells. These results indicate that ATRA is able to 
influence the distribution of modified WDR5 in NIH 3T3 cells and most likely facilitates its 
translocation to the nucleus. Together, all these findings suggested that sumoylated WDR5 with 
its interaction with mHotiarm1 plays an important role in impacting changes in H3K4me3 and 
H3K27me3 occupancy in epigenetic regulation of Hoxa1 and Hoxa2 genes.  
 In conclusion, my research has found that mHotairm1 is a new noncoding transcript in 
mouse that regulates the expression of Hoxa1 and Hoxa2 through the recruitment of 
MLL1/WDR5 to their chromatin. In NIH 3T3 cells, only sumoylated WDR5 is present in the 
nuclei and interacts with MLL1 and mHotairm1. Following treatment with ATRA, there is an 
increased sumoylated WDR5 in the nucleus, indicating this modified WDR5 plays a key role in 
ATRA induced expression of Hoxa1 and Hoxa2 (Fig. 6.2) 
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Figure 6.2. Schematic model of mHotairm1 regulation of Hoxa1 and Hoxa2 expression via 
MLL1/sumoylated WDR5 mediated histone-modification. Sumoylated WDR5 translocates to 
cell nuclei and binds to the MLL1 histone methytransferase complex and lncRNA Hotairm1 to 
induce H3K4me3 occupancy on both Hoxa1 and Hoxa2 gene promoters and enhance their 
expression. 
 
6.4 Future directions 
In my experiments, a direct regulation of Hoxa2 gene expression by the microRNA miR-
669b was demonstrated in NIH 3T3 cells. I have also demonstrated expression of miR-669b in 
the developing mouse palate using real-time PCR which has a complementary expression profile 
to Hoxa2 in the developing palate. However, it is not known whether miR-669b has direct role in 
regulating Hoxa2 expression in the developing palate. To study the function of miR-669b in 
mouse palate development, first an overexpression of miR-669b in mouse embryonic palate 
mesenchyme (MEPM) cell cultures generated from developing mouse palate would be needed. It 
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would be necessary to show whether Hoxa2 expression, at both transcriptional and translational 
level, is downregulated in the MEPM cell cultures after overexpression of miR-669b. 
To gain an overview of the spatial distribution profile of miR-669b and Hoxa2 in all four 
stages of developing mouse palate, an in situ hybridization histochemistry system would need to 
be undertaken. Locked nucleic acids miRNA probes would be used to achieve higher specificity 
for the detection of miRNA (Nielsen, 2012; McEwen et al., 2016). Mouse palatal organ culture 
has previously been developed in our lab (Smith et al., 2009) and I would use these to determine 
the role of miR-669b in mouse palatal development by overexpressing miR-669b in mouse 
palate organ cultures. It is already known that loss of Hoxa2 function in mice decreases palatal 
fusion rates and increases in cell proliferation rates (Smith et al., 2009). Whether overexpression 
of miR-669b influencing palatal growth and fusion would also need to be tested. 
Further investigation into the function of mHotairm1 is also required. To study the 
function of mHotairm1 in mouse palate development, an improved in situ hybridization 
histochemistry system with higher sensitivity is required so that the distribution of mHotairm1 in 
all four stages of developing mouse palate can be examined. It has been suggested that the 
sensitivity of traditional RNA in situ hybridization is too low to visualize lncRNAs in many 
cases (Raj et al., 2008). Recent years, approaches have been made to achieve single molecule 
RNA in situ hybridization, methods including the usage of multiple probes against one target 
RNA (Raj et al., 2008; Bayer et al., 2015), usage of chemically modified nucleic acids in probes 
to strengthen binding specificity (Li et al., 2013) and the amplification of fluorescent signals 
(Larsson et al., 2010; Shah et al., 2016). These technologies may help better visualize 
mHotairm1 expression in developing palate. 
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Downregulation of mHotairm1 would be achieved in mouse palatal fusion cultures using 
siRNAs and the impact of mHotairm1 on palate fusion and proliferation rates can then be 
examined. Also mHotairm1 knockout mice can be generated and the effect of mHotairm1 on 
mouse embryo development can be studied in detail. The consequence of loss-of-function of 
mHotairm1 on Hoxa1 and Hoxa2 gene expression as well as their downstream targets can be 
examined. The function of mHotairm1 can also be studied at the cellular level. LncRNAs 
transcribed from the Hox loci have been reported to be able to regulate cell cycle, cell 
differentiation and apoptosis (Liu et al., 2016; Lian et al., 2016; Bertani et al., 2011; Zhang et 
al., 2009). Downregulation of mHotairm1 can be achieved in different cell lines using siRNAs 
and the influence on cellular activities can be examined. 
In my study, the sumoylation of WDR5 was demonstrated by immunoprecipitation but 
the amino acid where sumoylation may occur has not been identified. Mass spectrometry would 
be used to determine the amino acid residue that is sumoylated and the key step in this method 
would be to enrich modified WDR5 protein samples. I previously used immunoprecipitation to 
accumulate modified WDR5 but unfortunately it was not of sufficient purity with contamination 
from the IgG heavy chain which also showed up at 50KDa position. In a future experimental 
design, GST fused MLL1 (amino acid 3810-3963) could be used to accumulate the modified 
WDR5 protein sample for mass spectrometry as my finding showed there is an interaction 
between MLL1 and modified WDR5. After identifying the site of sumoylation on WDR5, 
mutation can be introduced to the amino acid and the role of sumoylation can be examined more 
thoroughly. The mutated WDR5 can be tagged with GFP and transfected into NIH 3T3 cell lines 
or MEPM cells to examine the consequence of loss of sumoylation on WDR5, which may affect 
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the cellular distribution of WDR5, its interaction with lncRNA and MLL1, and the regulation of 
gene expression.  
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Appendix 1. DNA sequence chromatogram of Hoxa2 promoter CpG island 1 from E12 
mouse palate genomic DNA 
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Appendix 2. DNA sequence chromatogram of Hoxa2 promoter CpG island 1 from E13 
mouse palate genomic DNA 
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Appendix 3. DNA sequence chromatogram of Hoxa2 promoter CpG island 1 from E14 
mouse palate genomic DNA 
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Appendix 4. DNA sequence chromatogram of Hoxa2 promoter CpG island 1 from E15 
mouse palate genomic DNA 
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Appendix 5. DNA sequence chromatogram of Hoxa2 promoter CpG island 1 from NIH 3T3 
cell line genomic DNA 
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Appendix 6. DNA sequence chromatogram of Hoxa2 promoter CpG island 1 from EG7 cell 
line genomic DNA 
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Mush 147-F: TGACTTGGAGCACTGGGA	  
Mush147-R: CTCTTGCCAGTTCAGCTTTCT 
 
 
 
 
Mush 147 (17-163 bp) 
TGACTTGGAGCACTGGGACCAAAGGGAGTCGAGACTGCCTTCTGCGCGCGCCCG
GCTTTGCGCGCCTCCGCCACCAGATGTGGGGGGATGGGAGGCCCCCTCCGCGGCC
CCTTCCCCACCCAGCCCAGAAAGCTGAACTGGCAAGAG 
 
Appendix 7. DNA sequence chromatogram of cDNA fragments amplified with mHotairm1 
primer Mush 147 F+R 
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Mush138-F: CCCACCCAGCCCAGAAAG 
Mush138-R: GTTTCAAACATCTACGTTCC 
 
 
 
 
Mush 138 (131-268 bp) 
CCCCACCCAGCCCAGAAAGCTGAACTGGCAAGAGGTCTGTTTTTCCTGAACCCAT
CCACAGCTGGGAGATTAATCAACCACACTGAAAATGGGGGTGTGGGGGAGGGAA
AGGAAGAGTTGGAACGTAGATGTTTGAAAC 
   
Appendix 8. DNA sequence chromatogram of cDNA fragments amplified with mHotairm1 
primer Mush 138 F+R 
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  Mush245-F: GAAAGGAAGAGTTGGAACGTAGA 
  Mush245-R: TGAGACTCAGGCCATAGAGTTA 
 
 
 
Mush 245 (236-478 bp) 
GAAAGGAAGAGTTGGAACGTAGATGTTTGAAACAAATGTGTATAAATAAATGAATT
TTTGATAACTCCGTTATTGACCTAGAAACTAGCAGCTTGGTAAGGGAACTCCATTCC
ACTCCACTCGTCCTAGAACTGGAAGTTTTTGTAGGCACTTTTCCTCTCCACACTCAAA
AGCTTGGGCTAGGGCCAACTCAGGCTGCCCAAGCCCATTTCTATTACTAATGTAACT
CTATGGCCTGAGTCT 
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Appendix 9. DNA sequence chromatogram of cDNA fragments amplified with mHotairm1 
primer Mush 245 F+R 
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MLL1 (amino acid 3810-3963)
 
 
 
 
 
Appendix 10. DNA sequence chromatogram of MLL1 (amino acid 3810-3963) cloning. 
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WDR5 (1-640 nt) 
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WDR5 (495-1005 nt) 
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Appendix 11. DNA sequence chromatogram of full length WDR5 cloning. 
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Appendix 12. mHotairm1 can only be amplified from cDNA samples using much138 F+R 
primers. cDNA samples were reverse transcribed from total RNA samples collected from E13 
mouse palate. Genomic DNA (gDNA) samples were also collected from E13 mouse palate. 
mHotairm1 specific primer much138 F+R were used in PCR. A 138bp DNA fragment can only 
be amplified from cDNA samples but not from genomic DNA. 
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